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Surgical treatment for severe functional MR often involves mitral annuloplasty to improve leaflet 
apposition and ultimately downsize the dilated mitral valve. However, the high rate of operative 
mortalities of up to 6 ~12% have limited the more expanded use of this procedure. Recently, minimally 
invasive percutaneous transvenous mitral annuloplasty (PTMA) approaches using entirely catheter-based 
methods have been developed to reduce procedural morbidity and mortality. One of the approaches is to 
utilize the proximal location of the coronary sinus (CS) to the mitral annulus (MA) to percutaneously 
deploy a PTMA device within CS vessel. When the device contracts, it indirectly reshapes the MA and 
decreases MR. Although the approach has been shown to be promising in several animal studies, device 
dysfunction and fatigue fracture have been reported in human clinical trials. In this research, integrated 
experimental and computational studies were performed to apply quantitative analysis to study the 
biomechanical tissue-stent interaction (TSI) between PTMA device and CS vessel. Both human and 
animal CS tissue properties were characterized experimentally and implemented into finite element (FE) 
simulation.  Realistic patient-specific geometries of the CS vessel were obtained from clinical imaging 
data and reconstructed into three-dimensional (3D) FE model. By incorporating proper tissue material 
properties and realistic 3D patient-specific geometries, FE simulation of the device deployment into the 
vessel could be achieved to investigate TSI and the associated biomechanics involved in the system.  
Quantitative understanding of the biomechanics in PTMA intervention is clearly an enabling step for 
science-based design of the devices. 
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1 Introduction* 
Cardiovascular disease remains to be the number one killer in the United States. Among various 
types of cardiovascular disease, valvular heart disease is a significant cause of morbidity and mortality. In 
the United States, it is estimated that approximately 85,000 heart valve related procedures are performed 
annually. Valvular heart disease is responsible for about 22,144 deaths per year [1]. The two most 
common valvular heart diseases are aortic stenosis and mitral valve regurgitation. Structurally, mitral 
valve is more complex than aortic valve, which result in under-treatment and consequently high rate of 
mortality. In this dissertation, my research effort primarily focuses on the study of mitral valve function 
and the modeling of the associated mitral valve intervention techniques. Thus, I will begin this chapter 
with a brief introduction of the heart and its four valves, then the normal mitral valve structure and 
function, followed by main clinical issues and current clinical treatment techniques for mitral valve 
disease. Then, I will give a brief overview of current mitral valve biomechanical studies, which will lead 
to the motivation of my research on the modeling of minimally invasive mitral valve repair. 
  
                                                     
* Some of the contents of this chapter are taken from:   
W. Sun, C, Martin and T Pham, "Computational Modeling of Heart Valve Function and Intervention ", Annual Review of 
Biomedical Engineering,  accepted.  
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 The heart and heart valves  1.1
The heart has four major valves: the aortic, mitral, tricuspid and pulmonary valves. As illustrated 
in in Figure 1-1, the tricuspid valve is located between the right atrium and right ventricle. The pulmonary 
or pulmonic valve is between the right ventricle and the pulmonary artery.  The mitral valve is between 
the left atrium and left ventricle. The aortic valve is between the left ventricle and the aorta. These valves 
share a common function which is to ensure unidirectional flow of blood in and out of the heart. 
Biomechanically, these four valves are primarily passive structures i.e., they open and close due to the 
differential blood pressure on each side of the valve leaflets. Closure of the valve is achieved by 
coaptation of the leaflets (or cusps). Proper coaptation of the leaflets prevents backflow of blood. 
Diseases of the valve often involve improper closure of the leaflets; and the two most common heart 
valve diseases are stenosis and regurgitation. Stenosis is narrowing of the valve orifice which results in 
constriction of the blood flow. Regurgitation, on the other hand, is dilation of the valve orifice which 
results in blood leaks back through the valve in the opposite direction. Other valvular diseases are 
rheumatic diseases which results in valve leaflet prolapse, or billowing of the leaflets, and sometimes 
cause regurgitation. The mitral and aortic valves are frequently affected by diseases because they are 
located on the left side of the heart, where hemodynamic conditions are highly dynamics and deemed to 
frequent alternations. The study in this dissertation will mainly focus on the mitral valve function and the 
modeling of the associated mitral valve intervention techniques. 
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Figure 1-1: Anatomical structure of the heart and the heart valves (adopted from www.webmed.com)  
 
 Mitral valve structure and function  1.2
The mitral valve (MV) is a complex yet elegantly structured cardiac valve that consists of four 
anatomic components working congruently during a cardiac cycle: an annulus, two leaflets, 
approximately 25 chordae tendineae, two papillary muscles, and the underlying left ventricular 
myocardium (Figure 1-2).  The mitral annulus (MA) of MV serves as a fulcrum for the leaflets. It is 
subdivided into lateral (anterior) and septal (posterior) portions that separated by the two trigones [2]. A 
lateral portion is mainly composed of cardiac muscles, while a stiff and dense fibrous section runs along 
the septal section. This fibrous tissue is shared by the non-coronary aortic valve leaflet, often called 
aortic-mitral curtain, where its left and right are formed by denser fibrous interleaflet triangles or trigones. 
This region is less prone to dilation compared to the muscular septal portion, which often undergo mitral 
repair by resecting extra tissues.  
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Figure 1-2: The anatomy of human mitral valve within a) the left heart and b) dissected from 
explanted heart showing mitral annulus, mitral leaflets, chords and papillary muscles. (Fig. a) 
is adapted from http://www.heart-valve-surgery.com. 
 
The MV has two leaflets, the larger anterior (AML) and the smaller posterior mitral leaflet (PML) 
that are connected by the anterior and posterior commissural leaflet portions (Fig. 1-2b). The two leaflets 
detach during diastole and coapt or meet during systole to prevent regurgitation. Both AML and PML 
have two zones, the smooth that runs radial from the annulus to mid belly section and the rough zones 
that ends at the leaflet free-edge, where rough zone corresponds to the insertion (bumpy) locations of 
chordae tendineae. Histology of the microstructure of the MV leaflet revealed that it is composed of the 
atrialias, spongiosa, fibrosa and ventricularis layers. Similar to aortic and other valve leaflet constituents, 
the main components of MV layers include the extracellular cells, interstitial fibroblasts and connective 
fibers. The atrialis comprises of a thin layer of endothelium and elastin/collagen fibers. The spongiosa 
layer is mainly consists of extracellular matrix inconsisting of proteoglycans (PGs) and glyosaminglycans 
(GAGs). The GAGs and PGs provide cushion to withstand compressive tension [3] and promote sliding 
of collagen bundles [4], particularly proteoglycans which bind to the surface of collagen fibrils to transfer 
load from fibril to the matrix to relieve the fibril stress [5]. The fibrosa is the thickest layer of the MV 
leaflet and is the main load-bearing layer, consisting of GAGs/PGs and abundant circumferential aligned 
collagen fibers from where the leaflets exhibiting its strength and stiffness under high systolic pressure 
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loading. The stiffness of collagen fibrils of porcine AML was estimated to be 95.5 ± 25.5 MPa from 
biaxial loading tension of > 20 N/m [6], compared to ~ 1 GPa stiffness of collagen strength found in 
normal tendon.  The ventricularis layer has elastin and collagen fibers with endothelial cell lining, where 
the chordae tendineae (chords) are attached to. The structure and material properties at these attachment 
regions were found to vary greatly due to the regional variations of collagen fiber angle and degree of 
alignment that affect the stress distribution of the entire mitral valve leaflets [7].  The fibrous chords are 
mainly composed of collagen bundles, which grant chord its stiffness and minimal extension that 
restraining the leaflets from pillowing into the left atrium (LA) during systole. There are three types of 
chords which are named in many ways, they are preferred as basal, marginal and strut chords herein. The 
basal chords originate from the base of the leaflets and marginal chords from free-edge zone. While both 
basal and marginal chords are multiple and vary in size, there are only two strut chords that attach at mid-
length of the ventricular surface of the AML. The chords can originate either from the two major papillary 
muscles (on the anterolateral and posterolateral walls) or multiple small musclebundles attaching to the 
ventricular wall. Normal MV function involves a proper force balance between each of its components 
working congruently during a cardiac cycle. 
 Hemodynamics of the MV is highly complex that involves changes in pressure, and spatial and 
temporal orientation of all components. Mitral valve opens during the diastolic filling cycle where the 
annulus and leaflets are in resting and passive state. At late diastole, after left atrial systole, the pressure in 
the LV begins to rise above the pressure of the left atrium, causing the mitral valve to begin closing. As 
the pressure in the left ventricle rises rapidly during systole, the two leaflets begin to coapt. The mitral 
valve leaflets experience large deformation during valve closure [8] that could bulge toward the left 
atrium. However, bulging of the mitral valve leaflet is prevented by the tension of the chordae tendineae. 
It has been shown that rupture of the chordae tendineae leads to malcoaptation of leaflets and 
consequently valve regurgitation [9].  Contraction and motion of active muscles in the left atrial [10], 
mitral annulus [11] and papillary muscles [12, 13] are also important for valve closure during systole. 
Therefore, a balance of the mitral valve apparatus during systole enables proper leaflet closing. 
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 Main clinical issues and current clinical treatment techniques for mitral 1.3
valve disease  
Heart valve disease is a significant cause of morbidity and mortality. In the United States, it is 
estimated that approximately 85,000 valve related procedures are performed annually. Heart valve disease 
is responsible for about 22,144 deaths per year [1]. In the past two decades, major advances have been 
made towards our understanding of the natural history of valvular heart disease.  These advances have 
resulted in enhanced diagnostics, as well as interventional cardiology and surgical procedures, and have 
increased patient survival. However, valve procedures still have an overall in-hospital mortality rate of 
4.22%, a figure that is much higher than that for many other cardiac procedures, including: coronary 
bypass graft surgery, percutaneous coronary intervention, and defibrillator implantation. 
The two most common presentations of valve disease are aortic stenosis and mitral valve 
regurgitation. Mitral regurgitation (MR) is an abnormal leakage of blood from the left ventricle (LV) back 
into the left atrium during systole (Figure 1-3). Pathological alterations affecting any mitral valve 
component, such as mitral annulus (MA) dilatation, papillary muscle displacement, leaflet calcification 
and myxomatous disease can lead to altered mitral valve function and cause MR [14].  
 
Figure 1-3: (a) a normal mitral valve function during systole and b) mitral valve with MR -  an abnormal 
leakage of blood from the leftventricle back into the left atrium during systole. (adopted from 
http://uvahealth.com) 
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MR is one of the most common valvular lesions with a prevalence of 1 to 2% among adults [15], 
and this prevalence rises up to 13.2% beyond the age of 75 [16]. Moderate to severe MR occurs in up to 
19% of patients after myocardial infarction and in 15% of patients with dilated cardiomyopathy [17, 18]. 
In these patients with functional MR, a combination of changes in left ventricular and mitral annulus (MA) 
geometry/function induces leaflet malcoaptation and regurgitation. Functional MR represents a major 
clinical challenge, often poorly recognized and undertreated, and is associated with high mortality [19].  
Standard treatment techniques for MR are MV repair or replacement. The MV repair, benefited 
from improved understanding of MV mechanics and function, is now a preferable surgical approach to 
valve replacement. Common MV repair techniques include triangular or quadrangular resection, slide 
annuloplasty, ring annuloplasty, chordal cutting and transposition [20], artificial chord use [21, 22] and, 
recently, percutaneous technologies[23]. Surgical annuloplasty has been a commonly used treatment 
technique for severe functional MR intending to improve leaflet apposition by posterior annular 
correction. However, the reported operative mortalities of up to 6 ~12% have limited the more expanded 
use of this procedure [24-27].  
 Current biomechanical analysis of mitral valve function and intervention 1.4
The MV’s primary function is essentially mechanical - preventing backflow of blood back to the 
left atrium during systole. Thus, biomechanics plays a central role in its function. Biomechanical analysis, 
encompassing experimental characterization of tissue properties, constitutive modeling of experimental 
data and computational simulations of tissue behavior, is playing an increasingly important role in 
enhancing our understanding of the normal MV physiological function, etiology of MV diseased states, 
surgical and interventional planning, and in the design and evaluation of artificial MV implants. In this 
section, I will give a brief review of methods of testing methods, modeling and computational simulation 
techniques. 
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1.4.1 Review of the state of the art of the biaxial testing method 
Testing methods to characterize MV tissue properties usually include uniaxial and biaxial studies 
of material properties of MV, and pressure-inflation tests of structural properties of MV. As shown the 
following chapters, I have been using the biaxial testing method extensively to obtain MV tissues 
mechanical properties, thus its testing setup and theories behind the data analysis are briefly summarized 
here.   
Illustrated on Figure 1-4 is a typical setup of a biaxial testing device. Biaxial experiments are 
generally performed a square piece of planar soft tissue, with the sample of about 10-25 mm of lateral 
length. The specimen is mounted to the biaxial device in trampoline-like fashion using thin threads, which 
allows the edges to expand freely in the lateral direction.  Testing is generally performed with the 
specimen completely immersed in phosphate buffered normal saline (pH 7.4) at room or body (37 C) 
temperature. The central target region must be sufficiently small and located away from the outer edges to 
avoid the tethering effects.  Thus, in the central target region the stress and strain field is generally 
considered homogeneous. 
 
Figure 1-4: a) The biaxial testing system with an actual testing setup, showing the camera, the 
two load cells, the two signal conditioners and the four motors; b) A representative specimen is 
submerged in an appropriate physiologic solution, marked with four black graphite particles 
(optical markers for strain measurement) and attached to the device via four hooks at each side.   
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 The following is a brief summary of the most important aspects of the kinematics of a biaxial 
mechanical test [28].  Consider deformation of membrane tissues under a biaxial stress state, including 
non-zero in-plane shear stresses.  For this case, let 0  and   be the (fixed) reference and deformed 
configurations of the continuous body, respectively.  Consider the general mapping 30:   R , which 
transforms a material point 0X  to a position ( )  x X  in the deformed configuration. For 
planar homogeneous deformations that occur during a biaxial test, this mapping reduces to 
    1 1 1 1 2 2 2 2 2 1 3 3 3x X X , x X X , x X    (1.1) 
where i are the axial stretch ratios and i measures of in-plane shear. i and i are also components of the 
deformation gradient tensor F, which for deformation described in eqn. 1.1 is  Grad( )F x or 
1 1 1
1 2 3
1 1
2 2 2
2 2
1 2 3
3
3 3 3
1 2 3
x x x
X X X
0
x x x 0
X X X
0 0
x x x
X X X
                                   
F     (1.2) 
where the out-of-plane stretch 3 h/H   is the ratio of deformed (h) to the undeformed  thickness (H) of 
specimen. F is a critical mathematical quantity since it completely describes the deformation state.  Since 
soft tissues are composed primarily of water and have negligible permeability [29], they can be 
considered incompressible so that J=detF=1.  From F the right Cauchy-Green deformation tensor is 
defined as C=FTF, from which the components of the in-plane Green-Lagrange strain tensor E = ½ (C – 
I), where I is the identity tensor.  E is the most common finite strain measure in the soft tissue literature 
due to the simplicity of the constitutive formulations. In practice the components of E are computed more 
directly using: 
      10 
2 2
1 2 1 1 2 2
T 2 2
1 1 2 2 2 1
2
3
k 1 k k 0
1 1( 1) k k k 1 0
2 2
0 0 1
E F F
                   
    (1.3) 
The components of F are determined optically to avoid any mechanical interference with the specimen.   
 As mentioned above, biaxial testing of biological tissues is performed using thin specimens (no 
more than ~3 mm, usually <1 mm) and acted on by only in-plane loads.  A state of plane stress is thus 
assumed so that the components ti3 (i=1,2,3) of the Cauchy stress t (force/deformed area) are 0.  During 
actual experiments one can directly measure only the initial specimen dimensions, so that the Lagrangian 
stresses T (force/unit original cross-sectional area) are used for convenience.  The components of T are 
computed from the measured axial forces P using 
1 2
11 22
2 1
P PT , T
hL hL
     (1.4) 
where h is the specimen thickness and Li are the specimen lengths. Since experimentally applied loads are 
normal to the edges, T12=T21=0.  The 2nd Piola-Kirchhoff stress tensor S is the most commonly utilized 
stress tensor for soft tissue constitutive theories, and is determined using S=TF-1. The Cauchy stress 
tensor t is determined using t=FT/J, which in component form is given by (with T12=T21=0): 
11 1 11 22 2 22 12 1 22 21 2 11t T , t T , t T , t T       (1.5) 
In the case where there is negligible shear strain (i.e. E12~0), the normal components of the two stress 
tensors are related by: 
S11 = T11/1, S22 = T22/2     (1.6) 
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1.4.2 Review of constitutive models of heart valve mechanical properties 
 Linear elastic models.  Early attempts to describe valve tissue properties relied on the linear 
elastic material model, following the generalized Hooke’s law [30, 31] 
    ࣌࢏࢐ ൌ ࡯࢏࢐࢑࢒ࣕ࢑࢒ ,      (1.7) 
where ોܑܒis the stress tensor,	૓ܓܔ is the strain tensor and ۱ܑܒܓܔ is the fourth order elasticity tensor. Linear 
elastic models are appropriate when the stress-strain relationship is indeed linear, and are typically 
restricted to relatively small deformations. Linear elastic material properties were chosen for various 
reasons [32-34], but mainly to simplify the simulation process in order to achieve numerical convergence 
in FE simulation solutions. Over the physiological range of pressures, valve tissues have been shown to 
exhibit a relatively linear stress-strain relationship [35]. However, for a FE simulation of valve 
deformation from the undeformed state to a deformed state, the valve material response is clearly 
nonlinear and the use of nonlinear material models is essential for any realistic valve simulations.  
 Fung-elastic model The Green-strain based exponential model proposed by Fung [29] is 
probably the most commonly used hyperelastic model for characterizing the mechanical response of soft 
tissues [29, 36]. A two-dimensional Fung-type strain energy function W can be expressed as: 
ܹ ൌ ௖ଶ ሾ݁ொ െ 1ሿ,                                                      (1.8) 
      ܳ ൌ ܣଵܧଵଵଶ ൅ ܣଶܧଶଶଶ ൅ 2ܣଷܧଵଵܧଶଶ ൅ ܣସܧଵଶଶ ൅ 2ܣହܧଵଵܧଶଶ ൅ 2ܣ଺ܧଶଶܧଵଶ           
where c and Ai are material constants, E is the Green strain tensor.  Note that Eqn. (1.8) has other variants  
that could be easily treated as a subset or expansion of this model [37]. Eqn. (1.8) is often used to model 
planar biaxial mechanical responses of valve tissues [38] and should be implemented with plane stress 
elements, such as shell or membrane elements.  One problem with Eqn. (1.8) is that the transverse shear 
stiffness in the 13 and 23 directions are undetermined due to the lack transmural response definitions in 
this model. As shown by Sun et al. [37], valve peak stress is insensitive to change of TSS values for the 
valve closure simulation. However, to simulate valve opening, the tissue bending response is critical, and 
without accurate transverse shear stiffness values, the use of Eqn. (1.8) may give inaccurate results.  The 
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details on the FE implementation of Eqn. (1.8) can be found in  Sun and Sacks [37]. The 3D Fung model 
has not been widely used to model valve functions. Labrosse et al. [39, 40] has successfully utilized a 3D 
Fung model in simulation of native AV deformation. 
 Strain invariant-based fiber-reinforced hyperelastic model.  Weiss et al. [41] and Holzapfel 
[42] presented a computational framework to implement strain invariant-based models that can 
accommodate the effects of one or two families of elastic fibers.  To use this class of models, typically, 
the valve tissues are assumed to be composed of a matrix material with two families of imbedded fibers, 
each of which with a preferred direction. The deviatoric strain invariant Iଵഥ  is used to describe the matrix 
material; and I4iഥ  is used to describe the properties of the fiber families. One example of such models 
proposed by Holzapfel et al. [42]  can be expressed as  
 W=C10൫I1ഥ-3൯+ k12k2 ∑ ቂexp ቄk2ൣκI1ഥ+൫1-3κ൯I4iഥ -1൧
2ቅ -1ቃ2i=1 + 1D ൫J-1൯
2
 , i=1,2  (1.9) 
where, C10, k1, k2 and D are material constants. Particularly, C10 describes the matrix material and D 
enforces near incompressibility. In addition, a dispersion parameter, κ, is used to describe the distribution 
of the fiber orientation. Local coordinate systems should be defined for each leaflet to include fiber 
orientations. There are several variations of the model that have been applied to heart valve simulations. 
Prot et al. [43] implemented the Holzapfel material model into the analysis of healthy and pathological 
human mitral valves. Wang et al. [44, 45] simulated AV and MV functions with a variation of the 
material model.  Similarly, in the study by Stevanella et al. [46], the MV dynamics were simulated where 
leaflet properties were characterized through a transversely isotropic model proposed by May-Newman 
and Yin [47], while the same material model was used by Conti et al. [48] and Auricchio et al. [49] to 
simulate AV biomechanics. 
1.4.3 Review of computational studies of MV function and intervention 
Kunzelman and co-workers were among the pioneers in developing 3D FE models of the normal 
[31] and pathologically altered [50, 51] MV. Their MV model, albeit limited by symmetric geometry 
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based on the excised porcine MV, included all the essential components of a MV. The model has been 
used extensively to analyze various MV repair procedures  [50, 52, 53].  Although various designs of 
annuloplasty rings including: undersized, rigid, semi-rigid, flexible, D-shape and dog bone shaped, are 
commercially produced, the optimal shape is uncertain.  Kunzelman et al. developed static FE models of 
the normal and dilated MV to simulate the effects of flexible and rigid annuloplasty rings [50]. 
Subsequently, Maisano et al. [54] and Votta et al. [34] showed that dog bone-shaped annuloplasty with 
selective reduction in the septolateral dimension is more effective than a conventional prosthesis for 
treating leaflet tethering in functional MR. These studies however excluded or simplified the LV 
geometry. Wong et al. [55] reconstructed a 3D FE model incorporating the LV, annulus and chordae 
tendineae from 3D cardiac MRI images of sheep. They successfully simulated the MR scenario and 
observed that the stress reduction with the saddle-shape MA was slightly greater than that of the 
asymmetric rings. More recently, research groups have begun to construct in vivo patient-specific MV 
models using clinical Echo [56, 57] and MRI [46, 58]. For instance, 3D Echo images were used by Xu et 
al. [56] to reconstruct MV models to predict leaflet and chordal stresses.  MV geometries were perturbed 
to examine how MV leaflet coaptation area, non-coapted leaflet area and inter-leaflet coefficient of 
friction, affect leaflet and chordal stress distribution. Their results indicated that mitral valve repair 
techniques that increase or preserve noncoapted leaflet area might decrease stresses and thereby enhance 
repair durability. Similarly, Stevanella et al. [46] utilized cardiac MRI to develop patient-specific MV 
models of one healthy subject and one patient with ischemic MR. Their diseased model captured actual 
regurgitant characteristics and revealed abnormal tensions in the annular region and subvalvular 
apparatus.  
One of the inaccuracies in MV modeling is the bulging of anterior leaflet into the atrium, which 
could be due to incorrect assumptions about chordal length, chordal origins and insertion points at the 
mitral leaflets. Such structure details are not distinguishable in the current clinical MRI or TEE images 
due to their poor spatial resolution. Multi-slice CT images offer much better spatial resolution, e.g., 64-
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slice CT of 0.625mm. CT images were used to reconstruct patient-specific MV models in the study by 
Wang and Sun [45].  In the study, the MV models incorporated not only the mitral leaflet thickness, but 
the papillary muscle locations, chordal origins, and chordal insertion points, as shown in Figure 1-5. 
Dynamic motions of the mitral annulus and papillary muscles were obtained from middle systole and 
middle diastole; and were prescribed as boundary conditions for the FE simulation. Simulation results 
were validated by comparing FE deformed MV geometries with the CT images at systole and a close 
match was obtained (Figure 1-5c) [45]. Significant bulging of the mitral leaflets was not observed at peak 
transmitral pressure [45].  As there is evidence of muscle fibers and innervation in mitral leaflets [59], 
Skallerud et al. [60]  applied a simple active stress component into modeling the porcine mitral valve, 
which resulted in a significant reduction in the leaflet bulging.  
Percutaneous catheter-based Edge-To-Edge (ETE) repair using MitralClip has grown rapidly in 
Europe during the past years.  Over 10,000 MitraClips have been implanted worldwide to date [61]. MV 
mechanics under ETE repair conditions are thus of great interest. Using idealized geometries of the MV 
and LV, Radealli et al. [62] and Fiore et al. [63] were able to provide a good estimation of the pressure 
drop across the ETE repaired valve and assess the leaflet stress pattern from the 8-mm ETE suture [64]. 
Consistent with clinical observations, FE simulations confirmed that using an annuloplasty ring in 
conjunction with ETE is favorable if mitral annular dilation is present, because it could reduce leaflet 
stresses [65, 66]. Dal Pan et al. [67] employed a parametric study of the ETE technique to investigate 
stress and strain distributions on leaflets at various suture positions and extension lengths as well as 
dilated annulus dimensions. The study provides useful analyses for technique improvement and 
optimization.  
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Figure 1-5: (A) The CT long-axis two chamber view of a close mitral valve (MV) showing a good 
visualization of chords and papillary muscles (PMs); (B) the short-axis and long-axis views of the 
reconstructed finite element (FE) MV model overlapped with the CT images; (C) the overlapping of 
geometries of the close MV valve from the CT scans (green) and the simulated result (red) after applied a 
pressure demonstrates a good match; open MV valve geometry and the anatomical locations of chordae 
tendineae with chordal origins and papillary muscles are shown in the (D) long-axis & (E) short-axis 
views.  
There are relatively few FSI studies on MV structural and hemodynamic function. Kunzelman et 
al. [68] developed a fully-coupled FSI model using the LS-DYNA (Livermore Software Technology 
Corporation, Livermore, CA). The model was substantially enhanced from their previous models [31] by 
incorporating a fiber-reinforced hyperelastic material model for the leaflets, non-uniform leaflet 
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thickness, branched chords and fluid flow. The simulation results agreed well with physiological data 
reported in the literature. By varying the parameters of the fiber model, the authors also investigated 
effects of pathological changes. More recently, Ma et al. [69] developed a FSI MV model using the 
immerse boundary method. The model was generated from MRI data of a healthy patient. Linear elastic 
material models were used for both leaflets and chords. From the simulation results, the authors 
concluded that the differences in the thicknesses of the leaflets play an important role in maintaining the 
physiological curvature of the MV leaflet during its dynamic motion. Neither Kunzelman et al. [68] nor 
Ma et al. [69] incorporated the left atrium and LV into their models. Dahl et al. [70], however, reported a 
FSI study on the MV behavior during LV filing with the realistic left atrium and left ventricle obtained 
from echocardiography. Although limited by performing a 2D simulation with prescribed rigid wall 
motions (thus, not a coupled FSI), their results underscored the importance of incorporating the 
asymmetric leaflet geometry and left atrium to obtain accurate MV flow fields.  
 Emerging percutaneous mitral valve repair methods  1.5
A number of new approaches to percutaneous treatment are now developing rapidly.  
Percutaneous edge-to-edge mitral valve repair using the MitraClip ® system is the only endovascular 
approach that demonstrates as a viable treatment option for severe MR patients when compared with 
standard surgical repair in a randomized trial. Over 10,000 MitraClips have been implanted worldwide to 
date [61]. However, a considerable number of patients with functional MR will present with extensive 
annulus dilatation and minimal vertical leaflet coaptation that potentially preclude them from this 
beneficial technology for anatomical reasons [71].  
Recently, since 2006, there have been several new minimally invasive transcatheter devices to 
treat MR utilizing the coronary sinus (CS), because of the advantage of proximity of the CS location to 
the MA, as a conduit to deliver a device that partially encircles the mitral annulus. Illustrated in Figure 
1-6 is one of PTMA devices. This PTMA device is consisted of a 12F-outer-diameter guide catheter and 
dilator, a 9F delivery catheter, and a nickel-titanium alloy (Nitinol) implant. The implant itself is 
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composed of three sections: a distal self-expanding anchor, a springlike “bridge,” and a proximal self-
expanding anchor. The proximal and distal self-expanding anchors, once embedded within the coronary 
sinus (CS), will expand and position at the CS ostium and the great cardiac vein (GCV) ends, 
respectively. The bridge element can be shortened. Hence, it will pull the proximal and distal anchors 
together, displacing the posterior annulus anteriorly and reducing the mitral annulus diameter in the 
septal-lateral distance. 
 
Figure 1-6:  Illustration of a PTMA device deployed into the CS vessel, which is adjacent to the mitral 
valve posterior annulus. “Ant.” for the anterior mitral leaflet and “Post.” for the posterior mitral leaflet. 
Several animal and human clinical trials using various PTMA devices have recently been 
conducted [27, 72, 73]. Although early clinical efficacy was demonstrated, device dysfunction and fatigue 
fracture were reported in these studies. The first-in-human clinical trial of the PTMA Monarc device, by 
Edwards Lifesciences as showed in Figure 1-6, in five patients was conducted by Webb et al. [72] in 
2006. In this study, device fracture at the bridge section was reported in three patients and severe MR 
grade recurrence was observed after bridge separation. In addition, although no severe injury of CS was 
detected, compression of surrounding artery (i.e., left circumflex artery) was reported [72-76]. Because 
      18 
the PTMA device is directly in contact with the CS, the biomechanical interaction between the device and 
the tissue could be a critical factor for device ending results. 
For three percutaneous devices reported in 2006 and 2007, the results were all suboptimal. The 
CARILLON device (Cardiac Dimensions, Kirkland, Washington), which consists of distal and proximal 
anchors (Nitinol and titanium) and joined by a Nitinol ribbon connector, could reduce the dilated annulus 
by manually pulling the proximal anchor toward the CS ostium. Duffy et al. [73] observed that the distal 
anchor of a Carillon PTMA device did not hold tension during device traction in two of five temporarily 
implanted patients. Due to the difficulty in anchoring to the CS wall, a second generation device was 
developed with a twist at the distal anchor. The device was implanted in humans for up 6 months of 
follow-up [77]. A total of 30 out of 40 patients successfully received the device with an average of 23% 
MR reduction. However, three patients suffered from CS perforation and dissection.  
Another device, Viacor (Viacor, Wilmington, Massachusetts), consists of up to three rigid Nitinol 
rods. Various rod sizes and stiffness are used to achieve the desired MR reduction. The issues with this 
device were associated with fracture, migration and delivery failures due to the vast difference in CS 
structures and geometries [27, 78]. Dubreuil et al. [79] reported temporary placements of a Viacor PTMA 
device in patients with an ischemic MR and MA dilation. They found that the MA diameter after the 
device implantation remained large compared to the surgical annuloplasty results. 
Following the study by Webb et al. [72], A more recent study in 2010 on the second generation 
Monarc PTMA device reported a reduction in MR by ≥ 1 grade at 12 months in 50% of 22 implanted 
patients [80]. Unsuccessful implantations were associated with the lack of appropriately-sized devices (n 
= 13), inaccurate device positioning resulting in no MR reduction (n = 4), device migration (n = 1) and 
fracture of the proximal anchor (n = 4).  
Currently only one device (Carillon, Cardiac Dimensions, LLC) remained in clinical trials. 
Despite the early failure and challenges encountered in these indirect approach techniques, the CS route 
remains highly attractive due to its simplicity. Thus, evaluation and knowledge of the CS structure and 
anatomy both before and during the implant procedure is critical.   
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Another minimally invasive mitral valve technique, called direct annuloplasty approach, involves 
direct implantation of a minimally invasive device into the mitral annulus, which is more similar to the 
surgical annuloplasty ring. So far two companies Mitralign and Guided Delivery Systems have developed 
devices using a direct approach. Although the direct approach has an advantage of avoiding coronary 
compression, it is more challenging than the indirect approach where the mitral annulus is assessing 
directly. Percutaneous mitral repair and replacement techniques are still in early development phase, and 
much more experimental and clinical trials are anticipated.  
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 Motivation of the dissertation  1.6
Percutaneous transvenous mitral annuloplasty technique is still at its infant stage. The underlying 
biomechanical interaction between venous and mitral tissue and PTMA device is largely unknown. 
Device fatigue failure, as reported by Webb et al. [72], reflects the pressing need for a clear understanding 
of the biomechanical environments that the devices experienced.  Unfortunately, up to today, there is no 
comprehensive study on the biomechanics of PTMA procedure in the literature.  
Quantification of the mechanical properties of the CS vessel is critical for estimating the tissue-
implant biomechanical interaction and for understanding device failure mechanisms. Although the 
anatomical studies of the CS have been well reported [81-83], there is a dearth of study on the mechanical 
properties of the tissue.  One of objectives of this dissertation research is to quantify the CS structural 
(Chapter 2) and material (Chapter 3) properties and compare them among different species, i.e., porcine, 
ovine and human, to elucidate the biomechanical difference between these species, which may explain the 
discrepancy between animal and human clinical trials.  To evaluate the cinching effect, via the contractive 
force of a PTMA device applied to the CS, on the change of mitral annulus area and the amount of MR, 
an ex vivo whole heart experiment study (Chapter 4) is needed. Building upon the experimental data, a 
computational analysis can be performed to quantify the stresses and strains that are on the CS tissue and 
PTMA stents. PTMA device deployment process requires two essential steps, 1) development of the 
anchoring stent, and 2) device contraction to reduce MR. Thus, the PTMA stent fatigue study should be 
conducted at the anchoring stents (Chapter 5) and the whole device with the bridge (Chapter 6).  
The overall goal of this dissertation is to investigate the biomechanics involved in the 
transcatheter repair of functional MR using the coronary sinus annuloplasty approach. Using a combined 
innovative experimental and computational approach, the biomechanics of PTMA can be effectively 
investigated. The objectives of this dissertation are: 
 Establish quantitative dataset for tissue structural and material properties and geometries 
related to the PTMA intervention.  
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 Provide engineering analysis of stress and deformation of mitral tissues undergoing PTMA 
intervention using computational methods. 
 Predict PTMA device failure modes and provide insights for implant design improvement 
Successful completion of the proposed work will establish a computational simulation procedure, 
not only applicable to Monarc PTMA, also to other future devices using the indirect coronary sinus 
approach. The procedure includes collection of experimental data and constitutive modeling techniques to 
characterize the mechanical properties of mitral tissue, and finite element modeling of mitral valve 
geometry (based on clinical cardiac images), which will enable the simulation of PTMA device 
deployment and device-tissue interactions, and prediction of PTMA failure modes. Such biomechanical 
simulations will allow one to virtually assess and predict results of PTMA intervention, which is 
unprecedented in academia and the heart valve industry.   
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2 Characterization of Structural Properties of Porcine 
Coronary Sinus Vessel* 
In the next two chapters, the three experimental studies used to characterize the biomechanical 
properties of the coronary sinus vessel will be introduced. The experimental characterization of tissue 
biomechanical properties  is challenging and important that provides information necessary to formulate 
constitutive relations as well as solving many boundary condition and initial value problems in 
biomechancs. The most common experimental methods for quantifying mechanical properties of soft 
tissues include tensile uniaxial test, planar biaxial test and inflation tests. Because the coronary sinus 
vessel serves as a conduit for the deployment of the PTMA device for the treatment of functional mitral 
regurgitation, characterization of CS structural response is an important step toward an understanding of 
tissue-device interaction in the PTMA intervention. In this chapter, structural characterization of the 
porcine CS vessel using pressure-inflation test and constitutive modeling using a four-fiber family model 
will be introduced.  
 
 
 
 
                                                     
* The contents of this chapter are published partially in: 
T. Pham and W. Sun, Characterization of mechanical properties of coronary sinus 
for percutaneous transvenousmitral annuloplasty, Acta Biomaterialia 6(11): 4336‐4344 (2010). 
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 Introduction 2.1
2.1.1 Anatomy and structure of coronary sinus vessel 
Coronary sinus is a large venous vessel that returns deoxygenated blood from the left heart and 
drains into the right atrium. It begins at the termination of the great cardiac vein (GCV), marked by the 
valve of Vieussens internally and the small oblique vein or vein of Marshall (OV) externally. Located in 
the sulcus of the atrioventricular groove, CS runs along the posterior side of the annulus of the left atrium 
and ends at the Thebesian valve, where it marks the CS ostium [81-83]. 
A study by Valle-Fernadez et al. [84] showed that there are dynamic changes in the relationship 
between CS/GCV and the MA. From 56 patient computed tomography angiographies, the distance 
between CS/GCV and MA progressively increased over the first 4 to 5 cm of the CS/GCV trajectory and 
decreased afterward (p < 0.001). The CS/GCV was larger in phase 40% (end-of-systole) than in phase 
75% (mid-diastole) and was smallest in phase 0% (end-of-diastole). El-Maasarany et al. [85] showed that 
there are three patterns for the CS/GCV and MA relation (described as six regions, each 36 degree wide): 
1) pattern A: CS was widely separated from the MA at 9.4, 10.6, 9.9, 9.1, 6.6 and 5.8 regions, 2) pattern 
B: CS was widely separated from the annulus at its ostium and became closer distally towards the GCV at 
11.6, 11.1, 10.6, 9.8, 8.3 and 7.0 mm, and 3) pattern C: a non-consistent pattern.  
These findings indicate that there is a highly variation in the CS/GCV/MA geometries and 
dynamic changes. Several studies also noted the coronary artery traverses between the CS/GCV and the 
MA [84].  Therefore, patient selection for the PTMA technique to reshape the MA using CS approach 
needs a detailed prospective imaging evaluation.  
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Figure 2-1: The major tributaries of the CS, with a) of the great cardiac vein (GCV) and the oblique vein 
of Marshall (OVM), b) the inferior left ventricular vein (VA). 
 
2.1.2 Porcine versus human models   
Porcine hearts were studied in various medical applications due to their similarity in structures 
with human hearts. Similar to human CS vessel, porcine CS vessel has the same major tributaries, which 
are the great cardiac vein (GCV), the oblique vein of Marshall (OV) that descends along the lateral and 
inferior wall of the left atrium and joins the GCV to form the CS, and the inferior left ventricular vein 
(VA) that drains from the diaphragmatic surface of the left ventricle (see Figure 2-1).  However, we 
noticed that there is a distinct difference between porcine and human coronary sinus. Unlike human OV 
which is small [81, 83], porcine OV’s diameter is as large as the CS’s diameter (see Figure 2-1a) and 
there is no obvious landmark that separates this vessel from the CS. Illustrated in Figure 2-2b is the CS 
cut along its long axis. The internal surface of the CS resembles the right atrial endocardium, other than 
the endothelium of a vein. The free wall of the CS is surrounded by a striated myocardial fiber (SMF) cuff 
that runs obliquely starting from the OV. Superior to this SMF sheet is a thin layer of connective tissues, 
which also surrounds the OV (Figure 2-2a). The anterior part of the CS is attached to the left atrial 
appendage (LAA), and the barrier between the LAA and CS can also be identified, see long-dashed line 
in Figure 2-2c. 
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Figure 2-2: –  a) Coronary sinus (CS) vessel fixed in 10% formalin in 2 days, with its 
connective tissue (CT) being peeled off exposing the striated myocardial fiber (SMF) layer,  b) 
axial view and c) its closer view of the CS’s inner wall with distinctive layers of SMF, CT, and 
left atrial appendage (LAA). The long-dashed line indicates the barrier between CS wall and 
LAA.  
In this chapter, we reported, to our knowledge, the first biomechanical characterization 
of the CS vessel using a porcine model. A pressure-diameter inflation test was performed on 
the CS vessel at its intact, in-service configuration, e.g. CS was not dissected from its 
surrounding myocardium, to quantify its in vitro mechanical responses. A structure-based 
strain energy function (SEF) was utilized to characterize the nonlinear hyperelastic properties 
of the vessel wall. In addition, the microstructure of the CS through histology was studied to 
elicit its structure and relate it to its mechanical properties. 
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 Materials and Methods 2.2
2.2.1 Pressure-inflation experiment 
Coronary sinus is a large venous vessel that returns deoxygenated blood from the left heart and 
drains into the right atrium. It begins at the termination of the great cardiac vein (GCV), marked by the 
valve of Vieussens internally and the small oblique vein or vein of Marshall (OV) externally. Located in 
the sulcus of the atrioventricular groove, CS runs along the posterior side of the annulus of the left atrium 
and ends at the Thebesian valve, where it marks the CS ostium [81-83]. In this study, we focused on the 
material characterization of the CS ostium region about 10 mm from the Thebesian valve since it is the 
region that is directly in contact with the proximal anchor stent of the PTMA device. Porcine hearts were 
used in this study because of similarity between porcine and human hearts for mitral valve related 
applications [86]. 
A total of seven fresh porcine hearts, typical of 6 - 9 months old with a weight range of 400 - 500 
g, were obtained from a local abattoir. Upon delivery with ice, they were subjected to vessel pressure-
inflation testing within 48 hours.  Prior to testing, the hearts were separated from excess tissues (e.g. aorta 
arch, fat) and blood clumps.  The right atrium was incised to expose the CS ostium and a small section 
about 5 mm from the CS ostium was detached from the left atrial appendage (LAA) for the purpose of 
connecting the plastic cannula to the CS for the inflow pressure. The plastic cannulas were varied in sizes 
to fit with various CS diameters (e.g. 4, 6, & 8 mm). The other end of the CS (at the junction of the CS-
GCV) was secured with a surgical forceps. To ensure pressure stabilization, all other branches of CS 
vessel were occluded with ligatures. Then the whole heart was submerged in a small plexi-glass tank (21L 
x 18W x 18H mm, 2.8 mm thick), and the front side of the tank was replaced with a thin (0.35 mm thick) 
clear plastic sheet for the purpose of imaging. The tank was filled with Ca2+-free saline solution at room 
temperature. The heart was stabilized by resting on a sponge placed at the bottom of the tank. The cannula 
at the CS ostium end was connected to the pressure gauge, which was linked by a flexible plastic tube to 
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the water tank where a hand-operated pump was used to apply pressure to the CS.  The ultrasound probe 
(7.5 MHz transducer of RT320, General Electronic Inc.) was projecting perpendicular to the CS at the 
clear plastic sheet side of the tank to collect 2D cross-sectional images of the CS, see Fig. 2-3a. Since the 
water tank is clear, ultrasound wave traveled through the tank, the water and to tissue and traveled back to 
the probe. All data were recorded at the cross section about 10 mm from the CS ostium.  
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Figure 2-3: A) An ultrasound image of cross section of the inflated CS vessel, with two line segments D1 
and D2 for measuring diameters and three line segments T1, T2, and T3 for thickness measurements; B) 
thickness measurements using the FWHM method (to obtain Tpixel, or thickness in pixel—width of the 
half amplitude of the peak), and C) diameter measurements (distance between the two crosses—in pixel), 
both processed by the Matlab improfile function.  
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Each specimen was subjected to preconditioning by inflating up to 80 mmHg and then 
venting the pressure back to 0 mmHg.  This process was repeated 20 times to minimize 
hysteresis.  Testing was then conducted by increasing pressure from 0 to 80 mmHg in 
increments of 5 mmHg per second. At each pressure, a 2D ultrasonic image of the CS cross-
section was taken immediately using a custom-made image capturing software. A total of 17 
images were taken for each heart, and inner diameter and CS wall thickness data were 
measured using an image post-processing code written in Matlab (Mathworks, Natick, MA). 
Utilizing ultrasound images to capture the cross-sections of CS geometry during the inflation 
test allows a direct measurement of tissue thickness. This method may provide a more accurate 
estimation of circumferential stretch and stress using Eqns 2.1-2.3 below, compared to other 
methods that used the derived thickness based on markers on the surface of vessel, particularly 
when the vessel is curved and partially imbedded in surrounding tissues. 
2.2.2 Ultrasound Image Analysis 
All images were imported into the Matlab program and analyzed using a Matlab function called 
improfile.  Briefly, the image processing technique involved identifying boundaries of tissues from the 
change of impedance of the medium when the ultrasound wave travels from water to tissue and from 
tissue to water. The change of impedance resulted in the change of the image intensity, where high 
(white) and low (black) intensity determine the tissues and water, respectively. The improfile function 
will identify the intensity values along a line or a multiline path specified by the user, performing 
interpolation to find the intensity value for each pixel, and graphing these intensity values. Both diameter 
and thickness values were determined by detecting the pixel-value along line segments (Fig. 2-3b & c). 
For diameter measurements, two line segments were drawn across the anterior-posterior and 
superior-inferior view on the vessel. As CS is partially imbedded in the myocardium, the inflated vessel 
circumference at low pressure may not be circular. Therefore, two measurements of diameters were 
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recorded and averaged. A center point was determined from an intersection of these two lines. Thickness 
was measured by drawing three lines, which originate from the center point and each goes separately 
through three different sections across the thickness, see Fig. 2-3a. Thickness measurement was estimated 
using a basic image analysis technique called Full-Width Half-Maximum (FWHM) [87]. Real 
measurements of tissues using a non-rotating thickness gauge (Mitutoyo, Model 7301) determined that 
FWHM provided a good approximation of thickness. Basically, FWHM is the full width of the section 
(across CS wall) at the half maximum value (intensity value). Three measurements of thickness were 
averaged to obtain the mean. Units in pixel were converted to lengths according to ultrasound image 
calibration. 
2.2.3 Histology 
Each CS vessel was removed from the heart and fixed in formalin for 24 hours prior to the 
histology process. Cross-sections through the thickness of both anterior and posterior CS sections were 
examined. Each sample was sliced into 6 μm piece in both circumferential and longitudinal directions 
using a cryostat microtome and then stained with the Verhoeff Van-Gieson (VVG) stain. Thus, the black 
strands are elastic fibers and the bright red materials are the collagen fibers. Muscle fibers can also be 
distinguished with a duller red or light brown color. Histological images were obtained through an 
Olympus220 digital camera that coupled to an OlympusCX41 light microscope and analyzed using 
LabView software (National Instruments, Austin, TX). 
2.2.4 Constitutive modeling 
The pressure-radius data were utilized to characterize CS mechanical properties using a four-fiber 
family SEF [88]. For a segment of CS with initial and deformed axial lengths of L and l, respectively, 
with the assumption of tissue incompressibility, the vessel wall volume, V, is a constant during the 
inflation. Thus, we have 
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ܸ ൌ ሺܤଶ െ ܣଶሻߨܮ ൌ ሺܾଶ െ ܽଶሻߨ݈	,    (2.1) 
where A and B denote initial, unloaded inner and outer radii, respectively, a and b denote deformed, 
loaded inner and outer radii, respectively. Following the method presented in Wicker et al. [88], the 
associated mean stretch ratios in the CS circumferential and axial directions were computed as 
ߣఏ ൌ 	 ሺ௔ା௕ሻ/ଶሺ஺ା஻ሻ/ଶ ,										ߣ௭ ൌ
௟
௅ ൌ
൫஻మି஺మ൯
ሺ௕మି௔మሻ .          (2.2) 
Note that both of the initial and deformed lengths were not experimentally measured in this study. 
Instead, using the Eqn. 2.1 and the assumption of tissue incompressibility, the axial stretch was calculated 
using the Eqn. 2.2 above.  The mean circumferential (	ߪఏ) and axial (	ߪ௭) Cauchy stresses [89] can be 
calculated using the pressure-radius experimental data in the deformed configurations, 
ߪఏ ൌ 	 ௉௔௛ ,         ߪ௭ ൌ 	
గ௔మ௉
గ௛ሺଶ௔ା௛ሻ,    (2.3) 
where, P is the luminal pressure (outer pressure was assumed to be approximately zero), ݄	 ൌ ܾ െ ܽ is the 
thickness, and ߨܽଶܲ	accounts for the luminal pressure acting over the projected inner cross-sectional area 
of the CS.  
We assumed that the CS behaves as a hyperelastic material following the concept of 
pseudoelasticity [29], the four-fiber family model W is expressed as   
ܹ ൌ	 ௖ଶ ሺܫଵ െ 3ሻ ൅ ∑ ൜
௖భೖ
ସ௖మೖ exp ൤ܿଶ
௞ ቀ൫ߣ௞൯ଶ െ 1ቁଶ൨ െ 1ൠ ,ସ୩ୀଵ    (2.4) 
where c, ܿଵ୩, and	ܿଶ୩ are the material parameters, the superscript k represents the kth fiber families. For the 
fiber families k = 1 and 2 represent axially (0˚) and circumferentially (90˚) oriented fibers, respectively, 
and fiber families k = 3 and 4 represent diagonally oriented fibers, see Fig. 2-4. Note that these fiber 
families do not reflect the physical fibers, instead they are the virtual fibers representing all fibers oriented 
in four directions throughout the vessel wall. The parameter ܫଵ is the first invariant of the right Cauchy–
Green tensor, ߣ௞ ൌ 	ටߣ௭ଶܿ݋ݏଶߙ଴௞ ൅	ߣఏଶݏ݅݊ଶߙ଴௞  is the stretch of kth fiber family, ߙ଴௞  represents the angle 
between the fiber family and the CS axial direction, with  ߙ଴ଵ	= 0, ߙ଴ଶ = 90, and ߙ଴ଷ ൌ െߙ଴ସ. For Eqn. 2.4, 
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		ܿଵଵ ൌ 	 ܿଵଶ, ܿଶଵ ൌ 	 ܿଶଶ, ܿଵଷ ൌ 	 ܿଵସ, and ܿଶଷ ൌ 	 ܿଶସ are typically assumed [88, 90, 91], therefore, a total of six 
parameters is needed to be determined.  
Finally, the associated mean circumferential and axial Cauchy stresses are [91], 
ߪఏ ൌ 	ߣఏ డௐడఒഇ,																	ߪ௭ ൌ 	 ߣ௭
డௐ
డఒ೥  .     (2.5) 
 
 
Figure 2-4:  Schematic of the vessel fiber orientation, with k = 1 and 2 are 0˚ (axial) and 90˚ 
(circumferential) oriented fibers, respectively; and k = 3 and 4 are diagonally oriented fibers. 
The constitutive model was fit to the individual experimental pressure-diameter data, yielding six 
optimal parameters for each dataset. In addition, the mean response of seven pressure-diameter data was 
obtained and fitted. The material parameters of the mean response (P_Mean_Exp_Data) and the mean 
values of the optimal material parameters (P_Mean_Para) were compared. The goodness of the fit was 
determined using the R-square value based on the Levenberg-Marquardt nonlinear regression algorithm 
using SYSTAT 10 (Systat Software Inc., Chicago, IL). Variation of test data was presented in terms of 
standard errors. 
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 Results 2.3
2.3.1 Mechanical responses of the coronary sinus 
Initial and maximum dilated diameters and thicknesses of seven specimens were listed Table 2.1. 
The mean pressure versus the inner diameter response of seven CS’s was illustrated in Fig. 2-5. The CS 
exhibited a S-shape curve, typical for blood vessels [89]. Below a pressure of 10 mmHg, the CS did not 
exhibit obvious dilatation. However, between a pressure range of 10 to 30 mmHg, there was a rapid 
extension of the CS diameter. As the pressure increased above 30 mmHg, the wall became progressively 
less distensible and nearly stayed flat at the high pressures.  At 30 mmHg pressure, the CS could be 
dilated approximately up to 60%, and at 80mmHg, up to about 88%. The CS vessel wall thickness 
decreased with the applied pressure (see Fig. 2-5b), as one would expect. 
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Table 2-1. Initial and maximum dilated diameters and thickness of seven specimens.  
 
Do is the initial diameter, D is the maximum distended diameter; To is the initial thickness, and T is the 
thickness at maximum pressure, 80 mmHg. All measurements are in mm.  
  
Specimen  D0 D T0 T D/D0 T/T0
1 4.90 12.50 1.37 0.71 2.55 0.52
2 3.11 6.55 0.56 0.55 2.11 0.98
3 5.04 10.09 1.12 0.63 2.00 0.56
4 8.54 11.72 1.06 0.62 1.37 0.58
5 7.06 10.86 1.54 1.02 1.54 0.66
6 4.22 7.59 1.54 1.15 1.80 0.75
7 6.00 10.95 1.42 0.63 1.83 0.44
Mean 5.55 10.04 1.23 0.76 1.88 0.64
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Figure 2-5:  a) The normalized pressure versus inner diameter experimental result from seven porcine 
CS’s inflated to a maximum pressure of 80 mmHg, b) the thickness change of the anterior section of the 
CS vessel. Data was expressed in terms of mean and standard error. 
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The mean stress versus stretch curves of the CS obtained from the pressure-inflation experiments 
can be seen in Fig. 2-6 for both axial and circumferential directions. The maximum stress values were 
35.5 ± 4.64 kPa and 75.95 ± 9.34 kPa for the axial and circumferential, respectively, under the 80 mmHg 
pressure. The response in the axial direction showed an initial contraction which ceased at about 10 
mmHg and followed by an extension at higher pressures.   
 
Figure 2-6:  Stretch-stress curves of the CS obtained from the pressure-inflation tests. The upper curve 
represents the response in the circumferential (Circ.) direction and the lower curve is for the axial 
direction. Data was expressed in terms of mean and standard error. 
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2.3.2 Microstructure of CS vessel wall  
The circumferentially-cut sections of the posterior (or the free wall) and the anterior (or a section 
attached to the LAA) CS vessel were illustrated in the Fig. 2-7. The posterior CS sections were covered 
by a layer of SMFs oriented circumferentially (see Fig. 2-7a). Within the CS wall, unlike other vessel 
wall, it was mainly composed of SMFs, with a small content of smooth muscle cell (SMC). The SMCs 
were only observed in bundles in the outer layer of the anterior section of the CS vessel (see Fig. 2-7b, 
arrow). The SMF orientations were similar in both anterior and posterior sections where they aligned in 
the circumferential direction in the luminal layer and realigned into transverse direction in the media 
layer. Collagen and elastin fibers were found throughout the vessel wall (see Fig. 2-7c & d), collagen 
fibers were slightly scattered in the SMF layer. Elastin fibers were aligned in the axial direction in the 
luminal layer and realigned into the circumferential direction in the media layer of the CS wall. Crimping 
of the collagen fibers were also observed in the axial direction in the CS luminal layer (see Fig. 2-7c).  
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Figure 2-7:  Circumferential-cut sections of a) the posterior (free wall) and b) the anterior wall 
of the CS. Close-up views of the CS at the luminal layer in the c) axial and d) circumferential 
axes. The arrow indicates smooth muscle cells (SMCs). 
 
2.3.3 Constitutive Modeling  
Material parameters and R-square values of seven individual specimens obtained from the four-
fiber family model fit were summarized in Table 2. The model could capture the tissue response well with 
the mean R-square value of 0.914 ± 0.036. The parameters of P_Mean_Para and P_Mean_Exp_Data were 
also listed in Table 2.2.   
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Table 2-2. Material parameters for the four-fiber family model. 
 
Illustrated in Fig. 2-8 was a comparison between the fits of two parameter sets. The fit was 
excellent for the P_Mean_Exp_Data parameters in both circumferential (solid line) and axial (long-dash 
line) directions. In contrast, the P_Mean_Para did not produce a desirable fit. It underestimated the axial 
direction and largely overestimated the fibers in the circumferential direction.  
Material parameters
R2
Specimen c (kPa) c11,2 (kPa) c21,2 c13,4 (kPa) c23,4 α0
1 0.00E+00 3.94E‐22 1.12E‐07 31.36 0.51 31.60 0.996
2 1.85E+00 3.25E‐21 1.36E‐08 2.21 0.23 60.34 0.800
3 1.57E+01 1.16E‐17 1.00E‐02 1.66 0.66 46.29 0.816
4 8.97E+00 3.50E‐21 2.31E+00 28.40 1.34 58.76 0.998
5 1.64E+01 2.76E‐20 2.43E+00 5.43 3.37 49.18 0.970
6 4.30E+00 1.00E‐05 1.00E‐02 1.17 1.40 70.81 0.823
7 3.01E+00 2.71E‐21 1.00E‐02 2.51 1.22 53.17 0.995
Mean_Para 7.18E+00 1.43E‐06 6.82E‐01 10.39 1.25 52.88 0.914
Standard Error 2.52E+00 1.43E‐06 4.36E‐01 5.07 0.39 4.68 0.036
Mean _Exp_Data 1.30E+00 2.23E‐17 1.87E‐08 28.88 0.91 42.03 0.998
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Figure 2-8: Fits of the mean experimental data of all seven specimens (P_Mean_Exp_Data) 
and mean parameters obtained from averaging individual parameters (P_Mean_Para). Solid 
lines are the circumferential fits and long-dash lines represent the axial. Fitting results show 
that parameters obtained from averaging experimental data (P_Mean_Exp_Data) provided a 
better fit. Data was expressed in terms of mean and standard error. 
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 Discussion 2.4
 Although mechanical properties of arteries have been studied extensively, there are relatively 
fewer studies on the mechanical properties of venous tissues [29, 89], and to our knowledge, none on the 
CS vessel. This is probably because the CS has seldom been treated as a load bearing tissue. Recent 
applications of PTMA devices for the treatment of MR utilize the CS as a hosting conduit for deployment 
and function of the devices. It is, thus, important to quantify the CS mechanical properties so that the CS 
tissue-device interaction can be better understood and the device failure as observed in Webb et al. [72] 
could be avoided in the future.  
In this study, we observed that the CS pressure-diameter response is generally similar to many 
artery and vein responses [92-95]. The CS was very distensible at low pressures and became much stiffer 
when over physiologic pressure (see Fig. 2-5a).  However, the difference between CS vessel and other 
vessels observed from our histological study was the presence of the high content of SMF in the CS wall, 
with a relatively lower content of collagen, elastin and smooth muscle cells. Apparently, the structural 
constituents of the CS were very different to that of a typical vein or artery, in which the collagen, elastin 
and smooth muscle cells are the premier constituents. Similar findings of SMF layers covering the CS 
were reported in the anatomical studies of human CS [81, 82]. It was argued that the CS vessel might be a 
small cardiac chamber that joins the other four chambers at the level of the crux cordis [81]. The 
histological structure obtained from this study appeared to concur that the CS may not be a cardiac vein, 
but rather a structural extension of the right atrial chamber because of the high content of SMF in the 
vessel wall.  
The four-fiber family model is an extension of Holzapfel’s two-fiber family model [90], which 
has been successfully utilized to model various blood vessel tissues [96-99]. In general, this model can 
capture the CS mechanical responses well. The model and the associated parameters obtained in this 
study can be implemented in numerical simulations to further investigate the tissue-implant mechanical 
interactions. The material constants of the model obtained from fitting of the experimental data might not 
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be unique. Multiple other sets of material constants may result in the same goodness of the fit. The issue 
of determinability of constitutive models has recently been discussed in Criscione 2004 and 2008 [100, 
101]. A new set of kinematic tensor basis proposed by Criscione [100] might have the potential to 
overcome the covariance or coalignment issues inherent in the kinematical variables of strain invariant or 
Green strain based formulations.  
Typically, the modeling approach with tissue micro-structure considerations, based on the 
pioneering work by Lanir 1979 [102], has employed either discrete [90, 103] or statistical distribution 
functions [104, 105] to describe orientations of tissue fibers. The four-fiber family model utilized the 
isotropic term for the tissue matrix substance and the anisotropic terms for the fibers at four assumed fiber 
directions. For the isotropic term, the parameter c represents the relative contribution of extracellular 
matrix (ECM). The mean value of 1.3kPa obtained in this study suggested the isotropic ECM played a 
significant role in CS wall responses. For anisotropic fiber responses, we observed that c1,2 was close to 
zero. It indicated that axial and circumferential fibers have negligible contributions. However, fibers in 
the diagonal direction, represented by c3,4, appeared to be responsible for most of overall tissue 
mechanical responses. Since we did not perform quantitative histology on the CS wall, a definitive 
correlation between the model predicted and actual fiber architectures cannot be established. 
The response in the axial direction varied from contraction to extension at low to high stress, 
respectively. As showed in Fig. 2-6, the initial decrease in axial stretch at low stress occurred 
simultaneously with the dramatic increase in the circumferential stretch. This behavior might be due to 
the tissue incompressibility, or volume preservation. However, as the CS wall consists of complex multi-
layer nonlinear, anisotropic tissue structures, the coupling between axial and circumferential directions 
could be more complex than that due to the tissue volume preservation.  
In our estimation of the CS wall stress, we utilized the ideal cylindrical model. However, the CS 
wall has an oval shape due to the partial attachment to surrounding myocardium (see Fig. 2-3a). During 
the inflation tests, the averaged minor to major axis ratio of the CS vessel was 0.48 at 5 mmHg, 0.7 at 
20mmHg, 0.85 at 50 mmHg and 0.93 at 80 mmHg. Using the cylindrical model in data analysis is a way 
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to represent the averaged stress in an oval shape. A precise estimation of stress in an oval shape should be 
as follows: Let m and n equal the semi-axes of an oval shape, with n > m. The minimal and the maximum 
stresses in the oval shape are  σ୫୧୬ ൌ 	 ୔୫୦  and σ୫ୟ୶ ൌ 	
୔୬
୦ , respectively, and the stress in between at the 
point (x, y) can be obtained by σሺx, yሻ ൌ 	 ୔୦ ቀy
ப୶
பୱ ൅ x
ப୷
பୱቁ, where s is the arc length on the oval shape. By 
the cylindrical model, we used σ ൌ 	 ୔ሺ୫ା୬ሻଶ୦ , which is the mean value between the maximum and minimal 
stresses. Thus, the maximum error we could have with the cylindrical model is σୣ୰୰ ൌ 	 ୔ሺ୬ି୫ሻଶ୦ , which is 
located at the minor and major axes of the oval shape. Based on the minor to major axis ratios during the 
inflation test, the maximum errors in the stress estimation were 26% at 5 mmHg, 15% at 20 mmHg, 7.5% 
at 50 mmHg and 3.5% at 80 mmHg. To convert them into actual stress values, they were 0.63, 1.78, 3.39 
and 2.63 kPa at 5, 20, 50 and 80 mmHg, respectively. 
 There are some limitations in this study. First, the sample size is small. We only 
performed experiments on seven porcine hearts. A larger number of specimens may provide a 
more statistical power in analyzing the data. Also, the extrapolation of the porcine CS 
mechanical properties to the human CS is currently unknown. A study of human CS tissue 
properties is currently ongoing in our lab. We hope that in the near future we could compare 
human and porcine data, and use them to explain why PTMA devices respond differently in 
animal and human clinical trials [27, 72, 73, 106-108]. Lastly, we only studied passive 
behaviors of the CS vessel. The in vivo observation by Barcelo et al. [81] using cine digital CS 
angiography showed the reduction of the CS’s diameter during the cardiac cycle, where the 
maximal diameter was observed at the ventricular systole, intermediate diameter during 
diastole and the minimal diameter at the atrial systole. This diameter change may be caused by 
active contraction of myocardial fibers or simply by the pressure change during the cardiac 
cycle. The further investigation on this phenomenon is also necessary. 
 Summary  2.5
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In this Chapter, we presented a study of biomechanical characterization of porcine coronary sinus. 
Under a 80 mmHg pressure-only loading condition, the CS vessel exhibited a S-shape pressure-radius 
response and could be dilated up to 88%. The model fitting results indicated that the four-fiber family 
model could capture the experimental data well. From the histology study, we observed abundant SMFs 
covering the CS and also within the CS vessel wall, while smooth muscle cells are very low in content. 
The elastin and collagen fibers are highly concentrated in the luminal and outer layers of the CS wall, but 
sparsely distributed in the medial layer. In future studies, we will conduct finite element analysis of the 
interaction between the CS vessel and the proximal stent, utilizing the mechanical properties of the CS 
vessel obtained in this study. We may also conduct the mechanical characterization of human CS using 
cadaver tissues. Nonetheless, this study represents one of early steps towards a complete understanding of 
the PTMA intervention and analysis of device failures observed in current clinical trials.  
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3 Comparison of Biaxial Mechanical Properties of 
Coronary Sinus Tissue from Porcine, Ovine and Aged 
Human* 
In this chapter, the material property characterization of the CS vessel using planar biaxial testing 
method will be introduced. Pre-clinical studies of PTMA devices often use animal models (i.e. porcine, 
ovine and canine) to obtain either acute or short-term animal trial outcomes. However, compare to pre-
clinical animal studies, human clinical outcomes were sub-optimal. To investigate underlying causes of 
the discrepancy between the animal and human results, in this chapter, the CS tissue properties of human 
were compared to ones of porcine and ovine and human models. The CS tissues were subjected to multi-
protocol biaxial tests and characterized by the Fung-type elastic model. Histological analysis was also 
performed to compare the difference in tissue microstructure among porcine, ovine and aged human CS 
tissues. 
  
                                                     
* The contents of this chapter were partially published in  
T. Pham and W. Sun, Comparison of biaxial mechanical properties of coronary sinus tissues from 
porcine, ovine and aged human species, Journal of the Mechanical Behavior of Biomedical Materials 6: 
21‐29 (2012). 
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 Introduction 3.1
Quantification of the mechanical properties of the CS vessel is critical for estimating the tissue-
implant biomechanical interaction and for understanding device failure mechanisms. Although the 
anatomical studies of the CS have been well reported [81-83], there is a dearth of study on the mechanical 
properties of the tissue. Recently, Pham and Sun [109] reported the diameter-pressure relation of porcine 
CS from a vessel inflation experiment. There are two limitations in the paper: 1) the experiment was 
conducted under relatively simple pressure inflation loading conditions, and 2) only the porcine CS was 
examined. Due to complex tissue-device interactions, quantification of tissue behaviors under multi-axial 
loading conditions may be needed. Moreover, a study of CS tissue properties from different species (i.e., 
porcine, ovine and human) may be helpful in understanding the outcomes among animal trials and human 
studies, and establishing a proper animal model to evaluate the device efficacy. 
 Materials and Methods  3.2
3.2.1 Materials  
The human cadaver CS tissues were selected from an age group of 86.5 ± 9.7 years old. Human 
cadaver hearts were obtained from Cardinal Biologicals, Inc. (Tyler, TX; n = 2) and National Disease 
Research Interchange (NDRI, Philadelphia, PA; n = 8). The use of human tissues was approved by the 
Institutional Review Board at the University of Connecticut. The hearts were fresh frozen within a post-
mortem recovery interval (15.32 ± 6.51 hours) and remained frozen until delivery on the next day. All 
hearts were stored in a -80˚C freezer and were taken out individually for testing within 3 months. Porcine 
hearts (n = 10, 6 - 9 months old with a weight range of 418.60 ± 71.81 g) from the Animal Technologies, 
Inc. (Tyler, TX) and sheep hearts (n = 10, 1 year old, 280.08 ± 28.17 g) from the Brother Quality, Inc. 
(Stafford Springs, CT) were obtained fresh and stored in a -80˚C freezer until testing within 2 weeks.  
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Following the two-stage slow thawing method proposed by Bia et al. to void tissue damages 
[110], each heart was held at room temperature (20˚C) for 30 minutes and then submerged in a 37˚C 
water bath until totally defrosted. The entire CS vessel could be removed from the heart because only the 
anterior section of the vessel is partially embedded in the myocardium, as shown in Fig. 3-1. After 
carefully procuring the vessel and removing the excess tissues (e.g. fat and loose connective tissues), a 
square specimen, about 15 mm in length, and at a region near the CS ostium end (or the proximal 
section), was excised for testing, see Fig. 3-1. The tissue thickness was measured at six regions with a 
thickness gauge (Mitutoyo, Model 7301) and the average value was recorded. Four small graphite 
markers were placed at the center on the inner surface of the posterior (i.e., myocardium-free) section of 
the CS vessel to demarcate a small quadrilateral for strain calculation. 
 
Figure 3-1: The anatomy of the intact coronary sinus (CS) vessel showing the excised location for biaxial 
testing. The image on the right shows the CS specimen mounted in the biaxial machine bath. C - 
circumferential, L - longitudinal, LA - left atrium, LV - left ventricle.  
 
3.2.2 Planar Biaxial Mechanical Testing of CS tissues 
Details on planar biaxial mechanical testing techniques and methods of analysis adopted in this 
study can be found in Sacks and Sun 2003  [38]. Briefly, all specimens were mounted in a trampoline 
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fashion, and the vessel circumferential and longitudinal directions were aligned with the primary axes of 
the biaxial test fixtures. Human tissue samples were tested in a Ca2+-free phosphate buffered saline (PBS) 
solution at 37°C. Due to their young age and relatively high muscle content, animal tissue samples were 
tested in a Ca2+-free and glucose-free Tyrode solution (mM: NaCl 136.9, KCl 2.7, MgCl2 1.05, NaHCO3 
11.9, NaHPO4 0.47, EGTA 2.0, and 0.1M papaverine) at 37°C. Using Ca2+-free solution is to minimize 
the active contraction of muscle fibers in order to obtain the passive mechanical properties of the CS 
vessel. Adding EGTA, a chelating agent with a high affinity for Ca2+, would actively remove the 
intracellular Ca2+ concentration. The similar protocols have been used in studies of passive blood vessel 
mechanical properties [111-115]. As reported by Tritthart et al. [116], exposing Ca2+-free solution several 
times in succession could have a comparable result as to the EDTA-containing solution. A stress-
controlled test protocol was utilized [117], wherein the ratio of the normal Lagrangian stress components 
T11 : T22 was kept constant with T12 = T21 = 0. Maximum load was applied without causing tears at the 
edges of the specimens. Preconditioning was performed to minimize tissue hysteresis. Each tissue 
specimen was preconditioned for at least 40 continuous cycles with T11 : T22 = 1 : 1. Seven successive 
protocols were performed using ratios T11 : T22 = 1 : 0.3, 1 : 0.5, 1 : 0.75, 1 : 1, 0.75 : 1, 0.5 : 1, and 0.3 : 
1. This range was chosen for extensive coverage of the in-plane strain state [38]. All specimens were 
cryopreserved  [110] after biaxial testing and stored at -80°C. 
3.2.3 Histology 
The structural constituents of the CS vessel, primarily elastin, collagen, and muscle fibers, were 
analyzed across the thickness.  After thawing and removing the cryoprotectant agent following a protocol 
proposed by Bia et al. [110], tissue specimens were fixed in 10% formalin for 24 hours. Each sample was 
dehydrated through a process of varied alcohol concentrations, embedded in paraffin, and sectioned at 5 
μm in thickness.  Samples were then mounted on  microscope slides and dried. After deparaffinization, 
slides were then stained with Verhoeff Van-Gieson (VVG). Elastic fibers could be visualized as black 
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strands, collagen fibers as red, muscle fibers as a duller red or light brown color. Histological images were 
obtained from an Olympus U-TVO.5xC digital camera coupled to an Olympus BX40 light microscope. 
3.2.4 Constitutive Modeling 
 The coronary sinus tissue was assumed to be homogeneous, non-linear hyperelastic and 
anisotropic. Therefore, the Fung-type elastic model [29] was used to characterize the biaxial 
experimental data. The in-plane second Piola-Kirchhoff stresses, S, were derived from a strain 
energy function W,  
௜ܵ௝ ൌ 	 డௐడா೔ೕ   (3.1) 
where Eij is the Green-Lagrange strain tensor and W is expressed as:  
 ܹ ൌ	 ௖ଶ	ሺ݁ொ െ 1ሻ     (3.2) 
and Q as: 
Q ൌ	ܣଵܧଵଵଶ ൅	ܣଶܧଶଶଶ ൅ 2ܣଷܧଵଵܧଶଶ ൅	ܣସܧଵଶଶ ൅ 	2ܣହܧଵଵܧଵଶ ൅ 2ܣ଺ܧଶଶܧଵଶ	 (3.3) 
with c and A1-6 are material parameters.  
 The constitutive model was fit to the seven stress-controlled protocols for each individual 
specimen to obtain the material parameters. The goodness of the fit was determined by the R-square value 
based on the nonlinear regression Levenberg-Marquardt algorithm in SYSTAT 10 (Systat Software Inc., 
Chicago, IL). Each parameter set was tested for convexity using the method in Sun and Sacks 2005 [118]. 
Variation of the parameters is presented in terms of the standard deviation.    
3.2.5 Data Analysis 
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The mechanical properties of the human CS were quantified and compared to those of 
ovine and porcine CS tissues. The tissue stiffness was investigated by means of the secant 
modulus at a low stress value of 15 kPa and a high stress value of 50 kPa. One of the human CS 
specimens (Specimen 2) has a maximum testable stress below 35 kPa in both the circumferential 
and longitudinal directions, therefore, was omitted in the stiffness analysis at 50 kPa. 
To quantify the degree of anisotropy (DA) among the specimens, the ratio of 
circumferential to longitudinal strains at 15 and 50 kPa stresses from the equibiaxial protocol 
(T11 : T22 = 1 : 1) was used. Thus, DA = E22 : E11. A DA value of 1 indicates an isotropic tissue 
response, whereas other values represent various degrees of anisotropy. In addition, the 
relationship between age and 1) thickness, 2) stiffness, and 3) maximum equibiaxial strain in 
human specimens were also investigated.   
3.2.6 Statistical Analysis 
Differences between means were determined using the analysis of variance (ANOVA) test 
followed by the Holm-Sidak test and the Dunn’s Method test for pair-wise multiple comparisons. The 
Independent two-sample t-test was used to determine significant differences in anisotropy. Non-
parametric tests, including the Wilcoxon signed-rank test and Mann-Whitney rank sum test, were used for 
non-normal distributed sample groups. Correlation was determined using the Pearson’s correlation 
coefficient (r), and p-values were calculated based on the aforementioned statistical tests. All values of 
measurement are presented as a mean ± standard deviation.  A probability value less than 0.05 was 
considered statistical significant, with high significance indicated by p < 0.001. Statistical analyses were 
performed using SigmaPlot (V11.0, Systat Software Inc., San Jose, CA). 
 Results 3.3
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3.3.1 Patient characteristics and specimen thickness  
 Table 3.1 lists characteristics of human hearts investigated in this study, including 
patient age, gender, cause of death, primary disease, and risk factors. The thickness of all CS 
specimens was determined.  Human (0.74 ± 0.16 mm) and ovine (0.78 ± 0.12) were not 
significantly different (p = 0.537). However, porcine CS (1.24 ± 0.18) was significantly thicker 
than human (p < 0.001) and ovine (p < 0.001). 
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Table 3-1. Anamnesis of patients. 
 
Specimens 
1 2 3 4 5 6 7 8 9 10 Mean ± SD 
Age (yrs) 69 88 78 96 95 79 98 87 80 95 86.5 ± 9.70 
Sex M F M F F F F F F M - 
PMR (hr) 22 11 10 21 7 11 18 8 21.5 23.7 15.32 ± 6.51 
Cause of death HB Alz CPA CPA RA CPA RA Alz ukn NC - 
Primary disease HB CAD CA ukn ukn Hyp ukn ukn PKD n - 
Risk factors 
Hypertension y n y n n y n n n n - 
Cholesterol n n n n n n n n n n - 
Diabetes y ukn n n n ukn y n n n - 
GERD n y n n n n n n n n - 
Pneumonia n n n n y n n n n n - 
Dementia n n n n n n n y n n - 
Atherosclerosis 
Coronary n y n n n n n n n n - 
PMR = post-mortem recovery time, Alzheimer’s = Alz, CA = cardiac arrest, CAD = Coronary artery 
disease, CHF = Chronic heart failure, CPA = Chronic pulmonary aspergillosis, COPD = Chronic 
obstructive pulmonary disease, GERD = Gastroesophageal reflux disease, HB = Heart blockage, Hyp = 
Hypertension, NC = Natural causes (old age), RA = Respiratory arrest, PKD = Polycystic Kidney 
Disease, ukn = unknown. 
 
3.3.2 Biaxial mechanical behavior 
Individual equi-biaxial responses for ten human CS vessels are plotted in Fig. 3-2-A&B. There 
was a large variation in mechanical responses in both circumferential and longitudinal directions within 
the human samples, particularly the circumferential response which varied the most from a minimum 
strain of 0.18 in Spec 6 to a maximum of 0.45 in Spec 7. At low stress, the circumferential direction was 
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very extensible, while the longitudinal direction stiffened more rapidly at low strain. At high stress above 
20 kPa, the tissue response in both directions exceeded the typical “toe” region and exhibited rapid 
stiffening.  
 
Figure 3-2: Equibiaxial results of ten human coronary sinus specimens in a) the circumferential (Circ.) 
and b) longitudinal (Long.) directions.  
To compare the stress-strain responses of human, ovine and porcine specimens, mean response 
curves for each species are plotted in Fig. 3-3. All tissues exhibited the nonlinear stress-strain behavior of 
a typical blood vessel. However, a more gradual transition from low to high stiffness regions was 
observed in ovine and porcine, while human CS had a more pronounced rapid stiffening effect at the 
transitional region in both directions. 
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Figure 3-3: Mean equibiaxial responses of human (H), porcine (P) and ovine (O) CS tissues in the 
circumferential (C) and longitudinal (L) directions.  
Differences in tissue properties among the species were examined by means of the secant moduli 
at stress levels of 15 and 50 kPa. In Fig. 3-4, a statistically significant difference was found between 
human and ovine (p < 0.001 at 15 kPa and p = 0.001 at 50 kPa) and between human and porcine (p = 
0.002 at 15 kPa and p = 0.003 at 50 kPa) in the longitudinal direction. Ovine and porcine tissues did not 
differ at either stress level (p = 0.449 at 15 kPa and p = 0.437 at 50 kPa). For the circumferential response, 
only human and porcine tissues were significantly different at 50kPa, with p = 0.024.  
      55 
 
Figure 3-4: Tissue stiffness computed at membrane tensions of 15 and 50 kPa, comparing between 
human, ovine, and porcine tissues. (*) indicates the statistical significant difference between the two pairs. 
Data are presented as mean and standard deviation.  
The DA value by means of the strain ratio at a stress of 50 kPa was determined. The anisotropy of 
human tissues (0.59 ± 0.26) was greater than those of porcine (0.78 ± 0.15) and ovine (1.02 ± 0.37). 
Ovine tissue exhibited a nearly isotropic response, which can be seen in Fig. 3-3. To further analyze the 
tissue anisotropy, a paired-t test was used to quantify the association between the two directions of each 
species. Human and porcine exhibited a statistically significant anisotropy with p = 0.004 and p = 0.002, 
respectively, while ovine tissues did not show anisotropy, p = 0.618. 
 Statistical analysis did not reveal any correlation between age and thickness, stiffness, 
and maximum strain in human specimens. Though there was not enough data to group the 
results based on medical conditions, equibiaxial data did show that stress-strain curves of three 
hypertensive patients were shifted to the left of the data range (Fig. 3-2). 
3.3.3 Constitutive Modeling 
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The constitutive parameters for each species are summarized in Table 3-2. The Fung-type elastic 
model was able to capture the CS planar biaxial mechanical behavior well with the high R-square (R2) 
value of 0.95 ± 0.03 for human, 0.93 ± 0.09 for porcine and 0.93 ± 0.05 for ovine. Representative curve 
fitting plots of human, ovine and porcine CS are shown in Fig.3-5.  
Table 3-2.  Fung model parameters for human, ovine and porcine CS specimen. Data are presented as 
mean ± standard deviation. 
Specimen C A1 A2 A3 A4 A5 A6 R2
Human  0.47 ± 0.28 28.62 ± 12.94 76.10 ± 30.76 1.99 ± 7.69 48.80 ± 16.52 -0.10 ± 4.08 -2.79 ± 8.66 0.95 ± 0.03
Ovine 6.22 ± 3.07 9.22 ± 8.77 12.28 ± 14.31 0.45 ± 3.86 10.82 ± 12.43 -0.25 ± 1.12 -0.24 ± 1.78 0.93 ± 0.05
Porcine 7.99 ± 10.17 4.17 ± 2.29 9.85 ± 6.45 1.59 ± 2.43 6.84 ± 2.97 -0.14 ± 0.56 0.20 ± 0.44 0.93 ± 0.09
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Figure 3-5: Representative stress-strain response data for human (top row), ovine (middle row) and 
porcine (bottom row) CS tissues (dot lines) fitted with Fung elastic model (red lines). CIRC - 
circumferential direction, LONG – Longitudinal direction.  
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3.3.4 Histology 
Differences in the microstructure between human, ovine and porcine specimens can be seen in 
Fig. 3-6. In Fig. 3-6, the circumferential histology images of CS posterior section of each species showed 
differences in the content of striated muscle fibers (SMFs) and elastic constituents. The intima layer of 
aged human CS tissues was composed of a highly dense network of collagen fibers which intertwined 
with longitudinal elastin fibers. It was prominently thicker than those of younger ovine and porcine 
tissues. The decrease in wall media in human tissues was accompanied by a significant decrease in the 
SMFs and a noticeable increase in collagen fibers. Elastin were found to be abundant in both the internal 
elastic lamina and the media but organized in multiple fragmented layers. In contrast, elastin fibers as 
well as collagen were less developed in younger ovine and porcine tissues.  
 
Figure 3-6 – The cross-section histological results of human, ovine, and porcine posterior CS sections in 
the circumferential direction. Human CS is thinner with less striated myocardial fibers (SMF) and 
exhibits a higher elastin/collagen contents than ovine and porcine CS in the intima layer. Black fibers - 
elastin, pink fibers - collagen, brown fibers - striated myocardial fibers. (x100 Magnification, bar length is 
200 µm).  
 Studies on the CS anatomy reported a continuous cuff of striated muscle surrounding the external 
wall of the CS vessel [81, 82]. Similar structure was observed in all specimens. However, in human CS 
tissues, the striated muscle cuff is scarcely distributed around the posterior wall, that is the free-wall 
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region of the CS. In contrast, the muscle cuff covered the posterior sections and accounted for the 
majority of the wall thickness in both ovine and porcine tissues. The anterior section of the CS wall for 
human, ovine, and porcine tissues was composed mainly of the striated muscle fibers with dispersed 
elastin and collagen fibers.   
 Discussion 3.4
3.4.1 Anatomical differences  
 Several anatomical differences of the coronary venous vasculature between human, porcine and 
ovine species were observed. First, the oblique vein of Marshal (OVM) of the left atrium is found in 
human while the left precaval vein (LPV) is seen in both porcine and ovine, see Fig. 3-7. Both the OVM 
and LPV are remnants of the left superior vena cava. The LPV is completely patent and its diameter is 
larger than that of the OVM, but they both have the same function, which is to drain blood into the 
coronary sinus. The porcine LPV is found to be the largest and appears to be a continuation of the CS. 
The larger LPV, in some cases, resulted in a reduction of CS length and a wider junction of the LPV, 
GCV and CS. This could possibly prompt stent slippage due to lack of anchoring if positioned near the 
junction. Second, the GCV was observed to be narrowest in porcine, and the ovine GCV was smaller but 
similar in size to the human GCV.  For the distal anchor of the PTMA device to be deployed, the GCV 
diameter needs to be equal or larger than 3 mm [80]. The porcine GCV appeared to be smaller than 3 mm 
in diameter and might not be suitable for the distal anchor deployment. Lastly, a high variation in the 
location of the left circumflex artery (LCX) was observed in all species, suggesting a careful imaging 
assessment prior to the procedure is necessary to reduce LCX perforation and impingement in the 
coronary flow in all species. 
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Figure 3-7 A sketch of the tributaries of the coronary sinus vessel, showing the tapered oblique 
vein of Marshall (OVM) in human and the patent left precaval vein (LPV) in ovine and 
porcine tissues. The great cardiac vein (GCV) of porcine is narrowest among the three species. 
(*) indicates the ostium of the CS vessel. 
3.4.2 Mechanical properties and implications of PTMA intervention.  
Our results showed that the excised human CS stress-strain relationship is non-linear and 
anisotropic with the circumferential direction being more compliant. When comparing with ovine and 
porcine CS tissues, human tissues were found to be stiffer and highly anisotropic. High stiffness of human 
CS tissues might be accounted for by the advanced age of the patients selected in this study (86.5 ± 9.7 
years). Tissue stiffness has been shown to increase with age due to the degeneration and fragmentation of 
elastin fibers [119] and an increase of collagen content [120, 121] which were observed in our human CS 
tissues.  Therefore, it is possible that the mechanical properties of older porcine and ovine CS tissues 
more closely resemble those of an aged human, although this has not been assessed.   
Animal models were first tested to evaluate the feasibility of the PTMA devices for the treatment 
of MR. Previous studies using ovine models demonstrated the feasibility of PTMA devices in reducing 
MR. However, for the human trials of three PTMA devices reported in 2006 and 2007, the results were 
suboptimal. Specifically, Webb et al. [72] reported fracture of the device bridge element in three of four 
patients implanted with a permanent Monarc PTMA device. Duffy et al. [73] observed that the distal 
anchor of a Carillon PTMA device did not hold tension during device traction in two of five temporarily 
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implanted patients. Dubreuil et al. [79] reported temporary placements of a Viacor PTMA device in 
patients with an ischemic MR and MA dilation. They found that the MA diameter after the device 
implantation remained large compared to the surgical annuloplasty results. A more recent study in 2010 
on the second generation Monarc PTMA device reported a reduction in MR by ≥ 1 grade at 12 months in 
50% of 22 implanted patients [80]. Unsuccessful implantations were associated with the lack of 
appropriately-sized devices (n = 13), inaccurate device positioning resulting in no MR reduction (n = 4), 
device migration (n = 1) and fracture of the proximal anchor (n = 4). Thus, the success of PTMA animal 
trials was not reflected in human trials. Even though doubts always exist regarding the validity of animal 
models and their applicability to humans, there is clearly a lack of scientific evidence and engineering 
quantification of the discrepancy between animal and human trials. 
In this chapter, we observed substantial differences in material properties between the animal and 
human CS, where the animal CS tissues were more compliant and deformable than the human ones. This 
indicated that the biomechanical environment in which the PTMA device is embedded was different in 
animals and humans.  Therefore, the PTMA device might function well in animal models due to a 
relatively low tissue-stent interaction force. In contrast, under the stiffer mechanical environment in 
humans, the PTMA device may experience a higher interaction force which could possibly affect its 
durability. This observation underscores the importance of having an appropriate animal model for 
evaluating device function for its ultimate use in human. 
3.4.3 Limitations and future study 
The age range for the majority of MR patients is 60-70 years. In this study, our patient group is 
87 ± 10 years old. The material properties of soft tissues were known to be stiffer with age and diseased 
cardiac tissues are age-related. However, in this study, we did not study the influence of age on the human 
CS tissues and only compared the available aged human group to animal types.  In addition, due to 
limited access to fresh human tissues, in this study, we used fresh frozen human tissues. To facilitate the 
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comparison of human, porcine and ovine tissues, we also froze fresh porcine and ovine tissues at -80°C 
prior to biaxial mechanical testing. Thus, by utilizing a similar freezing protocol for all of our samples, we 
could avoid inconsistency in tissue storage. Nonetheless, the fact that we do not have fresh human tissue 
is a limitation of this study.  
 Our histological analysis showed that CS is non-homogenous and composed of layers of 
constituents (elastin, collagen, and striated myocardial fibers). In this study, the CS was modeled as a 
single-layer homogenous structure. A multiple layered material model incorporating structure-motivated 
phenomenon might provide a more accurate estimate of layer-specific material properties [122]. Other 
imaging methodologies such as scanning electron and two-photon laser scanning confocal microscopy 
might be helpful for collagen and fiber structural analysis (e.g., the fiber diameter and undulation period), 
to further correlate the structural findings with the mechanical properties of the vessel. Moreover, PTMA 
devices interact with the CS wall as well as the surrounding tissues, i.e., the mitral annulus, leaflets, 
chordae tendineae and the adjacent myocardium. To fully evaluate the PTMA device function, the 
mechanical properties of these interposed tissues, besides the CS wall, need to be quantified as well. 
Lastly, the sample size for each species in this study was relatively small; a larger sample size would 
provide more conclusive results. 
 Summary 3.5
We observed a discrepancy in mechanical and microstructural properties of CS vessels in aged 
human, ovine and porcine species. Overall, the human CS vessels were stiffer in both the circumferential 
and longitudinal directions than the ovine and porcine CS vessels. Higher collagen, lesser SMF, and 
fragmented elastin fibers found in human CS tissues demonstrated the effects of aging. This study also 
showed that the mechanical properties of CS tissues varied largely among patients. PTMA device studies 
involving animal models should be evaluated carefully given the distinguishable mechanical and 
structural differences between aged human, ovine, and porcine CS vessels obtained in this study. 
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4 Quantification of Tension to Cinch the Mitral Annulus 
Through the Coronary Sinus* 
As mentioned in Chapter 1, PTMA device’s main function is to shrink or cinching the mitral 
annulus to reduce the dilated mitral annulus, thus improve MR. Currently, there is a lack of information 
on the magnitude of the cinching force required to shrink the mitral annulus.  In addition to the structural 
and material property characterizations of the CS vessel conducted in Chapter 2 and Chapter 3, in this 
chapter, an ex vivo whole heart study was performed. An novel experimental setup was developed to 
obtain the relation between cinching force, via the CS vessel imbedded in the heart, and mitral annular 
area reduction, using a ovine model.   
 Introduction 4.1
Previous investigation on MA mechanics demonstrated the tension was lower in the commissural 
section (17.8 N/m) compared to anterior (40.0 N/m) or posterior (30.6 N/m) sections of the annulus [123-
126]. These studies offered insights into the underlying mechanism of annular dilatation. Annuloplasty 
complicates the annular mechanics by undersizing the dilated MA geometry [127].   Some studies 
measured the forces generated by the myocardium on a prosthetic device and correlated them with 
changes in MA geometry. The maximum in-plane MA force generated by the myocardium on  a rigid 
annulplasty ring in a porcine mitral valve was 6 – 8 N at mid-systole[128]. The influence of a flexible ring 
was studied in swine models and the maximum force was in a range of  4.4 – 13.9 N [129]. Later, the 
development of saddle-shape bioprosthetic valve represented a novel advance in design to reduce the 
leaflet stress [130-133]. In a comparative study, the forces on the anterior and commissural annular 
                                                     
* The contents of this chapter were partially published in:  
S.  Bhattacharya, T. Pham,  Z He,  W Sun, “Tension to passively cinch the mitral annulus through 
coronary sinus access: an ex vivo study in ovine model”, Journal of Biomechanics, (submitted). 
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segments of the flat ring were 0.72 ± 0.14 N and 1.38 ± 0.27 N, respectively, while the saddle-shaped ring 
exhibited nearly zero[134].   
These studies, however, only provided knowledge of cyclic forces that a device could experience 
during implantation, e.g. myocardial forces acting on the device, but not the force generated by devices 
necessary to reduce the dilated MA. A fundamental question arises: what are the contributions from active 
myocardial contraction, passive myocardial deformation, hydrostatic blood pressure and leaflet annulus 
tension to the forces on the devices? The answer  will not only  facilitate the design and increase safety of 
annuloplasty devices but help to understand myocardial function and MA dilatation mechanism. In this 
chapter, an ex vivo technique was developed to quantify the CS cinching tension. The goal is to form a 
baseline value of cinching tension needed to correct dilated MA. The ovine model has been used 
extensively in experimental mitral valve mechanics studies [135, 136] and pre-clinical studies of TMVR 
[137-139]. The impact of cinching tension on the MA area, septal-lateral (S-L) and commissure-
commissure (C-C) diameters and leakage in dilated valves were investigated.   
 Materials and Methods 4.2
4.2.1 Specimen Preparation 
 Ten fresh adult ovine hearts (mean weight: 313.5 ± 51.90 gram) were obtained from a local 
slaughter house. The hearts, which were not tested within 48 hours upon arrival, were cryopreserved at -
80°C [110]. Studies have shown that a short period of cryopreservation do not induce significant changes 
in vascular tissue mechanical properties [140-143]. For each heart, the left atrium was carefully removed 
to expose the mitral valve (MV), the MA, the CS vessel and CS ostium. Small graphite markers were 
affixed to the MA to demarcate the area to be measured (Fig. 4-1c). A suture was inserted within the CS 
vessel with one end tied at the GCV end and the other end exited the CS ostium. The coronary arteries 
and CS attributes were occluded by sutures. 
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Figure 4-1: a) An image of the mitral valve (MV) cinching system consists of a computer acquisition 
system, a force transducer connects to a slider and a digital camera; b) a top view of a representative heart 
showing the location of the MV, the tissue dye highlighting the measured MV area, the coronary sinus 
(CS) vessel, the Great Cardiac Vein (GCV) vessel and the cinching force, F; c) the representative 
captured digital images of the reference area, A0 and the area after pulled at a distance, Ai. 
 
4.2.2 The MV cinching system setup 
The experimental system consists of a water column, a pump, a clear Plexiglas solution chamber, 
a custom-made rigid supporting structure, a slider system, one digital camera and a computerized data 
acquisition system (Fig.4-1a).  Each heart was stabilized by fixing the right ventricle to the custom-made 
supporting structure placed inside the Plexiglas chamber. The left ventricle (LV) pressurization was 
achieved by injecting saline solution into the LV through a cannula, which was inserted into the 
ascending aorta vessel and passed the aortic leaflets.  The water column, fabricated with a large-bore 
tubing attached to the aortic cannula. Ethylene-Glycol-Tetraacetic acid (EGTA, 2.0 mM) and papaverine 
(0.1M) were added to the saline solution (37ºC) to minimize the active contraction of muscle fibers in 
order to obtain the passive mechanical properties of the heart. The LV pressure was controlled by the 
height between the saline level in the water column and the mitral annular plane [144]. A quasi-static 
system was chosen as the MV experiences highest force during peak systole or when the valve is fully 
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closed. A peak hydrostatic systolic pressure of 90 mmHg is chosen for the physiological pressure of an 
ovine heart [145, 146]. The leakage volume was measured by an amount of fluid regurgitated back into 
the left atrium during pressurization. The testing chamber was threaded with an outlet tube that drained 
the regurgitated fluid into a graduated cylinder for leakage measurements.  
The slider system consists of a force lever, which was connected to a 10 N force transducer 
mounted on a linear stage. The handle of the linear stage can be manually rotated to linearly displace the 
force lever with an accuracy of ± 0.01 mm. The force transducer was connected to high-performance data 
acquisition device (National Instrument,NI SCC-68/SCC-SG24, NI 6351). A custom-made LabVIEW 
program was created to record the force transducer data at each displacement. The force transducer was 
calibrated prior to each experiment. The MA measurements were obtained from a digital camera mounted 
perpendicular to the MA plane.  
4.2.3 Experimental protocol 
Each heart was preconditioned by applying 10 consecutive pressure loading (90 mmHg) cycles. 
The experimental measurements including the MV cinching tension, MV area, leakage and MA area 
measurements were obtained during the three phases when the mitral valve was: 1) open (no pressure, 
P0), 2) close (pressurize at 90 mmHg, P90), and 3) altered or dilated at 90 mmHg pressure (P90-D). The 
P0 was performed to measure the cinching force generated by the suture inside the CS vessel during the 
passive relax state. The P90 was chosen as a baseline value for normal valve function during left 
ventricular filling. For P90-D, the MV dilation was achieved by injecting phenol (95%), into the muscular 
MA using a needle. The toxic substance in phenol can damage the structure and function of the muscle 
and has been utilized in an in vivo study to simulate the dilation of the mitral annulus [147]. To cinch the 
MA, the suture end at the CS ostium was pulled in the direction perpendicular to the C-C direction of the 
MA (Fig. 4-1b). For each pull, a linear displacement, d, of 2 mm for a total of 9 displacements in each 
phase was achieved (di, i = 0, 2, 4…12, 16 and 20 mm).  
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4.2.4 Data acquisition and analysis 
The cinching tension (T) and the corresponding image of MA were measured simultaneously at 
an instant of a displacement. All the MA dimensions were measured using ImageJ (National Institute of 
Health). The MA area, A, was defined as the area encompassed by the markers. The S-L diameter was 
calculated as the distance between the two markers placed on the mid-septal and mid-lateral mitral 
annulus, and the C-C diameter was measured as the distance between the two markers placed on the 
commissures (Fig. 4-1c).  The leakage (L/min) was measured after visualization of full expansion of the 
LV and closing of the MV for 20 seconds.    
4.2.5 Statistics  
All measurements are shown as mean ± standard deviation (SD). The analysis of variance 
(ANOVA) test followed by the Holm-Sidak test and the Dunn’s Method test were used to compare 
measurements between the three phases. Data were tested for normality using the Shapiro-Wilk test. The 
Student’s t-test was used to determine significant differences. The paired Student’s t-test was employed to 
determine the significant changes in parameters at a certain pull distance. Correlations between the 
parameters were determined using the Pearson’s (for normal) and Spearman (for non-parametric data) 
correlation coefficient (r). A probability value less than 0.05 was considered statistical significant, with 
high significance indicated by p < 0.001. All statistical analyses were performed using SigmaPlot (Systat 
Software Inc., San Jose, CA) and SYSTAT (Systat Software, Chicago, IL). 
 Results 4.3
The MA deformation after each incremental load increase of a representative ovine heart during 
the three phases is shown in Fig. 4-2. The decrease in the mean MA area after each pull in each phase is 
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shown in Fig. 4-3a. Prior to pulling, the MA area increased 23.34 ± 18.02% from P0 to P90 and dilated 
further by 22.83 ± 0.06% in P90-D. Upon pulling about 16 mm (d16), the dilated MA area was reduced by 
26.17% (from 8.35 ± 2.00 cm2 to 6.62 ± 1.85 cm2) and similar to the baseline value (6.80 ± 1.89 cm2). 
From Fig. 4-3b, at d = 16 mm, T required to reduce the dilated MV area to the baseline was 2.10 ± 0.47 
N. It can also be seen that T generated by the suture (P0) alone without pressurization was 0.38 ± 0.10 N. 
 
Figure 4-2: Images of a representative mitral valve deformation at d = 0, 4, 8, 12, 16 and 20 mm during 
the three phases: (P0) when the mitral valve was open at zero pressure), (P90) close or pressurized at 90 
mmHg, and (P90D) after the mitral annulus was dilated and pressurized. (Dimension is in millimeter) 
 
The mean S-L diameter increased significantly by 26% from the baseline to dilation (from 2.23 ± 
0.31 cm to 2.81 ± 0.25 cm, p < 0.001). At d16, the mean S-L diameter was significantly lower than d0 
(2.14 ± 0.27 versus 2.81 ± 0.25, p < 0.001) and below the baseline value (2.14 ± 0.27 cm to 2.23 ± 0.31 
cm, p = 0.485). The C-C diameter was increased by 11% after dilation. However, the C-C diameters 
obtained during P90-D remained unaffected throughout the experiment (Fig. 4-3c). The mean C-C 
diameter in P90 at d0 was 3.09 ± 0.39 cm and in P90-D at d16 was 3.36 ± 0.36 cm, p = 0.121.  A summary 
of comparisons of the MV area, the S-L and C-C diameters and the leakage rate between baseline at no 
pull (d = 0) and dilated condition at 16 and 20 mm pulling distances (d = 16 and 20) are listed in Table 4-
1.  
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Table 4-1.  Summary of ovine heart data showing the mean and standard deviation (SD) of the mitral 
valve area (MV), septal-lateral (SL) and commissure-commissure (CC) diameters, leakage at 90 mmHg 
pressure and the change in pressure during the experiment.    
 
 
During pressurization of 90 mmHg
Baseline  Dilated 
at d=0  at d=0  at d=16 at d=20 
MV (cm2) 6.80 ± 1.89 8.35 ± 2.00 6.62 ± 1.85 6.27 ± 1.77
S‐L dia (cm) 2.23 ± 0.31 2.81 ± 0.25* 2.14 ± 0.27† 2.01 ± 0.26†
C‐C dia (cm)  3.09 ± 0.39 3.42 ± 0.36 3.36 ± 0.36 3.38 ± 0.35
Leakage (L/min)  0.09 ± 0.07 0.18 ± 0.09 0.09 ± 0.07 0.08 ± 0.05‡
* compared to baseline d=0, P < 0.001, † compared to dilated d=0, P < 0.001, ‡ compared to
dilated d=16, P < 0.05
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Figure 4-3: The relations between distance pulled and a) area (cm2), b) force (N) and c) septal-lateral (S-
L) and commissure-to-commissure (C-C) diameter of the ovine hearts in three phases of valve open 
(P=0), valve close at 90 mmHg pressure (P=90) and valve dilation at 90 mmHg (P=90 Dilation). Data are 
shown as mean ± standard deviation. 
 
The relation between MA area and T in each phase is shown in Fig. 4-4a.  At a maximum pulling 
distance (d20), a small tension of 0.6 N was required to shrink 58% of the MA area during P0. At the same 
tension, as expected, only 9% and 11% MA reduction were achieved for P90 and P90-D, respectively. At 
15% MA area reduction, the tension of both P90 and P90-D was 1 N. After this point, the P90-D response 
curve shifted down slightly, indicating a larger tension would be required to shrink the MA area. The 
decrease in the MA area was accompanied by the reduction in the S-L and C-C diameters, and no 
difference was observed between P90 and P90-D, see Fig. 4-4b. At 2.10 ± 0.47 N, when the dilated MA 
area returned back to the baseline value, a 21.30 ± 5.6% reduction in the MA area and a 24.18 ± 5.28% 
reduction in the S-L diameter were achieved.   
 
Figure 4-4: The relation between (a) mitral annulus area and cinching tension, and between (b) S-L and 
C-C diameters and cinching tension. Data are shown as mean ± standard deviation. 
 
Figure 5-5 shows the changes in the MA area, the tensions and the leakage rates from the initial 
(d0) to the final (d24) pulling distances. In the normal hearts, we observed a small leakage of 0.094 ± 0.070 
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L/min. After phenol application, the leakage rate increased to 0.181 ± 0.008 L/min or by 93%. The 
progression of annular cinching caused the MA area to decrease progressively with leakage rate (r = 
0.992, p < 0.001 for P90 and r = 0.957, p < 0.001 for P90-D). The T was reversely correlated with leakage 
rate (r = -0.983, p < 0.001 for P90 and r = -0.912, p < 0.001 for P90-D). Leakage was reduced to normal 
leakage rate at 1.71 N, and the MV area approached to normal at 6.76 cm2. 
 
Figure 4-5: The correlations between the mean leakage rate and mean mitral area and mean cinching 
tension in the a) normal and b) dilated conditions. Solid and dashed lines are the linear fits of the data. 
The d0 indicates no pull, and d20 is 20-mm pulling distance. 
 
 Discussion 4.4
Despite the increase in the development of TMVR devices, limited information is available on 
device forces required to restore normal valve function. An ex vivo technique developed in this study aims 
Leakage (L/min)
0.04 0.06 0.08 0.10 0.12 0.14 0.16 0.18 0.20
A
re
a 
(c
m
2 )
4
5
6
7
8
9
10
Fo
rc
e 
(N
)
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Ar
ea
 (c
m
2 )
4
5
6
7
8
9
10
Fo
rc
e 
(N
)
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
d0d20
d0
Δ = 93 %
Normal
Dilated
Area (dilated)
Linear Fit (Dilated area)
 r2 = 0.92
Force (dilated)
Linear Fit (Dilated force)
 r2 = 0.83
Area (normal)
Linear Fit (Normal area)
r2 = 0.98
Force (normal)
Linear Fit (Normal force)
 r2 = 0.97
Te
ns
io
n 
(N
)
Te
ns
io
n 
(N
)
      72 
to quantify the cinching tension (T) needed to restore normal MA from dilation in the passive ovine heart 
model. The MA dilation was achieved up to 22.83% and the S-L and C-C diameters were increased by 
26% and 11% upon dilation, respectively. Various studies have demonstrated significant changes of MA 
in either ischemic or acute cardiomyopathy that resulted in significant MR. An in vivo animal study 
demonstrated  that in chronic ischemic MR condition, the entire mitral annular regions, including the 
fibrous (anterior) and muscular (posterior) sections, dilates proportionally [148]. Timek et al. [149] 
showed that the progression of acute ischemic MR in ovine models was characterized as 20% - 28% 
(mild/moderate – moderate/severe) increase in MA area and 14% - 19% increase in S-L diameter. For 
human study, significant MR caused by ischemic cardiomyopathy was characterized as 31% increase in 
MA area and 17% and 11% increase in S-L and C-C diameters [150]. Thus, the increase in both MA area 
and S-L and C-C diameters in this study showed an indication of MA dilation.   
The loading condition on the MA is primarily due to the LV pressurization achieved by the 
hydrostatic pressure.  The T from the suture is, therefore, an additional force on the LV wall and the 
leaflets connecting to the MA to balance the hydrostatic pressure force. From Fig. 4-3, during the P0, T 
generated by the suture was 0.06 ± 0.01 N (P0, d = 4 mm), resulting in MA area of 4.88 ± 1.63 cm2.  The 
T required to reduce to a similar MA area with a presence of the hydrostatic pressure was 2.80 ± 0.56 N 
(P90, d = 20 mm). Thus, the increase in T as the result of hydrostatic pressure can be calculated as P90 – 
P0, approximately 2.74 N or increased by 4557%. This drastic increase in T between P0 and P90 
indicates that LV pressure is an important factor in determining the effective T of the device. To 
determine the change in T with the presence of MA dilation, the difference between T at P90 and P90D 
was obtained. At a MA area of 6.3 ± 1.8 cm2, T of P90 and P90D were 0.41 ± 0.09 N and 2.62 ± 0.43 N, 
respectively, resulting in 2.21 N, or increased by 539%. Since the pressure was constant for both phases, 
this increase in tension directly relates to the impaired muscular tissue around the MA due to phenol 
injection. Thus, we can view this suture cinching tension as a compensation force in MA reduction. In 
other words, T indicates the maximum force to be generated by the device necessary to restore normal 
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MA geometry without active myocardial contraction, and usually depends on severity of annular 
dilatation.   
The cinching tension, however, can be less in magnitude during LV contraction. An in vivo ovine 
study of Siefert et al. [151], they measured the MA forces using a custom-made device with strain gauges 
placed directly on the MA in S-L and C-C directions [151]. The mean S-L and C-C forces of normal 
ovine group at 90 mmHg were 3.9 ± 0.8 N and 2.6 ± 0.6 N, respectively. In another study [152], the same 
group found a significant decrease in the S-L forces as the result of ischemic MR with inferior left 
ventricular infarction. Their findings support the notion that the active contraction mechanism might have 
been impaired in ischemic MR [153-155]. Daimon et al. [153] found that their IMR patient group had an 
attenuated mitral annular motion and a reduction in MA contraction by 23.0 ± 6.5% compared to the 
normal group of 42.6 ± 7%. In addition, their analysis showed that annular contraction was the strongest 
determinant of the severity of MR among the annular measurement. The hydrostatic pressure in this study 
is not considering in vivo annular contraction and expansion of myocardial fibers. Thus, the active 
contraction properties of the MA might relieve this suture tension. However, active contraction in relation 
to cinching tension is remained to be determined.  
 The experimental technique used in this study for MA restoration only allowed a significant 
reduction in the S-L dimension while the C-C dimension remained unchanged, which can be seen in Figs. 
5-3&5-4. The impact of C-C dimension in restoring MV competency, however, is still a debate. Several 
clinical and experimental studies have shown that S-L dimension has a prominent role in functional MR 
[156] and that reduction in S-L diameter alone is sufficient to restore leaflet coaptation [157, 158].  
Restoration of normal MV by cinching the MA was adopted by several novel methods. A device 
called the cerclage, was designed and tested in swine subjects to shrink the entire annular circumference 
and S-L diameter [159]. The device is made of a braided non-absorbable suture that encircles the mitral 
annulus via the CS vessel, septal myocardicum, right ventricle and atrium path, and tying the two ends.  
Using 16 swine subjects, the S-L diameter reduction was measured at three tension forces (200g, 400g 
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and 600g), and a maximum of 20% of the reduction in both systole and diastole at 600 g (~6 N) of tension 
was observed. This high magnitude of tension could be the result of  shrinking a massive muscular 
structure that included both MA and right ventricle.  Timek et al. demonstrated  that S-L diameter 
reduction was achieved by more than one trans-annular sutures connected from locations on the anterior 
fibrous region to the posterior annulus[160, 161] but no force was measured. Recently, Jensen et al. [162] 
found that at 32% of trans-annular trigone-posterior annulus distance reduction at three different location, 
the peak forces were 1.2 ± 0.9 N, 1.5 ± 1.0 N, and 0.8 ± 0.2 N with no significant difference between 
them. Interestingly, the sum of the forces ranged from 0.12 ± 0.03 N to 3.5 ± 1.3 N, which matches our 
results even though force directions and suture techniques were different. Their cyclic traction suture 
forces increased with increasing levels of downsizing as our cinching tensions increased with increasing 
MA area reduction. It should be noted that the magnitude of forces measured is dependent on the type of 
device [162] and how it shapes the MA. Difference in the locations of device implantation (e.g. within the 
CS vessel or directly on the MA) and various hemodynamic and boundary condition could affect both 
MA geometry and mechanics.      
Currently, there is a lack of understanding of biomechanics involved in the device design and 
optimization of TMVR devices, possibly due to the complex MV geometries. Fortunately, in the past 
decade, the mechanical testing techniques and constitutive modeling in cardiovascular mechanics have 
improved tremendously. Human tissue material properties can now be tested extensively [163], modeled 
and implemented in computational studies [45]. Improved computational models of MV has evolved [31, 
46, 164-167] and predicted several diseased states [43, 168-170].  Thus, the data in this study can be used 
in validation of computational models to predict the functionality of TMVR devices.  
There are several limitations in this study. The data are valid for isolated MA dilation model 
which is distinctly different from ischemic MR model [171]. The mitral valve closure due to the 
hydrostatic pressure could alter the native MA mechanics by the expansion of the global LV. Leaflet 
coaptation height, depth and tethering length were not recorded as the result of 2D imaging, thus, MR 
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grade was not classified. Future study using 3D echocardiography as an imaging acquisition technique 
will provide a new insight into the 3D dynamic behavior of the MV during cinching. This study did not 
account for global expansion and contraction of left ventricle, in vivo annular contraction and expansion 
of myocardial fibers. Thus, the active contraction properties of the MA and left ventricle may relieve this 
suture cinching tension. 
 Summary 4.5
This chapter investigated the cinching tension required to reduce MA dilation in passive ovine 
heart model. The MA was dilated up to 22.83%. A mean force of 2.1 ± 0.47 N was required for 21.30 ± 
5.6% in MA area reduction, reduced leakage by 51.72 ± 16.19% and restored the normal condition with a 
significant reduction in the S-L dimension. The cinching tension generated by the suture acts as a 
compensation force in MA reduction, implying the maximum tension to be generated by annuloplasty 
device to restore normal MA geometry. Several approaches that utilize the CS to rectify MA dilation have 
been developed, but long-term durability is yet to be achieved due to current fatigue and fracture events. 
Therefore, knowledge of the cinching force with the corresponding MA geometry will greatly contribute 
to the development and design of future TMVR devices and understanding of myocardial contraction 
function. 
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5 Simulated Biomechanical Interaction between 
Coronary Sinus and PTMA proximal anchoring stent* 
 
In previous chapters, we have collected experimental data and obtained material parameters from 
various constitutive models to characterize the mechanical properties of mitral tissues. From this chapter 
and onwards, we will implement the tissue properties and material models into Finite Element (FE) 
simulation and analysis. In this chapter, we will first introduce a method to analyze the biomechanical 
interaction between stent and tissue model using only a proximal section of the PTMA and a simplified 
CS geometry. As we performed and compared tissue properties between human and animal models in 
previous chapters, we will also applied different tissue properties and elucidate any difference between 
the human and animal models in the assessment and prediction of PTMA intervention. The FE software, 
ABAQUS (Pawtucket, RI), will be used throughout the dissertation as the finite element implementation 
platform due to its wide commercial availability.  
  
                                                     
* The contents of this chapter were partially published in:  
T Pham, M Deherrera and W Sun, “Biomechanical interaction between coronary sinus and proximal 
anchoring stent in percutaneous treatment of mitral regurgitation”, Computer Methods in Biomechanics 
and Biomedical Engineering 6(11): 4336–4344, 2012. 
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 Introduction 5.1
5.1.1 Nitinol stent and application  
Nickel Titanium or Nitinol (NiTi) material is known for its superelasticity or the ability to return 
to original shape after severe deformation. NiTi can be stretched over 10% and still return to its original 
length [172].   Figure 6-1a shows the loading and unloading cycle of Nitinol relative to other living 
tissues that is characterized by a pronounced hysteresis. Compare to stainless steel, NiTi is much weaker 
and exhibits a lower ultimate tensile strength. However, the loading and unloading curves exhibit plateau 
regions, which a large strain can be gained on loading and the same strain can be relieved upon unloading, 
without significant increase or decrease in loads or stress. Macroscopically, when stress is applied to 
NiTi, the superelastic NiTi changes its crystal structure from austenite to martensite. The Austensite (A) 
structure is cubic in nature, while the martensite (M) structure is complex monoclinic structure. When 
stress is removed, the material returns to the original structure and recovers its original shape.  
While superelasticity is the result of a stress induced phase transformation, shape memory is the 
result of a thermal phase transformation [173]. The transformation temperature of NiTi is characterized 
by four transformation temperatures: the martensite start temperature (Ms) which is the temperature at 
which the material starts transforming from austenite to martensite, martensite finish temperature (Mf), at 
which the transformation is complete and the material is fully in the martensite phase; austenite start 
temperature (As) at which the reverse transformation from austenite to martensite starts; and austenite 
finish temperature (Af) at which the reverse phase transformation is completed and the material is fully in 
the austenite phase. When cooling and in absence of applied load, the material transforms from austenite 
into twinned martensite with no shape change (Fig. 5-1c-phase A). At this stage, NiTi loses its stiffness. 
By applying a pure mechanical load, a full phase transformation from twinned martensite to fully 
detwinned martensite can be observed (Fig. 5-1c-phase B). Upon the presence of temperature Af, a 
complete shape recovery is observed upon unloading, resembling elastic material behavior (Fig. 5-1c-
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phase C). The effect of shape change and temperature dependency of NiTi is known as Pseudoelastic 
Effect, which described in a stress-strain relationship as shown in Fig. 5-1d.  
Nitinol is one of very few alloys that is both pseudo-elastic, thermal shape memory and 
biocompatible. Thus, NiTi has become suitable material for a variety of self-expanding (SE) stents. These 
SE stents are manufactured with a targeted diameter larger than the vessel diameter, so that they can be 
crimped and restrained in a delivery system, then elastically released into the vessel. Early design of NiTi 
stent was used in non-vascular applications, in a form of round or flat wire. For instance, Endocare s 
Horizon Stent was used for the relief of bladder outlet obstruction and IntraCoil Stent for treatment of 
patients with superficial femoral artery and popliteal artery lesions [173]. One advantage of simple wire 
coil is the capability to retrieve the stent. As mentioned earlier, NiTi stent loses its stiffness at cooler 
temperature, thus, retrieving can be easily done by a cold saline.  
In the mid-1990s, the laser cutting tubular NiTi stents become popular in many peripheral and 
vascular treatments.  Early examples of laser-cut tubular NiTi stents are Angiomed Memotherm and the 
Scimed Radius stents. The Memotherm was a rigid, closed-cell design with a diamond shaped pattern, 
and the Radius is a flexible open-cell design with sequential rings and periodic peak-to-peak non-flex 
bridges. More recent designs employ variations and/or combinations of these basic design features, e.g. 
SMART Stent (from Cordis), Jostent SelfX Stent (Jomed) and Dynalink Stent (Guidant).  
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Figure 5-1: a) Biomechanical compatibility of Nitinol: deformation characteristics of Nitinol and living 
tissues, adopted from; b) schematic stress-strain diagram for Nitinol and stainless steel; c) macrostructure 
of NiTi showing the Austenite and Martensite phases; and d) stress-strain curve of NiTi material. Images 
from (a) and (b) are adopted from [174].  
 
A distinctive feature of NiTi tubular stents is its nonlinear response and hysteresis. These unique 
features create such a great advantage for endovascular stenting applications. To illustrate this, the 
schematic stress-strain curve for NiTi can be described in the cycle of crimping a stent into a delivery 
system, deploying, releasing it into the vessel, as shown in Fig. 5-2 [173]. The stress axis is put as the 
hoop force and the strain axis as stent diameter. Since the stent is always manufactured in a way such that 
the final expanded diameter is larger than the vessel diameter, it needs to be crimped into the delivery 
catheter, from point a to point b, then packaged, sterilized and shipped. During the implantation, stent will 
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be released into the targeted vessel, expanding from point b until further expansion is prevented by 
impingement with the vessel (point c). Since the stent did not expand to its pre-set shape, it continues to 
exert a low outward force, called chronic outward force (COF). From point c to point d, stent will exhibit 
a force that will resist recoil pressures or any other external compression forces. This force is much 
stronger than the unloading force (point c to point e), which is called the radial resistive force (RRF). In 
summary, the stress hysteresis of NiTi allows a very low radial force, or COF, even stent is oversizing. 
The stent generates forces that resist compression, or RRF, until plateau stress is reached. It has been 
shown that the low COF allows vessel to remodel with less intimal hyperplasia [175].  
 
Figure 5-2: Schematic stress hysteresis and concept of biased stiffness as demonstrated with 
the cycle insertion into delivery system/deployment/compression of a tubular stent. Adopted 
from [173].  
 
5.1.2 Tissue-stent interaction (TSI) studies using Finite Element Analysis (FEA) 
Upon delivered, the stent comes into contact with the vessel wall, thus the COFs impose 
mechanical stresses on the vessel wall. In return the hemodynamic conditions (e.g. blood pressure) in the 
      81 
vessel generate cyclic pulsating load that accounts for the fatigue life of the device and eventually result 
in mechanical failures. The schematic of this cycle is illustrated in Fig. 5-3.   As self-expanding stents 
have proven to reduce vessel recoil and restenosis as compared to balloon expandable stents and provide a 
less invasive alternative for the treatment of endovascular disease [176], adverse events as the result of 
stent mechanical fatigue could result in undesirable clinical events  such as thrombosis and intimal 
hyperplasia [175] and particularly reoccurrence of MR in PTMA intervention. In order to prevent these 
adverse events, it is important to understand the tissue-stent interaction (TSI) and their mechanical factors 
that contribute to adverse outcomes during stent deployment process and after stent implantation.  
 
Figure 5-3: Biomechanical interaction between stent and tissue schematic 
Studies on the mechanical behaviors of NiTi stents and their interaction with surrounding vessels 
have been conducted by many researchers. Wu et al. [177] evaluated the biomechanical properties of NiTi 
carotid stents and their interactions with carotid arteries using FEA. Their TSI results showed that stent 
with shorter struts may have better clinical results and that stent geometries have an impact on vessel 
geometrical changes. Kleinstreuer et al. [178 studied the mechanical behavior (e.g. vessel stresses, stent 
strain and radial forces) and fatigue performance of different NiTi materials and grafts during crimping, 
deployment and cyclic pressure loading within the abdominal aortic aneurysm (AAA). Using the fatigue-
life diagram, they were able to predict the acceptable AAA stent-graft design during crimping and cyclic 
pressure loading. Azaouzi et al. {Azaouzi, 2012 #209] used Finite Element analyses (FEAs) to simulate 
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the deployment of self-expanding NiTi stent into the artery under pulsatile loading.  The authors analyzed 
the impact of stent geometries on the arterial and to assess the influence of artery on the deformation field 
within the stent. They concluded that stent geometries (e.g. length, width and thickness of strut) have an 
influence on stent strength and the amount of stent oversizing has an impact on stent fatigue life. 
Auricchio et al. [179] expanded FEA studies of self-expanding stent by evaluating three different stent 
designs (e.g. laser-cut open-cell, laser-cut closed-cell and braided closed-cell) in a patient-specific carotid 
artery. The authors found that stent design with closed-cell provides higher lumen gain and stent 
configuration and size have a limited impact on the vessel straightening.  
Although extensive work has been done to evaluate the self-expanding NiTi stents, little or no 
attention has been focused on characterizing the biomechanical interaction between the NiTi PTMA stent 
and the CS vessel. In this chapter, we present FEA of stent deployment within the CS vessel, considering 
the realistic material models of CS vessels. Our FEA provides quantitative measures of stress and strain 
of both stent and vessel and estimates fatigue life of stent, a very important key issue for medical 
implants.  
5.1.3 Human versus animal models  
 Animal studies have demonstrated the effectiveness of PTMA devices to reduce MR in heart 
failure induced by rapid pacing in the short- term [7-9]. However, initial human trials were suboptimal. 
The adverse events included compression of the left circumflex artery, perforation of vessel branches, 
device migration and device fracture [10-14]. Some of these issues may be improved by a detailed 
anatomical assessment of the CS and its tributaries prior to the procedure using imaging modalities such 
as multidetector computed tomography. Device dysfunctions involving device migration and fracture, 
however, are mainly associated with the biomechanical interaction between CS tissues and the device that 
is largely unexplored in the literature. In pre-clinical trials of cardiovascular interventional devices, 
animal results are often used as a guide for device design and development. However, without a 
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quantitative understanding of the difference between animal and human tissues and the associated device-
CS tissue interactions, the development of these devices based on ad hoc and trial-and-error approaches 
can be time-consuming and costly. In the present study, we first established a finite element (FE) study to 
evaluate the biomechanical responses of the proximal anchor of this PTMA device when interacted with 
the human and porcine CS walls. In addition, we chose two Nitinol stent materials to investigate the 
impact of stent material stiffness. The biomechanical interactive properties between the stents and the CS 
vessels were quantified by measuring the contact forces, vessel wall stresses, strains and fatigue safety 
factor of stents were analyzed. 
 Materials and Methods 5.2
5.2.1 Model Geometries 
The complete FE model for the stent deployment simulation consists of the proximal stent, the CS 
vessel, and the stent expanding and crimping sheaths. Geometrical and numerical details of the models 
are listed in Table 5-1. The proximal anchor can be thought of as an elastic lattice, deriving its strength 
from the joints and bending action of component struts. Because of the lack of symmetry in this part, the 
entire anchor has been modeled. The stent geometry, after the laser cut from a cylindrical Nitinol tube and 
electroplishing, was 21 mm in length with an inner diameter (ID) of 1.6 mm and a thickness of 0.3 mm, 
as shown in Fig. 5-4a. This stent geometry was further deformed, through a series of expansion and 
annealing process, to an expanded shape as shown in Fig. 5-4b. Typically, the stent anchor’s diameter is 
oversized and larger than the CS’s diameter by 2 – 4 mm [180]. Therefore, it was expanded from an ID of 
1.6 mm to a targeted ID of 14.90 mm, assuming the CS’s ID is 12 mm. The radial expansion was carried 
out in the FE simulation by displacing the expanding sheath that placed inside the stent anchor in 
increments of 3, 4, 6, 8, 12 and 15.50 mm in outer diameter (OD), each followed by an annealing step. 
The annealing process was simulated using a built-in function in ABAQUS (*anneal) where stent stresses 
and strains were set to zero. By dividing one large deformation step into several steps of small 
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deformations with an annealing process, the potential damages to the stent that may be caused by large 
deformations can be effectively reduced. The final deformed geometry of the stent anchor is shown in 
Fig. 5-4b, in which it was composed of two strut cells in the axial and twelve in the circumferential 
directions. The two pairs of stent struts were joined by a strut link (Fig. 5-4c). Crimping and release of the 
stent anchor were achieved by displacing the cylindrical crimping sheath located externally of the stent 
anchor inwardly and outwardly, respectively.  
 
Figure 5-4: a) The 3D undeformed shape of the stent prior to expansion-annealing process, 
showing the connector and the stent body that is composed of 12 struts in the circumferential 
(z) and 2 in the axial (x) directions; b) the 3D deformed shape of the stent after expansion-
annealing process; and c) the two struts of the stent are united by a strut link. The strut is 
twisted asymmetrically after the process. 
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Table 5-1. Geometrical and Finite Element modeling measures of all models 
 
 
A study by El-Maasarany et al. [85] on the anatomy of the CS vessel showed that 80% (32/40 
patients) of human specimens had coronary sinus as a cylindrical shape near the opening into the right 
atrium. Thus, we simplified our CS vessel model to a cylindrical tube, with an inner diameter of 12 mm 
and a thickness of 0.74 mm [181], to facilitate the comparison between different CS tissues and stent 
materials.  
The 8-node hexahedral linear incompatible mode element (C3D8I) was chosen to mesh both the 
CS vessel and the stent as C3D8I is preferred for stent analysis due to the nature of bending during 
loading. The 4-node quadrilateral element (M3D4R) was modeled for the expansion and crimping 
sheaths.  A mesh sensitivity analysis was performed, see appendix A for more details. 
 
5.2.2 Material properties and constitutive modeling  
The two different Nitinol materials, Nitinol 1 (N1) and Nitinol 2 (N2), were utilized in the 
simulations, adopted from Kleinstreuer et al. [182] with modifications. For an isothermal analysis as the 
Models
Dimension (mm)
Element type  No. of elementsUndeformed
CS 
ID
Thickness 
Length
12
0.74
60
C3D8I * 43,199
Stent 
ID
Thickness
Length
1.60
0.30
21
C3D8I * 114,219
Sleeve_expand
ID
Thickness 
Length
11
‐
41.5
M3D4R † 2,231
Sleeve_crimp
ID
Thickness 
Length
15.52
‐
41.50
M3D4R † 2,231
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one presented here, the stent material model can be defined by a stress-strain curve and “breakpoint” 
stresses, as shown in Fig. 5-5a. The inputs to this model are the two moduli of Elasticity, the plateau 
transformation strain and the five stress breakpoints. From Table 5-2, it can be seen that N1 material is 
stiffer than N2 material with higher austenite (EA) and martensite (EM) moduli. 
Table 5-2. The material parameters of CS vessels and stents 
 
 
The mechanical properties of the coronary sinus of both human and porcine were obtained from 
the pressure-inflation tests of porcine (n = 7, 6-9 months old) [183] and human (n = 4, 85.25 ± 7.41 years 
old) CS vessels. Briefly, the human CS vessels were subjected to the mechanical test while they were 
intact (i.e. the CS vessel was not dissected out of the heart). After 10 preconditioning cycles, the vessels 
were incrementally dilated up to 80 mmHg of pressure.  The dilated CS diameters were measured to 
obtain the CS pressure-radius curve, from which the hoop/axial stress-stretch relation were calculated 
[183]. We chose the Ogden isotropic nonlinear hyperelastic model [184] to characterize the experimental 
data, 

       i i iN a a ai 1 2 32
i 1 i
2W ( 3)
a ,     (6.1) 
where μi and ai are the material constants and λi are the principal stretches. The mean data from four 
human and seven porcine specimens were fitted with the Eq.6.1 to obtain the material parameters. The 
goodness of fit was determined using R-square value based on the Levenberg-Marquardt nonlinear 
µ1 (MPa) a1 µ2(MPa) a2 µ2(MPa) a2
Human 127.653 5.928 -63.082 11.851 4.674 19.317
Porcine 8.213 10.608 22.689 -5.748 -12.515 9.184
EA(MPa) νA EM
(MPa)
νM εL SL EL SU EU SCL T
Nitin-1 70,000 0.3 47,800 0.3 0.063 600 670 288 254 900 37
Nitin-2 40,000 0.3 18,554 0.3 0.04 390 425 140 135 585 37
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regression algorithm using SYSTAT 10 (Systat Software Inc., Chicago, IL). The Ogden model curve 
fitting results for both human and porcine tissues are illustrated in Fig. 5-5b & c. 
 
Figure 5-5:  a) A typical stress-strain curve for Nitinol material, mean b) human and c) porcine 
CS stress-stretch curves fitted with the Ogden model. 
 
5.2.3 Boundary and loading conditions  
The expanded geometry of the stent was crimped in a catheter prior to the PTMA deployment. In 
the simulation, the stent was crimped to an OD of 11.98 mm using a displacement-controlled deformation 
of the crimping sheath, see Fig. 5-6. After the stent release and deployment in the CS vessel, the 
biomechanical interaction between the device and the CS wall is rather complex. Here, we briefly 
described the procedure and interactive forces involved: The proximal stent anchor is released from the 
delivery catheter and deployed into the CS ostium. The expansion of the stent generates contact forces 
between the CS tissue and the stent, which enable anchoring of the stent to the CS wall. A biodegradable 
suture keeps the bridge links "open" and elongated; upon dissolution, the links close, the bridge length is 
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reduced and the proximal and distal stent anchors are brought closer together, reshaping and reducing the 
mitral annulus in the septal-lateral distance. Therefore, the bridge segment will impose an axial force on 
the proximal stent. In addition, an internal venous pressure of 10 mmHg will also deform the CS wall and 
affect the stent-tissue interaction. The major biomechanical loading steps in this process are illustrated in 
Fig. 5-6. In the simulation, we developed three corresponding steps as follows: 
Step 1 – Contact between CS wall and stent anchor during the stent deployment. The contact was 
established by removing the crimping sheath to release the proximal anchor to contact with the CS inner 
wall.   
Step 2 – Effect of axial contraction force due to the bridge contraction. An axial load with a 
magnitude of 2.45 N in the axial direction was applied to the connector elements to approximate the 
pulling force generated by the contraction of the bridge section that occurs upon dissolving of the 
biodegradable suture [185].  
Step 3 – Deformation due to the pulsatile blood pressure in the CS vessel. An incremental 
pressure, from 0 to 10 mmHg, was imposed on the luminal surface of the CS wall to mimic the 
physiological condition.  
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Figure 5-6: (Top) The crimping process was carried out by applying displacement control on 
the crimping sheath to decrease the diameter of the stent to less than 12 mm. (Bottom) The 3-
step TSI simulation: step-1: release the crimping sheath, step-2: apply an axial load of 2.45 N, 
and step-3: apply a pressure of 10 mmHg to the inner wall of CS. 
 
The coefficient of friction between the stent and CS inner wall contact surfaces was set to 0.1 in 
steps 1 and 2. For step 3, the contact definition was set as a non-slipping condition (an ABAQUS option: 
ROUGH) to imitate the effect of long-term tissue in-growth in-between the stent struts. The FE analysis 
was performed with the ABAQUS/Explicit release 6.11 on a high performance computing (HPC) Linux 
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cluster with Intel Xeon X5650 Westmere cores. The following output variables were analyzed in each of 
the three steps.  
5.2.4 Finite Element output variables  
1) Stress and strain. The von Mises stress was used to report the magnitude of peak stresses 
induced by stents on the vessel wall. To facilitate comparison between different models and avoid the bias 
caused by local high stress concentration, the 99-percentile values of the peak stresses of the CS vessel 
wall were evaluated [186, 187]. The 99-percentile values were computed by excluding 1% of all nodes 
containing the highest values (See Appendix A Table A2 for comparison between maximum (MAX) peak 
and 99-percentile stresses). Stent strains were analyzed with the maximum tensile strain variable 
(SDV24).  
2) Contact forces. Contact forces between the outer stent surface and the inner surface of the CS 
vessel were extracted from the model. Elevated contact forces in the vicinity of stent struts may lead to 
injury of the CS inner wall, or ultimately causes tears of the posterior CS wall. Conversely, insufficient 
radial contact forces will prevent proper device anchoring. The contact forces have normal and shear 
components, denoted by CNF and CSF, respectively, and are expressed as: 
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.,      (6.2) 
where nc is the total number of nodes of the stent cell that are in contact with the CS inner wall, and 
NFi,post and SFi,post are the normal contact force and shear contact forces, respectively, at each node after 
deployment.  
3) Stent fatigue analysis and safety factor [182]. Quantitative studies of metal fatigue often utilize 
the well-established Goodman-Haigh diagram [188], which is recommended by the FDA for stent fatigue 
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analysis [188, 189]. In Goodman diagrams, a pair of the mean stress or strain and its  amplitude (or half-
amplitude) at a particular point is plotted and compared with constant life curves [189] for that particular 
material.  The mean tensile strain, ɛ, and the half-amplitude oscillating strain, Δε, at a given node are 
calculated by: 
max min
max min
( ) / 2
( ) / 2
mean  
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 
  
,       (6.3) 
where εmax and εmin are the maximal and minimal strains, upon the application of 10 mmHg at a node on 
the PTMA stent after deployment. For a Nitinol material, the constant life curves from Pelton et al. [190] 
were used. Using the 0.4% strain amplitude delineated by the constant life line [190], the stent fatigue 
safety factor can be predicted using the equation: safety factor = 0.4%/half-amplitude strain. Four cases 
were analyzed: human-N1 (human CS vessel interacts with N1 stent), human-N2 (human with N2), 
porcine-N1, and porcine-N2. 
5.2.5 Impact of stent strut thickness  
The evaluation of PTMA device performance was performed based on two criteria: 1) inducing a 
minimal vessel injury and 2) enabling stent mechanical function (i.e., anchoring and fatigue life).  The 
mechanical stress on the vessel wall induced by the stent strut cells often provokes vascular wall injury 
that stimulates the intimal hyperplasia [191]. Therefore, to minimize the vessel wall stress, the structural 
compliance of the stent needs to be low to meet the compliance of the vessel wall. In the meantime, the 
stent itself also needs to have enough structural strength to withstand the cyclic mechanical changes 
induced by cardiac pulsatile pressures, and have enough radial force for its anchoring mechanism.  
The purpose of this study is to alter the stent design to reduce radial interactive forces. The 
approach includes maintain the same material properties of the stent and varying the strut thickness. Two 
stents models with different strut thickness values were developed. The results from these models include 
peak stresses and strains, interaction forces (shear and normal) of the CS wall and the stent, as well as the 
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device fatigue life and safety factor were compared to the original design, and differences between these 
design can provide insights into the stent designs that may help to reduce future device failure in the 
PTMA intervention.  
Table 5-3. Values of undeformed design parameters of different stents 
 No. of strut  
 Length Thickness Circ. Axial No. of elements 
Original 26 0.30 12 2 114,000 
Mod1 26 0.23 12 2 91,370 
Mod2 26 0.18 12 2 68,532 
 
 Results  5.3
5.3.1 Vessel wall stress  
The von Mises stress distributions on the CS vessel wall in Step 1 are illustrated in Fig. 5-7. It can 
be seen that peak stresses were located on the regions of the CS wall that were in contact with the strut 
links of the stent. The N1 stent induced the highest peak stresses on the human model, whereas N2 stent 
had the lowest peak stresses on the porcine model. The 99-percentile peak stress in the human CS induced 
by N1 stent was about two-fold higher than that in the porcine tissue, i.e., 31.40 kPa in human vs. 13.36 
kPa in porcine. The stresses induced by N2 stent were slightly lower than those of N1 stent for both 
human (30.97 kPa) and porcine (12.57 kPa) tissues. In steps 2 and 3, as shown in Fig. 5-8a, there was a 
slight increase of the stresses in both human and porcine CS walls.   The application of the axial force at 
the connector end and the internal pressure could result in the loss of wall apposition at the proximal end 
of the stent. As illustrated in the Fig. 5-8c, the porcine model had a gap between the vessel wall and the 
stent, whereas a better stent apposition was achieved in the human vessel, as shown in Fig. 5-8b. 
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Figure 5-7:  Contour plots of von Mises stress distribution on the human and porcine coronary 
sinus walls after initial contact with Nitinol stents (N1 and N2).  
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Figure 5-8: a) The 99-percentile peak von Mises stresses on human and porcine vessel walls 
imposed by N1 and N2 stents in the 3-step TSI simulation, b) the human-N1 interaction with a 
good stent apposition, and c) the porcine-N1 interaction where stent is separated from the 
vessel wall. 
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Figure 5-9: a) The relation between stents’ inner diameter and radial force during crimping. 
Lines across the graph represented the maximum normal forces generated from stent N1 in 
human and porcine and dotted lines presented the N2 after step 1; the normal and shear forces 
in the 3-step TSI simulation for b) human and c) porcine in the 3-step TSI simulations. 
 
5.3.2 Contact forces 
Maximum interactive radial forces of 16 N and 9.5 N were needed to crimp N1 and N2 stents 
from the ID of 14.90 mm to 11.98 mm, respectively, as shown in Fig. 5-9a. In Step 1, the maximum radial 
forces imposed by the stents on the human CS wall were about three times larger than those in the porcine 
model, i.e., 5.99 N versus 1.86 N. It can be seen that in Fig. 5-9b & c, the stent N1 generated slightly 
higher normal and shear forces than the stent N2 at the initial contact in step 1, i.e., 5.99 N and 0.50 N vs. 
5.78 N and 0.44 N for human and 1.86 N and 0.17 N vs. 1.83 N and 0.15 N for porcine, respectively. 
Both normal and shear forces slightly increased when applied an axial force of 2.45 N. In step 3, when a 
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pressure was exerted to the inner vessel wall, shear forces increased while normal forces dropped due to 
the tissue in-growth contact condition. 
 
Figure 5-10: a) Visualization of the stent N1’s undeformed geometry prior to crimping (left) 
and of the shape and strain contour of the stent after crimping overlapping with the shape after 
the step-3 (right); b) the maximum tensile strains in each step of both stents in the human and 
porcine TSI simulations.  
 
5.3.3 Stent strain and fatigue analysis   
Stent strain. Fig. 5-10a illustrates the un-deformed and crimped stent shapes, as well as the shape 
after step 3 for the N1 stent. The stent deformed nearly back to its original configurations at the end of the 
step 3. As shown in Fig. 5-10b, the peak strains of stent N1 stent did not fluctuate much throughout the 3-
step simulation in both human and porcine models whereas they increased significantly in the N2 stent 
after step 1. The maximum strain on the stent in Fig. 5-11a was found to be at twisted struts near strut 
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links in all simulations. During steps 2 and 3, high strain regions were observed mostly at the strut link 
locations near the connector region (Fig. 5-11b).  
 
Figure 5-11: a) Common maximum local strain observed on the stent strut in all steps (N1 
stent is shown), and b) regions that are under high strain after applied a pressure to the inner 
vessel wall for stent N1.  
 
Fatigue analysis of stents. The Goodman diagrams in Fig. 5-12 plotted the fatigue-life responses 
of the two stents under a cyclic loading pressure of 0-10 mmHg. Although all strain values of the N2 stent 
in human and porcine tissues were below the constant life line curve of 0.4%, they were more scattered 
and wide-spread compared to the N1 stent. The maximum oscillating strain of the N1 stent in the human 
model was 0.23%, and its safety factor was 1.72. The safety factor of the N2 stent was higher, 2.98, with 
the oscillating strain of 0.13%. When deployed in porcine tissue, the N1 stent had a safety factor of 4.07. 
In contrast, a very high cyclic strain of 0.34% observed in the N2 stent resulted in a relatively low safety 
factor of 1.17.   
5.3.4 Impact of stent strut thickness 
Stress and strain analysis.  It can be seen in Fig. 5-4 that the stent strut was twisted after 
expansion and annealing. The stent outer surface is not smooth. Thus, it is necessary to perform the 
expansion and annealing procedure to obtain accurate per-deployment stent geometries. Table 6.4 lists all 
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the maximum Von mises stresses and strains of the vessel wall, as well as three stent models. Both Mod1 
and Mod2 stents are softer than the original stent model, resulted in higher maximum strains on the stent 
after releasing the stents. Stresses on the stent increased as strains increased.  
Table 5-4 Maximum von Mises stresses and strains of CS wall and stent models 
 STRESS (MPa)  STRAIN 
 Steps Original Mod1 Mod2  Original Mod1 Mod2 
C
S 
W
A
L
L
 
1 3.47E-02 3.44E-02 3.30E-02  0.23 0.23 0.23 
2 3.66E-02 3.55E-02 3.52E-02  0.26 0.23 0.28 
3 3.58E-02 3.55E-02 3.46E-02  0.27 0.25 0.25 
ST
E
N
T
 
1 1001.00 955.00 947.40  2.49E-02 2.40E-02 2.38E-02 
2 358.60 380.00 371.60 4.96E-03 5.40E-03 5.32E-03 
3 444.70 480.30 525.90 6.37E-03 6.88E-03 7.54E-03 
 
Normal and shear forces.  Because stiffer stent generated a higher normal force, Mod1 and 
Mod2 stents exerted less forces compared to the original stent, as shown in Fig. 5-9a. There is a slight 
difference in forces between the stent models in steps 1 and 2 but no difference was observed in step 3. 
No device slippage was observed in step 2. Shear forces, illustrated in Fig. 5-9b, increased in step 
3demonstrating the tissue in-growth over time. 
5.3.5 Stent fatigue analysis 
The strain amplitude of the original model is 8.43E-2% and the safety factor is 4.75. Decreasing 
in strain amplitudes of Mod1 and Mod2 (6.61E-2% and 6.68E-2%) resulted in higher safety factors of 
6.05 and 5.98, respectively. Changing stent thickness does not reduce the fatigue life of the stent in the 
PTMA intervention. As shown in Fig. 5-12, strain points on the Goodman diagram of Mod1 and Mod2 
are similar to the strain points of the original design, and all are condensed and below 0.1% strain 
amplitude and 1% mean strain.  
This computational study indicated that PTMA device performance can be improved by altering 
the stent thickness. By reducing the stent thickness at a particular value, stress on the vessel wall can be 
reduced without compromising the stent anchoring forces and fatigue life.  
      99 
 
Figure 5-12:  Goodman diagrams presenting the fatigue life of stents N1 and N2 after applied a 
10 mmHg of pressure in the vessel walls, the black line represents the predicted fracture above 
0.4 % strain amplitude for a range of mean strains. 
 
 Discussion  5.4
5.4.1 Interaction forces and stent migration implication   
In this study, we simulated and compared the biomechanical interactions between two anchoring 
stents and two CS vessels – the human and porcine CS vessels. Under the same loading and boundary 
conditions, the stents deployed into the stiffer human vessel underwent much higher interactive normal 
contact forces than when deployed into the porcine vessel. In addition, a larger gap between the porcine 
wall and the stents was observed, suggesting that the potential for stent migration is much higher in the 
porcine model than in the human model. This result underscored the importance of the CS tissue 
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mechanical properties, and also brought up questions on the validity of using animal models to evaluate 
the device performance. We recently performed biaxial mechanical testing of CS tissues from three 
species: aged human (86.5 ± 9.7 years old), porcine (6 - 9 months old) and ovine (1 year old) tissues. It 
was also found that there were substantial mechanical property differences among these three species 
[192], with the aged human tissue being much stiffer than animal tissues. Older animals may provide 
stiffer tissue properties that are similar to aged humans, although this hypothesis has not been assessed. 
In step 3, the contact definition between the CS wall and the stent was set as a non-slipping 
condition to imitate the effect of long-term tissue in-growth in-between the stent struts. This contact 
condition was designed mainly to study the long-term stent fatigue damage, during which tissue in-
growth would occur. It should be also noted that the axial pull mechanism from the bridge elements of the 
PTMA device occurred gradually and would not be fully active until the imbedded suture dissolved 
completely over approximately 1 month. During this period of time, stent anchoring inside the vessel may 
be enhanced because of the tissue in-growth. In the immediate post-deployment period, the normal 
contact force would be the dominant force. Without the axial pull the chance of stent migration is low. 
Moreover, the PTMA procedure is a beating heart operation, any immediate migration of the device may 
be corrected immediately in the operation.  
Additionally, to investigate the no tissue in-growth condition, we further investigated the normal 
and shear forces in step 3 by setting the coefficient of friction between the stent N1 and the human CS 
inner wall as 0.1. From the simulation results, no stent migration was observed in step 3. The normal 
force of 3.55 N was similar to the original (rough, non-slipping) model of 3.52 N. The shear force, 
though, was reduced to 0.34 N while the shear on the original model is 3.34 N, as one would expect.  
Another factor that could impact the stent migration is the CS geometry. We assumed the CS 
vessel was a cylindrical tube at the anchoring location. The actual anatomic geometry of the CS vessel has 
a larger diameter at the ostium and becomes narrower towards the GCV vessel, which may help prevent 
the stent from migrating towards the GCV vessel.  However, this effect was not investigated in this study.  
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5.4.2 Vessel and stent fatigue damage implication  
Vessel wall stress. Stent migration and perforation of CS vessel wall are the two competing 
factors that require a delicate balance of the expansion force of the deployed stent. A higher interactive 
force will facilitate the stent anchoring but may also cause damage to the CS vessel wall. The maximum 
peak stresses on the CS wall were about 0.5 – 1 MPa for the human model and about 20 – 200 kPa in the 
porcine model. Currently, the published data on the ultimate tensile strengths (UTS) of human CS wall 
tissues are limited. One study reported the UTS of porcine CS vessel, which are in the range of 1.66 – 
2.57 MPa [193].Thus, based on the simulated peak stresses and the reported UTS of porcine CS tissue, 
the perforation of porcine CS wall would not occur. Moreover, we noticed that the peak stresses were 
concentrated on a very small number of nodal points, which represented less than 0.06% of total nodal 
points of the CS wall and were mainly located at the regions of the proximal and distal ends of the stent. 
The high stress concentration might be due to the excessive bending of the elements as a result of 
geometrical changes from expanded tissue-stent contact region to the non-tissue-stent contact region. 
Thus, to avoid local stress concentrations, the 99-percentile peak stress was adopted for the comparison 
among the four models [187, 194].  
Stent fatigue analysis. In this study, we investigated the stents made of two different Nitinol 
materials. We found that the interactive forces induced by the two stents were similar; however, the 
fatigue safety factors of the four models were quite different. The stent N1 had a lower safety factor when 
deployed in human than porcine, while stent N2 had a better safety factor in human than porcine model.  
This result suggested that the stent material properties could have an impact on stent durability, but not 
significantly on its interactive responses with the CS tissues. Thus, a greater impact on the biomechanical 
interactions may be achieved by changing the structural design of the stent.  Computational and clinical 
studies [195, 196 , 197] have shown that decreasing the stent strut thickness has favorable outcomes in 
terms of lower chronic vessel stresses and lower clinical restenosis rate, which may be a direction for 
further improving the stent design. 
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5.4.3 Clinical relevance  
Currently, there are several percutaneous devices utilizing a similar trans-coronary sinus concept 
to reduce the dilated mitral annulus. For instance, the CARILLON device (Cardiac Dimensions, Kirkland, 
Washington), which consists of distal and proximal anchors (Nitinol and titanium) and joined by a Nitinol 
ribbon connector, could reduce the dilated annulus by manually pulling the proximal anchor toward the 
CS ostium. Due to the difficulty in anchoring to the CS wall, a second generation device was developed 
with a twist at the distal anchor. The device was implanted in humans for up 6 months of follow-up [77]. 
A total of 30 out of 40 patients successfully received the device with an average of 23% MR reduction. 
However, three patients suffered from CS perforation and dissection. Another device, Viacor (Viacor, 
Wilmington, Massachusetts), consists of up to three rigid Nitinol rods. Various rod sizes and stiffness are 
used to achieve the desired MR reduction. The issues with this device were associated with fracture, 
migration and delivery failures due to the vast difference in CS structures and geometries [27, 78]. 
Patients not only have high variability in CS anatomical structures, the mechanical properties of CS also 
varied greatly, as shown previously by Pham and Sun [192].  
The current adverse events are associated with vessel injury (e.g. perforation and dissection) and 
device malfunctions (e.g. migration and fractures), which possibly are the results of mechanical mismatch 
between the implanted devices and the CS tissues. For instance, the CARILLON anchors were formed by 
two wires twisted together. Hence, lack of a sufficient stent-tissue contact surface might result in high 
stress concentration leading to perforation of the CS wall, as well as high possibility of device slippage. 
Fractures of the VIACOR device might be due to its lack of flexibility and stress reduction (due to its rod 
structure) to accommodate the dynamic motion of the CS vessel wall. Clearly, rigorous engineering 
analysis is warranted for the investigation of these device malfunctions. 
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6 Simulation of Complete PTMA Device Deployment into 
Patient-specific CS*  
In the previous chapter, we have introduced a FE method to analyze the biomechanical 
interaction between the proximal stent and the ostial region of the CS vessel. In this chapter, we added 
several key components of the delivery systems which are essential to the final deployed configuration as 
seen clinically. It is well known that human anatomy is highly variable and the procedural outcomes of 
any medical devices are essentially related to anatomic considerations. In this study, for the first time, we 
will introduce FEA of a complete PTMA device being deployed within a selected patient-specific CS 
model. Several techniques used to reconstruct 3D patient-specific model will be first reviewed in Sections 
6.1.1-2 and a technique of reconstructing the CS will be introduced in Section 6.2.1. Next, the analysis of 
tissue-stent interaction (TSI) will be divided into two phases. In phase 1 in Section 6.2, three patient-
specific CS models were selected and PTMA stents were modeled with a simplified bridge section. A 
complete PTMA stent with bridge section and the entire deployment process will be introduced in Section 
6.3. Evaluation of the stent and its interaction with the CS vessel as well as the predicted clinical 
outcomes were analyzed for each phase.  
 
 
 
 
 
                                                     
* Some of the contents of this chapter are taken from:   
W. Sun, C, Martin and T Pham, "Computational Modeling of Heart Valve Function and Intervention ", Annual Review of Biomedical 
Engineering, accepted.  
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 Introduction  6.1
6.1.1 Patient-specific noninvasive imaging modalities   
Much of the recent advancement in valvular heart disease evaluation and treatment can be 
attributed to the advent of noninvasive cardiac imaging modalities, such as echocardiography (Echo), 
magnetic resonance imaging (MRI), and computed tomographic imaging (CT), which are now being used 
extensively for diagnostics and risk evaluation.  Clinicians rely heavily on Echo for evaluating aortic and 
mitral valve morphology.  In particular, transesophageal echocardiography (TEE) is used extensively for 
the evaluation and diagnosis of MV pathology as well as the feasibility of repair.  The 2D TEE provides 
high quality images of the MV, yet sometimes the site and degree of prolapse can be incorrectly identified 
from 2D images [198-200].  Consequently, 3D TEE is being increasingly adopted.  However, as TEE has 
a relatively poor spatial resolution compared to MRI and CT, MRI is preferred for analyzing valvular 
flow characteristics. Because CT has been shown to facilitate accurate and reproducible AV annular 
measurements compared to Echo [201], it is more relevant in geometric measurement applications, 
particularly in transcatheter aortic valve (TAV) intervention where AV geometries are of importance.  
6.1.2 Valvular imaging process and segmentation  
The precise patient-specific geometry and location of valvular features is of critical importance 
for the proper diagnosis and treatment of valvular diseases.  Recently, several research groups have 
obtained in vivo AV and MV geometries using Echo [57, 202-204], MRI [33, 46, 58] and multi-slice CT 
scans [44, 45, 205-207]  to reconstruct patient-specific aortic and mitral valve models.  From these 
images, it is often difficult to identify the more delicate valvular substructures such as the leaflet free edge 
and chordae tendineae.  A more accurate description of the valve structures is achievable, but these 
methods often employ manual tracing or manual geometrical reconstruction by point selection and 
interpolation [57].  Now, many groups are using semi-automatic methods to segment the valve structures 
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from clinical images through standard image processing techniques such as intensity-based thresholding 
to distinguish the valve structures from the surrounding blood pool [32, 44, 58, 207].   
Many of the segmentation methods discussed previously are static or at one time snap-shot.  The 
segmentation process would have to be repeated for additional time points in order to analyze the 
dynamic valve geometries through the cardiac cycle.  Real-time visualization of the 3D valve geometries 
throughout the cardiac cycle could also greatly benefit clinicians.  There are now a couple dynamic valve 
models in the literature to address this need.  Veronesi et al. [208] were among the first group to quantify 
the 3D AV and AV dynamics from matrix array transesophageal images.  The AV and MV features were 
semi-automatically detected and then automatically tracked through the cardiac cycle.  Ionasec et al. 
[209] have also developed a dynamic model of the aortic and mitral valves with the ability to capture 
morphologic and pathologic differences over an entire cardiac cycle based on the trajectories of landmark 
points.  The robustness and accuracy of the method was demonstrated by extensive experiments on 1516 
TEE and 690 cardiac CT volumes with an average processing time of 4.8 seconds and an average 
accuracy within 1.45 mm of the expert defined ground-truth.  The use of subject-specific dynamic valve 
models for pre-operative planning holds great promise; however, an automated, fast, and user-friendly 
method to load 3D imaging data, refine them into nonlinear FE models, and from there to further 
visualization and simulation processing has not yet been accomplished.   
In this Chapter, we adopted the semi-automation method to reconstruct the geometry of the CS 
vessel for the purpose of analyzing the tissue response after PTMA stent deployment. Full phase cardiac 
MSCT scans were collected from patients at Hartford Hospital (Hartford, CT). Institutional Review Broad 
approval to review de-identified images was obtained for this study. Selected patients with very good 
visualization of the CS geometry were selected and digitized at our laboratory.  
 Modeling the biomechanical interaction of a whole PTMA deployment 6.2
into the CS  
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6.2.1 Patient-specific model of the CS vessel 
Del Valle-Fernandez et al. [84] studied the dynamic anatomy and the relationships of the 
CS/GCV and its spatial relation with the MA using multi-detector computed tomography angiography 
(MDCTA). Through the injection of nonionic contrast media through a peripheral vein, CS vasculature 
could be visualized and at various phases of a cardiac cycle (40%, 75% and 0% of the RR interval 
presenting the end-systole, mid-diastole and end-diastole, respectively) were analyzed using the EKG 
signal. They found that the geometries of the CS/GCV were statistically significant different among the 3 
phases of the cardiac cycle, with the largest diameter and area observed at phase 40% (end-systole) and 
the smallest dimensions observed at phase 0% (end-diastole). Therefore, the reference (initial) geometry 
of the CS/GCV was reconstructed at the end-diastole phase.  
 The MSCT examination was performed on a GE LightSpeed 64-channel volume computed 
tomography scanner. In general, a total of 2000 slices of images with thickness of 0.625 mm were 
collected for the whole cardiac cycle [205]. A collimation of 25-30 × 0.625 mm and a rotation time of 375 
ms were used resulting in a temporal resolution of less than 200 ms depending on the heart rate and pitch. 
Typically, 10 phases can be obtained for each cardiac cycle. MSCT images of the CS at end-systole and 
end-diastole were imported into Avizo 6.7 software (VSG, Burlington, MA) for 3D reconstruction and 
evaluated using a selected range of Hounsfield units. The end-systole was identified on a frame after 
mitral valve closing and before mitral valve opening, while the end-diastole was identified prior to mitral 
valve closing and after mitral valve opening. For each phase, the CS ostium was first identified at the 
right atrium in view 3 in Figure 6-1, which shows the curved planar geometry of the vessel. Upon 
manually tracing the CS in several frames, the cross section of the CS were automatically marked in 
views 1 and 2,  which show the CS relative position to the mitral valve. The 3D presentation of the vessel 
was formed after generating a surface and formulating tetrahedral mesh in Avizo.  
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Figure 6-1: The 3D reconstruct of the coronary sinus (CS) using three views, xy (view 1), YZ (view 2) 
and XZ (View 3) using Avizo image-processing software and meshed using Hypermesh software. 
6.2.2 Patient selection   
From the 14 CS vessel reconstructed models, three CS models were selected for the analysis of 
PTMA stent deployment. The geometrical measurements of the CS vessel includes the CS and GCV 
diameters, the length of septal-lateral and anterioposteior mitral annulus, the distances between the CS 
ostium and middle cardiac vein, between the middle cardiac vein and left marginal vein, between the 
great cardiac vein and the left marginal vein, see Figure 6-2. Table 6-1 summarizes the CS and GCV’s 
diameters and their respective proximal and distal anchor’s diameters. 
Table 6-1. Patient CS geometries and their respective stent geometrical measurements.  
 
 
Length (mm)  Thickness (mm) Inner Diameter (mm)
CS Stent CS GCV Prox Dist CS Prox GCV Dist
P1  103.67 82.45 0.61 0.51 0.30 0.30 10.53 14.88 (+4) 4.71 8.47 (+4)
P2  108.20 76.00 0.74 0.37 0.30 0.25 6.76 12.00 (+5) 5.21 6.83 (+2)
P3  118.70 89.20 0.74 0.37 0.30 0.30 10.04 14.88 (+4) 4.24 8.47 (+4)
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Figure 6-2: Representative CS vessel identified from a patient CT images in a) short-axis and b) long-
axis views, and c) the CS vessel geometrical measurements.  Lsl – length of septo-laterol mitral 
annulus, Lap – anteroposterior length, Dgcv – Great Cardiac Vein dia., Dost – CS ostium dia., 
MCV – Middle Cardiac Vein, LMV – Left Marginal Vein 
 
6.2.3 Tissue properties and modeling techniques  
The CS material parameters were obtained from fitting the experimental pressure-inflation data 
collected from four cadaver CS vessels to the nonlinear hyperelastic Ogden model as specified in Chapter 
5. Please refer to Table 5-2 and Fig. 5-5 for the mean values of material parameters and mechanical 
behaviors of human CS vessels and of a Nitinol stent material, respectively.  
The simulation process was divided into three steps:  Step 1:  Releasing both anchors into 
contacts with the CS wall. Step 2: Connecting the bridge element to the distal anchor connector.  Step 3: 
Applying the CS pressure in the vessel wall. The analysis was run with ABAQUS/Explicit v6.9 on a 
Linux cluster using 12 2.8GHz CPUs. The tissue-stent interaction (TSI) was evaluated based on the 
following parameters: 1) the normal and shear contact forces between both of the stents and the 
corresponding vessel wall, 2) the maximum tensile strain of the stents and maximum principal strain 
imposed on the CS vessel wall, and 3) Von Mises stresses of CS wall.  
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6.2.4 Finite element simulation results  
Figure 6-3 a&b show the CS and GCV strain and stress distributions in the three-step simulation. 
Due the smaller size of the GCV, all GCVs were overstretched more than the CS ostium. As the result, 
the GCVs exhibited significantly higher stresses and strains compared to the CS ostial regions.  It could 
be that the tortuosity of the CS vessel plays a role in the overall wall stress. For instance, for the less 
tortuous vessel, stent can conform well to the vessel curvature and no local high strain to be observed. 
Patient 3 has a very tortuous CS geometry where the GCV section was constricted, as shown in Figure 
6-4. As the result, highest wall stress was observed, see Figure 6-3b. The radial forces generated by the 
distal anchors were greater than by the proximal anchors after stent release and come in contact with the 
vessel wall in step 1, Figure 6-3c. The normal forces were greater than the shear forces in all simulation, 
which indicated a less likely of stent migration. From Figure 6-3c, it can be seen that patient 2 exhibited 
lower distal normal force than proximal normal force. It could be that the GCV was only 11% over 
dilated while patients 1 and 3 were 32.22% and 38.29% over dilated, respectively.  
We approximated the mitral annulus area by measuring the change in the region encircled by the 
CS vessel from the undeformed to the final step. The results show that on average, 15% of the area was 
reduced in three patients.  
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Figure 6-3: a) CS vessel stress and strain results and the normal in the three simulation steps; and b) 
normal and shear forces of the proximal and distal anchors after stent release and come in contact with the 
CS vessel wall in Step 1.  
 
 
Figure 6-4: Strain distribution on the cs ostial and Great Cardiac Vein sections after step 3.  
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 A consistent increase and decrease pattern of normal contact forces was observed in all patient 
results, see Figure 6-5. Shear forces were very low in step-1 due to the stent expansion. The shear forces 
increased dramatically in step 2 as the bridge section connected to the distal stent. Shear forces become 
greater in step 3 in patients 2 and 3 after applied a CS pressure of 20 mmHg. However, because it was not 
significantly greater than the normal force, no stent migration was observed. In patient 3, the shear force 
was smaller than the normal force. This could be that the bridge section is slightly longer.  
 
Figure 6-5: The reactive forces in each of the three deployment steps for three patients, and the CS/stent 
deformed shapes of the three patients. 
 A longer bridge section in patient 3 could affect the functionality of PTMA stent. It can be seen in 
Table 6-2 that the stent length for patient 3 is 89.20 mm or bridge length of 48.96 mm, which is longer 
than patients 1 and 2. As the result, patient 3 has a lower reduction in mitral annular area compared to 
patient 1, 13.88% versus 16.75%. For patient 2, although the bridge length is shorter than patient 1, it’s 
CS length is 5 mm greater, which resulted in smaller mitral annular area reduction. To summarize the 
     112 
results, the shorter the stent is relative to the CS length, the more reduction is in mitral annular area, 
although too short stent might increase the chance of stent slippage.  Table 6-2 also shows the change in 
the left ventricle end-systolic (LVES) from patients undergo PTMA intervention in Harnek et al. study. It 
has been shown that the mitral annular size linearly correlates with the changes in left ventricle end-
systolic (LVES)/end-diastolic (LVED) volume. Therefore, this study showed that a reduction in mitral 
annular area is within the range reported in clinical study.  
Table 6-2. The reduction in mitral area and the left ventricle end-systolic (LVES) and the corresponding 
stent length.  
 
 
 Modeling of a complete PTMA device deployment with a delivery 6.3
catheter system 
In this section, we selected a patient from our database to study the TSI incorporating two 
additional features: (1) a complete PTMA stent model with ‘spring-like’ bridge section incorporating the 
effect of bio-degradable material and (2) a complete stent deployment process including the stent delivery 
catheter components. By adding these two features, PTMA stent deployment and its interaction with the 
CS vessel wall will be more accurately simulated and analyzed.    
6.3.1 Patient selection 
The patients chosen for this study was a 49 years old female. She was selected for CT scans for 
suspicion of coronary artery disease. However, from her full-heart CT scans, there was no sign of 
calcification in her coronary arteries, as well as no indication of calcification elsewhere. Her left ventricle 
size was normal and the mitral leaflets coapt properly at mid-systole phase. Therefore, this patient is 
considered healthy.  
CS_L
(mm)
Stent_L 
(mm)
Bridge_L
(mm) ΔA (%) Δ‐LVESV (%) Follow‐ups
P1 103.67 82.45 41.50 ‐16.75 Harnek et al. ‐6 3 mo
P2 108.22 80.63 43.13 ‐7.91 ‐4 6 mo
P3 118.80 89.20 48.96 ‐13.88 ‐17 12 mo
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6.3.2 Modeling of complete PTMA device with pre-stretch biodegradable materials 
The PTMA device consists of three components: the proximal, distal and bridge. Details on the 
modeling method of the proximal anchor were previously mentioned in Chapter 5. The structure of the 
distal anchor is similar to the proximal anchor but smaller in size and the number of strut cells. There are 
9 and 2 cells in the circumferential and axial directions, respectively. The bridge section is a ‘spring-like’ 
section that can be elongated and retracted. A biodegradable material (BMD) is incorporated within the 
bridge section and maintains the device in an elongated form before and during implantation. The 8-node 
hexahedral linear incompatible mode element (C3D8I) was chosen to mesh the stent as C3D8I is 
preferred for stent analysis due to the nature of bending during loading without experiencing hourglass 
effect for relatively coarse mesh. The proximal and distal anchors were modeled with 2,251 and 1,371 
elements and 8,432 and 5,048 nodes, respectively.  The 8-node hexahedral linear reduce-integration mode 
element (C3D8R) was chosen to mesh the bridge with 1,723 elements and 6,264 nodes. The 
biodegradable component was modeled using 468 C3D8R elements with 1664 nodes. The CS vessel was 
also modeled using 18,630 C3D8R elements and 25,020 nodes with four layers through the thickness. For 
the C3D8R element, hourglass control stiffness was utilized to mitigate the strain-free hourglass modes 
when loaded in bending. In order to ensure proper hourglass control was used, the kinetic energy was 
carefully monitored and kept below internal energy.  
The tension of the bridge is determined by prestretching the entire bridge. To prestretch the 
bridge, displacement control was used to extend the bridge about 20 mm. According to the manufacture 
standard, PTMA device length is 20 mm shorter than the CS implantation length. In order to retain the 
tension of the bridge after the bridge was prestretched and throughout the simulation, BDM, which is 
modeled as brick element, was incorporated within the bridge cells, as shown in Figure 6-6. Contacts 
between the BDM and the bridge elements were enabled after the first prestretch step with a rough 
surface interaction (*friction, rough).   
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Figure 6-6: Proximal and Distal Anchors and the bridge section with biodegradable material (BDM). The 
popup window shows a realistic and simulation demonstration of three bridge cells with three BDM’s 
sandwiched in-between.   
6.3.3 Delivery catheter system and process    
6.3.3.1 Components of the delivery catheter system  
The delivery catheter system consists of several components. In this study, we did not include a 
complete delivery system. We mainly focused on the biomechanical interaction between the device and 
the CS vessel, therefore, we simplified the system to include: the crimper, guide wire and catheter. Other 
anchoring components were also used during stent crimping and releasing within the catheter: inner tube 
and plate components are to stabilize the bridge section and the distal stent during crimping, respectively. 
Figure 6-7 shows the delivery components as well as their respective locations.  
6.3.3.2 Stent crimping process  
Both the proximal and distal anchors were crimped to a 3 mm ID catheter. The crimper was 
modeled as a cylindrical tube with shell elements.  Displacement-controlled deformation of the crimper 
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was utilized to crimp the stent to the diameter smaller than 3 mm. The inner-tube component, modeled as 
cylindrical tube with shell elements, was also radially displaced during this step to stabilize the bridge 
element during crimping. The 4-node quadrilateral element (M3D4R) was used to mesh the crimper, 
catheter and inner tube with 966, 12426 and 2173 elements and 987, 9752 and 2214 nodes, respectively.  
 
Figure 6-7: Prior and after crimping process showing the geometries of the PTMA stent, crimper, 
catheter and inner tube. 
6.3.3.3 Deployment of PTMA stent and boundary conditions    
Deployment of the PTMA stent was first achieved by delivering a catheter into the CS vessel. 
The delivering route of the catheter was specified by a motion path along the CS vessel. Clinically, the 
geometry of the CS vessel can be visualized by injecting a contrast agent and imaging with 
echocardiography. A practitioner then can have a visualization of a CS geometry and then maneuver the 
catheter through the vessel. The motion path is formulated and carried out by a set of unit vectors, their 
angles of rotation and velocities. 
The unit vectors were selected at various locations within the CS vessel. The angles of rotation 
between two unit vectors were calculated from their rotational matrix. According to Euler’s rotation 
theorem, any rotation of a rigid body may be described using three angles: ߮, ߠ, ϕ. A rotation of an angle 
of ߮	about x-axis is defined as:  
ܴ௫ሺ߮ሻ ൌ 	 ൥
1 0 0
0 cos	ሺ߮ሻ െsin	ሺ߮ሻ
0 sinሺ߮ሻ cos	ሺ߮ሻ
൩    (6.1) 
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A rotation of an angle of ߠ	about the y-axis is defined as:   
ܴ௬ሺߠሻ ൌ 	 ൥
cos	ሺߠሻ 0 sinሺߠሻ
0 1 0
െsinሺߠሻ 0 cos	ሺߠሻ
൩    (6.2) 
A rotation of an angle of ϕ	about the z-axis is defined as:   
ܴ௭ሺϕሻ ൌ 	 ൥
cos	ሺϕሻ െs	inሺϕሻ 0
sin	ሺϕሻ cos	ሺϕሻ 0
0 0 1
൩     (6.3) 
A generalized rotation matrix can be described as:   
ܴ ൌ 	ܴ௫ሺ߮ሻܴ௬ሺߠሻܴ௭ሺϕሻ ൌ ൥
Rଵଵ Rଵଶ RଵଷRଶଵ Rଶଶ RଶଷRଷଵ Rଷଶ Rଷଷ
൩     (6.4) 
To solve for ߰, we know that  
ୖయమ
ୖయయ ൌ tan	ሺ߮ሻ       (6.5) 
Then 
߰ ൌ atan2ሺRଷଶ, Rଷଷሻ      (6.6) 
Where atan2(y,x) is the arc tangent of the two variables x and y. When cos(ߠሻ  < 0, then ߰ ൌ
atan2ሺെRଷଶ, െRଷଷሻ. To prevent this, the equation 6.6 can be modified as  
߰ ൌ atan2ሺ ୖయమୡ୭ୱ	ሺఏሻ ,
ୖయయ
ୡ୭ୱ	ሺఏሻሻ      (6.7) 
A similar calculation holds for finding ϕ. We know that   
ୖమభ
ୖభభ ൌ tan	ሺϕሻ      (6.8) 
To solve for ϕ 
ϕ ൌ atan2ሺ ୖమభୡ୭ୱ	ሺఏሻ ,
ୖభభ
ୡ୭ୱ	ሺఏሻሻ      (6.9) 
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To solve for ߠ, we know that   
Rଷଵ ൌ 	െ sin ߠ       (6.9) 
Then,  
ߠ ൌ െarcsinሺRଷଵሻ      (6.10) 
The motion path was controlled by applying the kinematic coupling constraint between a node 
and the tip of the catheter. Basically, a kinematic coupling constraints the tip of the catheter (i.e. a set of 
slave nodes) to the translation and rotation of a master node in a specified manner. It is useful in this case 
since a larger number of slave nodes are constrained to the rigid body motion of a single master node. 
Each slave node of the tip of the catheter has a unique relationship with the master node, therefore, the 
kinematic coupling constraint can be considered as a combination of general master-slave constraints 
{ABAQUS}. The motion of the catheter can be described as turning, twisting and rotating. Therefore, a 
kinematic coupling constraint can be used to prescribe a twisting and turning motion without constraining 
radial motion. Due to the tortuosity of the CS, a total of 12 locations were selected from the ostium to the 
entrance of GCV, as shown in different views of CS vessel Figure 6-8. The translational and rotational 
boundary conditions were imposed on the master node, preferred as refnode, in each step to perform the 
concerted maneuver through the CS vessel. 
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Figure 6-8: A representative CS vessel shows different views of the virtual deployment of the PTMA 
device performed by generating a delivery pathway along the guidewire positioning within CS vessel, and 
the graph shows the vectors in 3D space. 
The CS pressure waveform is assumed to be mimicking the atrial pressure prior to mitral valve 
closure. Since the simulation process was treated as quasi-static and only analyze at the end-diastole, a 
range of pressure was chosen to simulate the CS pressure, as demarcated in red box in Figure 6-9a.  This 
pressure wave was applied to each step during the deployment process to simulate the pulsatile blood 
flow inside the CS. As shown in the pressure waveform of the entire cardiac cycle in Figure 6-9a, 
pressure within the CS does not exceed 20 mmHg. Therefore, we generalized the CS pressure as shown in 
the Figure 6-9b.  
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Figure 6-9: The CS pressure waveform obtained from a) standard physiological pressure waveform and 
b) extracted CS pressure. 
The guide wire was modeled as a hollow cylindrical tube that has a curvature similar to the CS 
geometry. To simplify the process, deployment of the guide wire will not be simulated; instead, it was 
created and meshed according to the CS curvature. Contact between the outer surface of guide wire and 
the inner surface of the catheter was enabled in order to prevent catheter from penetrating the CS vessel 
wall.  
Next, the deployment of the PTMA stent was carried out by retracting the delivery catheter. 
Basically, additional 12 steps were performed in which the magnitude of displacement were equal and 
opposite direction of the forward delivery route. The distal anchor was first deployed into the CS vessel 
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by retracting the catheter at position 11 and the proximal anchor at position 4 (Figure 6-8). According to 
the procedure in the instructor manual of PTMA device, the stent needs to be pulled back until the 
proximal anchor is at the desired target site. This strategy is numerically implemented as follows. At 
position 5, the contact between the proximal anchor and the catheter was set to ‘rough’ so that as the 
proximal anchor is pulled back to the direct of the CS ostium, the entire device was also dragged towards 
the same direction. Because the distal anchor was already expanded at the GCV end, the friction helps to 
resist the anchor slippage. However, if the distal anchor’s diameter is undersized, stent migration is 
inevitable. After this step, the rough contact between the proximal anchor and the catheter was released 
and proximal anchor release continued at the position 4.  
The final step was of the simulation is the contraction of the bridge to cinch the CS vessel. This 
step involved removing the contacts between BDM and bridge elements. This step might result in high 
inaccuracy due to the high kinetic energy as the stent bounced back to its contracted and non-stretched 
geometry. To minimize this affect, viscous damping was added to the bridge section. 
Most contact algorithms were performed using either ‘general contact’ or ‘contact pair’ 
algorithms. The ‘general contact’ was set for stent only due to unspecified surface interactions, which 
automatically detects and computes all interactions within the domain. The ‘contact pair’ algorithm was 
modeled as master-slave surfaces which were specified by users. Table 6-3 list all the contact surfaces 
and their algorithm and friction coefficients.   
Table 6-3. Contact surfaces and their contact algorithms and friction coefficients  
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6.3.4 Post-processing 
The simulation was similar to the data analysis methods performed in Chapter 5, in this simulation 
process, CS stress, stent strain, interactive forces and stent fatigue were analyzed throughout the process. 
Figure 6-10 shows which components of the model were analyzed during particular steps. Particularly, 
only the bridge section was analyzed during the stent pre-stretch step. In this step, the distal anchor was 
fixed and displacement controlled was applied to stretch the bridge and its cell with a total of 20 mm. The 
tension of the bridge was measured at the proximal stent connector as total reaction forces. Peak stress 
and strain of the bridge was analyzed for potential failure. In the stent crimping step, both proximal, 
anchor and bridge sections were analyzed for peak stress/strain, though bridge section was expected to 
exhibit minimum stress since only displacement was imposed with no deformation. For the catheter 
deliver steps, peak stress/strain of the stent was checked only in the initial deliver step to ensure no high 
localized stress. It is assumed that stress will not significantly highly than the peak stress in the previous 
crimping step since only displacement control was imposed on the catheter to move the stent into the CS 
vessel. However, kinematic energy with respect to strain energy of the stent was monitored throughout 
the entire deliver process. The interaction between the CS and the catheter was carefully monitored in the 
catheter delivery steps to ensure no CS peak stress or damage. In the stent release in the CS vessel step 
and the last step of the stent contraction, all components were analyzed in details. Additionally, the mitral 
annular area was measured to determine the functionality of the PTMA device.  
Contact bodies  ABAQUS contact 
algorithm
Friction coefficient 
Or rough (no slippage)
Bridge/Biodegradable Contact pair Rough
Crimper/Stent Contact pair 0.1
Stent/Catheter Contact pair 0.9, 1.0
Catheter/Guidewire Contact pair 0.01
CS/Guidewire Contact pair 0.01
CS/Catheter Contact pair 0.05
Stent/CS Contact pair 0.1, 0.9
Stent General contact 0.1
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Figure 6-10: Schematic of stent deployment process and selected (checked) components to be analyzed.
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6.3.5 Results 
6.3.5.1 Stent prestretch, crimping, release in catheter and delivery process  
As shown in Figure 6-11, an uniform expansion of the bridge section of the  PTMA stent can be 
observed. With the imbedded bio-degradable material, the PTMA stent bridge has a peak strain of 10.2%. 
The reaction force has a steep increase at the displacement of less than 9 mm and then levels from 9 – 16 
mm of the displacement.  
 
Figure 6-11: a) The stent pre-stretch step where the bridge is prestretched to obtain the bridge tension, 
maximum strain on the stent at the end of the step is 10.2%; b) the measurement of reaction forces (RF) 
or bridge tension force after prestretched, showing the RF and displacement relationship, which 
correspond to the stress-strain Nitinol characteristics.  
 
With the crimping catheter reducing its diameter, the anchoring stents (both proximal and distal 
anchoring stents) were crimped into a small diameter, as shown in Figure 6-12. Note that upon the release 
of the stent into the delivery catheter, the bridge stent is not straight, but wavy due to the force balance of 
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between anchoring stents and the bridge. The proximal anchor has a peak strain of 14.9%, whereas the 
distal anchor has a peak strain of 17%. It is clear that the distal anchor has a relatively larger oversize than 
the proximal stent. Note the maximum strains did not increase after release into the catheter.  
 
Figure 6-12:  The geometry of the stent prior and post crimping process and release into the catheter. The 
strain distribution (SDV24) of proximal and distal anchors. Maximum strains did not increase after 
release into the catheter.   
 During the stent delivery process, it can be seen from Figure 6-13 that the delivery catheter would 
not induce additional stress and strain on the CS and anchoring stents. At the start of the catheter delivery, 
the CS wall stress is about 0.029MPa. When it is delivered about half way into the CS, the CS wall stress 
is about 0.031, and the end of the delivery, it is about 0.032 
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Figure 6-13: Peak stress and strain of CS, catheter, proximal and distal anchors and bridge section during 
the catheter deployment steps. 
 
 Due to the shape-memory characteristics of Nitinol material, both anchors spring open during the 
release steps. Figure 6-14 and Table 6-4 show the maximum stent strains of selected increments during 
the simulated release steps. The spring-open shape of the stent is similar to the realistic shape of Nitinol 
stent during release step that observed clinically. Maximum strains of both proximal and distal anchors 
are similar, between 0.138 – 0.161. Strain reduced significantly from 0.153 to 0.048 and from 0.138 to 
0.024 for distal and proximal anchors after completely removed from the catheter, respectively. The 
bridge section strain remained between 0.10 – 0.14 during the entire release step. This demonstrates that 
during release step, stent will not experience any critical peak stress that could eventually result in fatigue 
damage.  
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Figure 6-14: Distal and proximal anchor releasing steps: strain distribution of the entire stent during the 
selected ten releasing increments.  
 
Figure 6-15 shows the peak von Mises stresses of both CS ostial region and GCV during the 
proximal and distal anchor release steps. The peak stress on GCV was 1.41 MPa after complete distal 
anchor release and decreased below 0.8 MPa following proximal anchor release. The proximal anchor 
release did not cause high stress at the CS ostium, peak stresses were below GCV stresses. The highest 
stress was during half-way release at a value of 0.73 MPa. It could be that GCV was over dilated, at 
69.1% while CS ostium was only dilated by 24%. It is interesting that although both anchors were 
selected so that they are 2 mm oversize, the GCV showed much over-dilation compared to the CS ostium. 
One reason could be the thickness—GCV thickness is half of CS ostium thickness (0.37 versus 0.74 mm, 
measured in Chapter 1).  
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Table 6-4. The maximum strains during release steps for distal and proximal anchors.  
 
 
Figure 6-15: Peak von Mises stresses on CS ostium and GCV regions due to stent release.  
 
Maximum Stent Strain (SDV24)
Steps Proximal anchor Distal Anchor Bridge
1 (Start) ‐‐ 0.161 0.14
2 ‐‐ 0.159 0.14
3 ‐‐ 0.153 0.10
4  ‐‐ 0.048 0.10
6 (Bridge pulling) ‐‐ ‐‐ 0.10
7 0.149 ‐‐ 0.10
8 0.160 ‐‐ 0.10
9 0.138 ‐‐ 0.10
10 (End) 0.024 ‐‐ 0.10
     128 
 The final form of the PTMA stent after deployed within the CS vessel is shown in Figure 6-16a. 
It can be seen that the distal anchor is not circular, while the proximal anchor is more uniformly expanded 
and conformed to the CS ostium. This could be due to the aggressive oversize of the stent anchor to the 
GCV section. At about 6.9 mm extension from the proximal anchor connector, maximum strain of 0.31 
was observed. Although the magnitude is relative low compare to maximum 8-10% strain value for 
Nitinol to reach to plastic deformation range, this peak could be higher due to stent fatigue overtime. It 
has been reported in the first clinical study by Webb et al. that bridge separation is observed at 9-mm gap 
between the proximal anchor and the shortened bridge at 22 days in one patient, 30 mm gap at 28 days 
and 41-mm gap at day 81 with the return of grade 3 MR. This could be due to the bridge length which 
could be too short for this particular patient. However, note that shorter bridge length might produce a 
better MR reduction. One possibility that could relieve high strain is increase the strut width of the bridge. 
In addition, strains on the stent strut along the connector direction were higher, similar to the observation 
in Stent strain and fatigue analysis.  
Figure 6-16b shows the reduction in mitral annular area after stent deployment. In Section 6.2.4, 
from the same patient, using the simplified bridge model, the MA area was reduced by 16.75%. In this 
section, the MA area reduced from 15.21 to 13.45 cm2, by 13.09%. The difference in MA reduction could 
be due to the simplified bridge model and delivery process. The results from this section show a more 
accurate CS curvature and stent conformity compared to Section 6.2.4. The addition of bridge section 
incorporating the biodegradable material and the delivery process could also produce more accurate 
responses.  
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Figure 6-16: A) A final deformed shape of the PTMA stent in two views and b) reduction in mitral area 
after stent deployment. 
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 Discussion  6.4
6.4.1 Tissue-stent interaction in PTMA intervention  
PTMA stent was selected based on patient geometries. Currently, both anchors were 2 – 4 mm 
larger in diameter than the CS and GCV diameters, and the bridge’s effective length is 20 mm shorter 
than the CS length. Our simulation result from this particular patient showed that the current criteria for 
PTMA stent selection might not be appropriate, such that the GCV section might need to be less 
oversized compared to the CS ostial section. From the preliminary study of the CS ultimate tensile 
strength (UTS), it shows that the human GCV samples were weaker than human CS samples, 1.0 versus 
1.5 MPa. By comparing the UTS with the peak stresses observed in this chapter, it can be seen that the 
GCV section is most likely ruptured due to its maximum stress (1.41 MPa) exceeding the UTS of 1.0 
MPa. However, the CS region’s maximum stress (< 0.8 MPa) was well below the UTS of 1.5 MPa. This 
demonstrates that sizing using diameter alone might not provide confidence on tissue damage, as the 
tissue properties are of important factor that could greatly affect the outcome of the procedure. 
Our study shows the regions of high strain distribution on PTMA stent that are similar to clinical 
observation. To prevent stent fracture at the bridge section, the second generation of PTMA device 
incorporated suture reinforcement. However, in the second clinical study by Harnek et al., they observed 
several stent fractures along the stent anchors, which were observed in our simulations. This information 
could shed some lights into the current PTMA stent problems of high strain and fatigue.  
6.4.2 Clinical significance of the study   
The TSI during catheter delivery and stent release cannot be visualized and analyze by 
practitioners during PTMA procedure. Thus, adverse events such as endothelial cell damage, vessel 
perforation and stent fatigue could eventually result in device failure and mortality. Quantitative 
understanding of the biomechanics is clearly an enabling step for science-based design of the devices. 
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This approach will avoid the currently observed disasterous fatigue failure and move towards patient-
specific sizing of the implants.   
6.4.3 Limitations  
There are several limitations of this study. First, the CS vessel was assumed to be fixed at both 
ends. The CS vessel starts at the right atrium and ends at the GCV which continues to descend into the 
left ventricle wall. Thus, it is appropriate that both ends of the CS will be fixed. Second, there is no 
surrounding tissues (i.e., connective tissues, myocardial tissues and mitral annulus) surround the CS 
vessel. The cinching force, due to lack of surrounding tissues, could be under estimated. Therefore, in this 
study, cinching force was not measured. The mitral annular area could also be overestimated due to the 
same assumption. However, this study focused mainly on the interaction between the device and CS 
tissues, the measurement of MA area was for the purpose of evaluating the simulation of the bridge after 
contraction and comparison between the two bridge models. Third, the material properties of human CS 
were not patient-specific and CS model was not obtained from MR patients. A database of human CS 
tissues was obtained in Chapter 2, which will be utilized in future studies in combination with a more 
robust material model. Currently, CT scan is not standard of care for patients with MR condition. 
However, such protocol can be developed and CT scan information will be valuable for MR geometries. 
Lastly, the simulation model was not validated with experimental data due to lack of imaging data from 
post-procedural patients. In Chapter 4, a method was developed to cinch the ovine MV ex vivo to obtain 
the cinching force and MA area. Thus, the computational model in this chapter can be validated by 
replicating this experiment using ovine heart model in place of human heart and PTMA stent in place of 
the suture. Future validation work will be further discussed in the next section.  
6.4.4 Future works 
In the future validation study, we will be developing a Nitinol material PTMA stent and the 
delivery process. There are several steps to achieve this: 1) obtain the laser cut stent geometry of the 
PTMA stent. The laser cut sent geometry is needed for stent manufacturers/vendors such as NDC, or 
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Memory, to laser cut the stent from a standard 10 mm or 6 mm Nitinol tube. We will first generate 
SolidWork geometry files for various final PTMA stent designs. Afterwards, the FE models of the stents 
will be generated from the SolidWork files using the software HyperMesh (Altair Engineering, MI). 
Computational simulations will be performed to study the stent forming process from the laser cut 
geometry to the fully expanded final shape. The laser cut geometry of the stent will be sent out to either 
NDC or Memory for fabrication. Once physical laser cut stents are obtained from vendors, we will 
prepare the necessary tools for the heat treatment and forming process to expand the laser cut tube to the 
fully expanded shape. 2) Deploy of the PTMA stents into an ovine heart via the coronary sinus (CS) 
vessel and measure deformation at passive state (i.e. vessel diameter and mitral annulus reduction) using 
ultrasound and 3D digital image correlation system. We will set up an ex vivo ovine heart model to 
perform the delivery of the stent into the CS vessel. Mitral valve annulus deformation, mitral valve orifice 
area and stent deformation will be obtained and correlated with the FE simulation results of the whole 
system stent. In vivo implantation of the PTMA stents is also an option. 
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7 Summary and Future Studies* 
In this chapter, I will summarize main findings of the previous Chapters (1 to 7). Major 
contributions from this dissertation will be highlighted. Then, I will discuss the areas for future studies.  
 Summary 7.1
In Chapter 1, a brief review of the heart and heart valves, and normal mitral valve structure and 
function was provided. Main clinical issues and current clinical treatment techniques for mitral valve 
disease were also summarized. Following it, I gave a brief overview of current mitral valve 
biomechanical studies on experimentally characterizing mitral valve tissue properties, constitutive 
modeling of valve elastic tissue, and computational studies of mitral valve function and intervention. 
Finally, I reviewed the recent mitral valve treatment techniques, in particularly the minimally invasive, 
percutaneous, transcatheter mitral valve repair, which leaded to the motivation of my research on the 
modeling of minimally invasive PTMA intervention for mitral valve repair.  
Since coronary sinus (CS) vessel serves as a conduit for the deployment of the PTMA device for 
the treatment of functional mitral regurgitation. Characterization of CS mechanical response is an 
important step toward an understanding of tissue-device interaction in the PTMA intervention. The 
purpose of the study in Chapter 2 is to investigate mechanical properties of the porcine CS vessel using 
pressure-inflation test and constitutively model the wall behavior using a four-fiber family strain energy 
function (SEF).  My results showed that CS vessel exhibited a S-shape pressure-radius response and 
could be dilated up to 88% at a pressure of 80 mmHg. Excellent results from model fitting indicated that 
the four-fiber family SEF could capture the experimental data well and could be used in future numerical 
simulations of tissue-device interaction. In addition, histology study was performed to identify the 
                                                     
* Some of the contents of this chapter are taken from:   
W. Sun, C, Martin and T Pham, "Computational Modeling of Heart Valve Function and Intervention ", Annual Review of Biomedical 
Engineering,  accepted.  
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microstructure of the CS vessel wall. I found a high content of striated myocardial fibers (SMFs) 
surrounded the CS vessel wall, which was also mainly composed of SMFs, while the smooth muscle cells 
are very low in content. The elastin and collagen fibers are highly concentrated in the luminal and outer 
layers and sparsely distributed in the medial layer of the CS wall. These structural and mechanical 
properties of the CS should be taken into consideration for future PTMA device designs. 
There are two limitations in the study of Chapter 2: 1) the experiment was conducted under 
relatively simple pressure inflation loading conditions, and 2) only the porcine CS was examined. Due to 
complex tissue-device interactions, quantification of tissue behaviors under multi-axial loading conditions 
may be needed. Moreover, a study of CS tissue properties from different species (i.e., porcine, ovine and 
human) may be helpful in understanding the outcomes among animal trials and human studies, and 
establishing a proper animal model to evaluate the device efficacy. Thus, in Chapter 3, I studied the 
mechanical properties of the CS wall from porcine, ovine and human models. The human cadaver CS 
tissues were selected from an age group of 86.5 ± 9.7 years old. The CS tissues were subjected to multi-
protocol biaxial tests and characterized by the Fung-type elastic model. Histological analysis was also 
performed to compare the difference in tissue microstructure among porcine, ovine and aged human CS 
tissues.  My results showed that the aged human CS tissues exhibited much stiffer and highly anisotropic 
behaviors compared to the porcine and ovine. Both of the porcine and ovine CS vessel walls were thicker 
and mainly composed of striated muscle fibers (SMF), whereas the thinner aged human CS had higher 
collagen, lesser SMF, and more fragmented elastin fibers, which are possibly due to the aging effects. I 
also observed that the anatomical features of porcine CS vessel might be not suitable for the PTMA 
deployment. These differences between animal and human models raise questions for the validity of using 
animal models to investigate the biomechanics involved in the PTMA intervention. Therefore, caution 
must be taken in future studies of PTMA stents using animal models. 
Since the PTMA technique uses a stent to cinch a segment of the mitral annulus (MA) and 
reduces mitral regurgitation. The cinching mechanism results in septal-lateral annular shrinkage. 
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However, the mechanism has not been characterized completely. In Chapter 4, a method was developed 
to quantify the relation between cinching tension and MA area in an ex vivo ovine model. The cinching 
tension was measured from a suture inserted within the coronary sinus (CS) vessel with one end tied to 
the distal end of the vessel and the other end exited to the CS ostium where it was attached to a force 
transducer on a linear stage. The cinching tension, MA area, septal-lateral (S-L) and commissure-
commissure (C-C) diameters and the leakage were simultaneously measured in normal and dilated 
condition, under a hydrostatic left ventricular pressure of 90 mmHg. From the experimental results, it can 
be seen that the mitral annulus area was increased up to 22.83% after MA dilation. A mean tension of 2.1 
± 0.47 N reduced the MA area by 21.30 ± 5.6% and S-L diameter by 24.18 ± 5.28%. Thus, leakage was 
improved by 51.72 ± 16.19% following by restoration of normal MA geometry. In conclusion: The 
cinching tension generated by the suture acts as a compensation force in MA reduction, implying the 
maximum tension needed to be generated by annuloplasty device to restore normal annular size. The 
relationship between cinching tension and the corresponding MA geometry will contribute to the 
development of future PTMA devices and understanding of myocardial contraction function.   
With the quantification and modeling of CS material properties, in Chapter 5, a finite element 
analysis was performed to investigate the biomechanical interaction between the proximal anchor stent of 
a PTMA device and the coronary sinus (CS) vessel in three steps including i) the stent release and contact 
with the CS wall, ii) the axial pull at the stent connector and iii) the pressure inflation of the vessel wall. 
To investigate the impact of the material properties of the CS tissues and of the stent on the interactive 
responses, the CS vessel was modeled with human and porcine CS material properties, and the proximal 
stent was modeled with two different Nitinol material properties with one being stiffer than the other. The 
simulation results indicated that the vessel wall stresses and contact forces imposed by the stents were 
much higher in human than porcine models. However, the mechanical differences induced by the two 
stent types were relatively small. The softer stent exhibited a better fatigue safety factor when deployed in 
the human model than in the porcine model. These results underscored the importance of the CS tissue 
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mechanical properties. Higher vessel wall stress and stent radial force were obtained in human model than 
those in porcine model, which also brought up questions as to the validity of using porcine model to 
assess device mechanical function. The quantification of these biomechanical interactions can offer 
scientific insight into the development and optimization of PTMA device design.  
In Chapter 6, I added several key components of the delivery catheter systems which are 
essential to the final deployed configuration clinically. Furthermore, the outcome of the procedure 
depends on a proper selection of device that is specific to a patient and his/her anatomical structure. It is 
well known that human anatomy is highly variable and the procedural outcomes of any medical devices 
are essentially related to anatomic considerations. In this chapter, for the first time, we introduced FEA of 
a complete PTMA device being deployed within a selected patient-specific CS model. Three patient-
specific CS models were selected and PTMA stents were first modeled with a simplified bridge section. 
Evaluation of the stent and its interaction with the CS vessel as well as the predicted clinical outcomes 
were analyzed for each phase. To accurately study the functionality of the device and its interaction with 
the CS vessel, the bridge section of the PTMA stent was modeled with a spring-like structure, similar to 
the realistic one, and with a built-in biodegradable material to allow the bridge to remain extended prior to 
its contraction. The entire stent crimping and deployment process was simulated that allowed detailed 
analysis of tissue-stent interaction: high stress concentration in the stent and on vessel wall, oversizing of 
the CS vessel and possible fracture locations of the stent based on peak strain value.  
Major contributions of this dissertation are:  
1. Reported, to our knowledge, the first study of the structural compliance of the porcine coronary 
sinus using pressure-inflation tests 
2. Reported, to our knowledge, the first study of the biaxial mechanical properties of the porcine, 
ovine and aged human coronary sinus using planar biaxial mechanical tests 
3. Reported, to our knowledge, the first study of aged human mitral leaflet mechanical properties.  
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4. Quantified the relation between cinching tension and mitral annulus area in an ex vivo ovine 
model 
5. Simulated the deployment of PTMA proximal stents into the CS using porcine and human models 
and with two different nitinol materials.  
6. Simulated the deployment of a complete PTMA device into a patient-specific CS.      
 Future Studies 7.2
7.2.1 Quantification of in vivo human tissue properties  
Although the use of aged-matched human tissue properties in valve simulations is a substantial 
improvement over animal tissue properties, there are also limitations to using ex vivo tissue properties 
from human cadaveric hearts.  First of all, ex vivo tissue properties are not patient specific.  Rather the 
tissue properties are selected from a cadaveric heart with similar characteristics (age, sex, etc.) to the 
patient of interest.  This requires a thorough testing database of human tissue properties from an array of 
patients with differing ages [210], genders, and degrees of disease because all these factors can 
significantly impact the cardiovascular tissue properties.  Furthermore, tissue property homogeneity is 
generally assumed over a particular region.  Ex vivo testing data generally only represents the average 
response from the center region of a specimen.  In reality, the tissue structure and the associated 
mechanical properties are heterogeneous. The ultimate goal would be to obtain the patient-specific tissue 
properties from non-invasive imaging modalities using either the inverse FE method or new techniques. It 
is possible to measure aortic tissue expansion over the cardiac cycle by utilizing time-elapsed non-
invasive imaging modalities [210].  The difficulty is that the physiological stress/strain range is rather 
narrow.  The challenge remains to be how to quantify the arterial material responses at low (0-80 mmHg) 
and high (>120mmHg) stress levels to obtain the complete material response from the un-stressed and un-
loaded state to the state of tissue dissection, tear and rupture.  Several groups have adopted an inverse FE 
procedure to perform stress analysis from in vivo imaging [211-213]; however, such approaches have not 
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been applied to valve tissues. A future effort could be to develop an inverse FE method which would 
utilize existing databases of human tissue properties to guide the inverse FE solution progress. 
7.2.2 Incorporation of the mitral apparatus and left ventricle model 
As mentioned in Chapter 1, the MV is a complex yet elegantly structured cardiac valve that 
consists of four anatomic components working congruently during a cardiac cycle: an annulus, two 
leaflets, approximately 25 chordae tendineae, two papillary muscles, and the underlying left ventricular 
myocardium.  To complete understand the biomechanics involved in the PTMA treatment of MR, one 
needs to incorporate the complete MV apparatus into the computational model.  
Currently, the tissue model is greatly simplified to only CS vessel without surrounding structure. 
In order to fully analyze the functionality of the PTMA device, it is important to incorporate the 
surrounding structure, which consists of the mitral valve, part of the left atrium, left ventricle and the 
surrounding connective tissues of the CS vessel.  I am in the process of constructing such a computational 
model, as shown in Figure 7-1. However, there are still many fundamental studies that remain to be done, 
including the characterization of material properties of each of those anatomic components.  I have 
completed, to my knowledge, the first study on the characterization of 21 aged human mitral leaflets. The 
results have been published and incorporated into this dissertation in the Appendix B.  
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Figure 7-1:  A FEM model of a whole MV apparatus together with the CS, left atrium and left ventricle.  
7.2.3 Image-based fluid dynamic and fluid structural interaction simulation 
Structural FEA, as conducted in this dissertation, can provide a full and detailed quantitative 
stress and strain analysis of regions of interest, while computational fluid dynamics (CFD) can provide a 
quantitative description of the flow characteristics, which was not performed here.  Fully-coupled fluid-
structure interaction (FSI) methods are also emerging to more comprehensively model valvular 
biomechanics.  However, the accuracy of computational simulations depends heavily on the valve 
geometry, material properties, and the loading and boundary conditions used.  Due to the complexity of 
the mitral valve, most of the early valve models utilized idealized, symmetric geometries of the valve 
structures and adopted linear elastic material properties. Only in the past several years have clinical 
images been utilized to develop patient-specific valve models with improved accuracy.  Most of the 
imaging modalities offer 3D volumetric, time-resolved data that encompass comprehensive structural and 
fluid flow information. Such 3D data, although largely unexploited in clinical settings, offers researchers 
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the possibility to reconstruct the 3D geometry of heart valves and study MV function and intervention at a 
patient-specific level, and pre-operative planning tools can be developed for a specific patient. 
Nonetheless, much more remains to be done in the areas of CFD and FSI studies of mitral valve 
intervention.  
7.2.4 Multi-scale modeling 
A normal heart valve functions at multiple length-scales, including organ, tissue, cell and 
molecular scales [214]. Since the overall behavior of the heart valve is linked to every length scale, 
alteration of one scale would trigger and activate changes in another. Thereby, one cannot fully describe 
the heart valve biomechanics from a single length-scale.  Mechanical stimuli, such as transvalvular 
pressures, impose stretches on the organ-scale that translate to the tissue-scale [215]. It has been shown 
that such dynamic deformation in-vitro can mediate the responses of valvular interstitial cells (VICs), 
which serve to maintain tissue structural integrity via protein synthesis and enzymatic degradation. The 
aortic VIC deformation under a quasi-static physiological pressure was quantified by Huang et al. [216]. 
They found that the nuclear aspect ratios, measured as an index of overall cellular strain, increased 
substantially from 4 to 90 mmHg, with the fibrosa layer exhibiting a greater rate of change compared to 
the ventricular layer.  Owing to the heterogeneity of the leaflet structure, Vesely and Noseworthy [217] 
studied the layer-specific mechanical properties of the porcine AV leaflet, by  separating the fibrosa and 
the ventricularis from fresh and glutaraldehyde-fixed porcine aortic leaflets, they found that although the 
two layers differ structurally, mechanically, they complement each other during AV function, e.g. more 
radial extensibility to facilitate valve closure. Later, Stella and Sacks [218] characterized the material 
properties of the layers using strip biaxial tests. Their mechanical data were later implemented in a series 
of computational studies by Weinberg et al. [219], who developed a computational model to simulate the 
mechanical behaviors of valves across the range of length scales. In their most recent study [220], a multi-
scale simulation in both solid and fluid domains was performed to analyze whether the geometric 
difference or the mechanical deformation difference causes the major differences in function and 
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pathology (e.g. calcification) between normal tricuspid and BAV valves. Interestingly, the model predicts 
that cell-scale deformations were similar in both valves regardless of organ-scale differences, suggesting 
calcification may instead be due to a genetic difference which gives rise to a difference in matrix 
constituents. Limitations of the study that may have affected their results include modeling both tissue- 
and cell-scales using isotropic constitutive relations, the use of homogenized BAV tissue structures, and 
the lack of BAV tissue properties. Although their cell-scale model was greatly simplified, their simulation 
was the first to link across the length scales to create a multi-scale model. Clearly, much more 
computational work remains to be done at cellular and molecular levels, and innovative methods linking 
both the spatial and temporal scales to simulate the development of pathological events remains to be 
developed.  
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 Conclusion 7.3
Minimally invasive percutaneous transvenous mitral annuloplasty (PTMA) devices have been 
shown to be promising in correcting MR in several animal studies, however, device dysfunction and 
fatigue fracture have been reported in the human clinical trials. These adverse events reflect a pressing 
need for a better understanding of the biomechanical interaction between a device and mitral valve 
apparatus. In this work, integrated experimental and computational studies were performed to apply 
engineering analysis of a minimally invasive mitral valve repair to study the biomechanical interaction 
between a PTMA device and surrounding tissues (i.e., CS vessel). A series of experimental methods were 
performed to characterize the biomechanics of the CS vessel, which have not been published in the 
current literature. Constitutive formulations were introduced to accurately model the tissue properties and 
apply to the finite element (FE) simulations.  Realistic patient-specific geometries of the CS vessel were 
obtained from clinical imaging data and reconstructed into three-dimensional (3D) FE model. By 
incorporating patient material properties and 3D patient-specific geometries, FE simulation of the device 
deployment into the vessel could be achieved to investigate the tissue-stent interaction (TSI) and the 
associated biomechanics involved in the system.  The results from experimental and computational data 
showed that the mechanical properties of human CS and valvular tissues were significantly stiffer than 
ones from animal models and also varied largely among the aging population.  These results underscored 
the need for carefully evaluating the biomechanics involved in the PTMA intervention and the importance 
of having an appropriate animal model for evaluating device function for its ultimate use in human. From 
the TSI simulation, detailed analysis include proper sizing of the device, high stress concentration in the 
stent and on the vessel wall during delivery and upon deployment, contact forces between the stent and 
tissues for tissue damage analysis and possible stent fracture based on fatigue analysis. It is hoped that the 
approaches developed in this work will provide a valuable tool that will allow one to virtually assess and 
predict the clinical outcomes of PTMA intervention and to facilitate optimal device design and 
development.   
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8 APPENDIX A: PTMA Element Selection and Mesh 
Sensitivity Analysis 
Element Selection. In this study, we used the C3D8I element that has 8-integration points with a 
5x5 layers of elements cross the stent and CS walls. For most of the stent analyses, due to the bending-
dominated loading nature of the stent, the maximum stresses/strains are usually detected at the stent 
surface. The incompatible mode eight-node brick element (C3D8I) is preferred for stent analysis because 
it provides a good estimation on peak stress and strain and does not suffer from the hourglassing 
phenomenon if the integration points are closer to the surface. Although the quality of the C3D8I element 
is far from the fully integrated brick element, of which the best results are usually obtained with quadratic 
elements, they are relatively low in computation cost. For the current analysis, the computation time takes 
about 14 hours with 50 CPUs running on Intel Xeon X5650 Westmere cores. 
Mesh Sensitivity Analysis. A selection of different mesh sizes was used to perform a mesh 
sensitivity analysis on the interaction of the CS vessel and PTMA proximal stent. Both of the 
CS wall and stent meshes were refined, and the results are shown in Table 9-1. The small 
differences (results from the end of step-1) between the three meshes suggest that mesh density 
has low impact on the simulation results. For the CS model, the mesh 3 achieved the smallest 
high stress compare with meshes 1 and 2. Therefore, the finest mesh 3 was chosen for both CS 
and stent models in this study. Table 9-2 shows all the maximum (MAX) and 99% stress values 
in each TSI step for all four models.   
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Table 8-1: Mesh sensitivity analysis 
 
 
Table 8-2 : Maximu (Max) and 99% peak stress of CS vessel wall 
 
  
Variables (Step‐1) Mesh 1 Mesh 2 Mesh 3
No. of element – CS vessel 25,920 34,561 43,199
von Mises Stress at 99% (Mpa) 0.044 0.035 0.031
von Mises Stress at 1% (Mpa) 1.109 1.097 0.884
No. of element – Stent  68,532 91,375 114,219
Strain (SDV24)  5.39E‐03 5.82E‐03 5.99E‐03
Normal forces (N)  6.514 6.071 5.993
Shear forces (N) 0.551 0.523 0.498
y y
STEP 1 STEP 2 STEP 3
99 %(MPa) MAX (MPa) 99 %(MPa) MAX(MPa) 99 %(MPa) MAX(MPa)
N1‐human  0.031 0.884 0.034 1.345 0.035 1.268
N2‐human   0.031 0.507 0.032 0.951 0.033 1.074
N1‐porcine 0.013 0.056 0.017 0.175 0.024 0.239
N2‐porcine 0.013 0.039 0.017 0.076 0.024 0.118
( ) p
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9 APPENDIX B: Material Characterization of Mitral Valve 
Leaflets* 
A complete study of the material properties of human mitral leaflets is reported in this section. The 
study characterized human mitral valve leaflets using biaxial testing method and fitted with Fung’s elastic 
model. Information obtained in this chapter will be useful for future incorporation of mitral valve into the 
left heart model, to study the patient-specific material properties of mitral valve with more accurate 
prediction of valvular mechanical responses. 
 Introduction 9.1
The prevalence of MV disease has been shown to be strongly associated with age of the patients, 
particularly in mitral regurgitation patients, increasing from 0.5% in patients aged 18 to 44 years to 9.3% 
in patients aged ≥75 years [15, 221]. Clearly, MV disease mainly affects the aged population. It is well 
known that aging has a substantial impact on soft tissue mechanical properties. Studies have shown that 
the stiffness of aortic vessels is much higher in aged patients compared with that of young patients [222-
226]. However, our knowledge on the mechanical properties of mitral valve tissues in aged patients has 
been very limited. Quantification of native tissue properties has many implications in the development of 
medical treatment and prosthetic device, and the understanding of physiological function and disease 
progression. For example, mitral valve repair, benefited from the improved understanding of mitral valve 
biomechanics, has now been acknowledged as desirable and superior to mitral valve replacement in 
virtually all pathologies of mitral disease [227].  
                                                     
* The contents of this chapter were partially published in  
T Pham, W Sun, Material properties of aged human mitral valve leaflets , Journal of Biomedical Material 
Research Part A, 2013, DOI: 10.1002/jbm.a.34939 
. 
     146 
Our current knowledge of mitral valve mechanical properties is mainly derived from that of 
porcine mitral valves [7, 228-235]. The assumption that porcine MV is similar to that of human ones is 
frequently adopted, even though it has not been rigorously validated. Indeed, there are numerous 
computational models of human mitral valve that had utilized porcine MV tissue properties [31, 46, 164-
167, 236]. Moreover, for prosthetic valve device approval, the Food and Drug Administration (FDA) 
mandates pre-clinical animal trials, using either porcine or ovine models, to demonstrate sufficient safety 
including performance and handling, as well as to study the efficacy of new valve devices [237]. While 
many disparate results between human and animal trials have been observed, the current assumption 
taken for heart valve device trials (such as for transcatheter valve intervention [137, 138, 238-241]) - 
porcine and ovine animal models are similar to those of aged humans – is still prevailing. 
In this chapter, the mechanical properties of aged human MV tissues, both mitral anterior (AML) 
and posterior (PML) leaflets, were characterized using the planar biaxial testing method. The MV tissues 
were obtained from individuals above 65 years old with no prior history of valvular disease. The material 
stiffness, extensibility and degree of anisotropy of the leaflet samples were quantified. Histological 
analysis was performed to examine tissue microstructural properties. The presence of abnormal valvular 
structures such as calcific deposits and disrupted fiber structure was assessed. Finally, the material 
properties of aged human mitral leaflets were compared with those of animal mitral leaflets published in 
the literature. 
 Materials and Methods 9.2
9.2.1 Materials and sample preparation  
A total of 21 hearts from 82.62 ± 8.77 years old human cadavers were obtained from the National 
Disease Research Interchange (NDRI, Philadelphia, PA). An approval was obtained from the Institutional 
Review Board at the University of Connecticut for human tissue research in this study. The selection 
criteria for the hearts were no history of valvular disease or any valvular repair or replacement. See Table 
     147 
9-1 for characteristics and medical history of all patients. All hearts were fresh frozen within a post-
mortem recovery of less than 24 hours and kept frozen during delivery. Upon arrival, the hearts were 
defrosted in a hot water bath, and the MV leaflets were dissected out. A total of 20 AML and 18 PML 
specimens were removed from the hearts and used in this study. All chordae tendineae were carefully cut 
off from the leaflets. The MV leaflets that could not be tested immediately were cryopreserved in 10% 
DMSO [110] and stored in the -80˚C freezer until testing. It has been showed that connective tissues can 
preserve their structural architecture [242] and mechanical properties [110, 243, 244] when store in a 
cryoprotectant agent at low temperature (-80°C). The cryopreserved specimens were thawed using a four-
step process [110] to remove cryoprotectant agent prior to testing.  Specimen thickness was measured and 
averaged at three locations in the belly region and two in the free-edge region (Fig. 9-1) using a thickness 
gauge (Mitutoyo, Model 7301). 
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Table 9-1. Patients’ medical history 
 
COPD - Chronic obstructive pulmonary disorder, HTN - Hypertension, HBP – High blood pressure, 
CAD - coronary artery disease, CHF - Congestive heart failure, CPA - chronic pulmonary aspergillosis, 
HA - heart attack. 
*Smoking = quit more than 5 years prior to death.   
Calcification 1 = focal, calcification 2 = densely distribution over the belly region, calcification 3 = 
complete calcification 
  
Specimen Age Gender Smoking Diabetes Heart Weight (g) Cause of death Heart related disease(s) Calcification grade
AML PML
1 69 M Unknown Unknown 733 CPA secondary to HA HTN 1 1
2 88 F n Unknown 342 Alzheimer CAD 2 no data
3 78 M Unknown Unknown 396 CPA secondary to HA HBP, HA 1 0
4 79 F y* Unknown 545 Respiratory failure CHF 2 1
5 81 F n y 330 Unkonwn Stroke 2 1
6 96 F y n 545 CPA None 2 1
7 95 F y* n 330 Respiratory arrest  None 2 1
8 79 F n Unknown 404 CPA HTN  1 1
9 98 F n y 303 Respiratory arrest None 1 1
10 82 M y* y 714 COPD HTN, CHF, CAD 2 1
11 75 M y* n 425 HA None  1 1
12 63 M y* n 369 Unknown HTN 2 0
13 75 F y* n 575 CPA HTN  2 1
14 82 M y* n 510 CPA HTN 2 1
15 83 M y n 412 Vascular Dementia HTN, CHF 2 no data
16 87 F y* n 295 Unknown None 2 no data 
17 80 F y* n 397 Unknown None 1 1
18 82 M y n 544 Aspiration Pneumonia None 3 3
19 95 M y n 425 Natural Causes (Age) None 2 1
20 87 F n n 490 Unknown None  1 1
21 81 F y* n 621 Alzheimer's related None  1 0
Mean  82.00 F:10 -- -- 464.00 -- -- -- --
SD 8.51 M:7 -- -- 130.86 -- -- -- --
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Figure 9-1. a) An image of one excised mitral valve from a cadaver heart. The testing regions are located 
in the dash square boxes and  above and below regions of the dashed curved lines on each leaflet are belly 
and edge, respectively; b) five regions of thickness measurements; and c) mounting position and 
alignment of the leaflet specimen.  
9.2.2 Biaxial mechanical test 
 Details on planar biaxial mechanical testing techniques and methods of analysis can be found in 
Sacks and Sun 2003 [38]. Briefly, all specimens were mounted in a trampoline fashion by continuous 
strands of silk suture looped along each of the four specimen sides, with the circumferential (CIRC) and 
radial (RAD) directions aligned to the loading axes of the biaxial test fixtures. In each specimen side, four 
barbless fish hooks (size 22) were punctured through the tissue thickness and spaced out evenly near the 
leaflet edge (Fig. 9-1-c). All specimens were tested in a phosphate buffered saline solution bath at 37°C. 
The four markers were affixed to the lower-belly region of the tissue above the line demarcating the edge 
and the belly regions (Fig. 9-1-b). This region was chosen due to its relatively homogenous fiber structure 
where collagen fibers are aligned to the circumferential direction. A stress-controlled test protocol was 
utilized [117], wherein the ratio of the normal Lagrangian stress components T11 : T22 was kept constant 
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with T12 = T21 = 0. Preconditioning was performed to minimize tissue hysteresis. Each tissue specimen 
was preconditioned for at least 40 continuous cycles with T11 : T22 = 1 : 1. The seven successive protocols 
were performed using the ratios T11 : T22 = 1 : 0.3, 1 : 0.5, 1 : 0.75, 1 : 1, 0.75 : 1, 0.5 : 1, and 0.3 : 1. The 
unloaded reference markers were obtained after preconditioning cycles and used to analyze all the 
consecutive protocols. 
9.2.3 Biomechanical analysis 
 The mechanical properties of valve leaflets were compared by means of secant modulus at three 
equibiaxial membrane tension levels: 1) at 10 N/m for tissue responses under small load, 2) at 60 N/m to 
produce responses at physiological level [245], and 3) at high load of 120 N/m for high stress state. From 
the equibiaxial protocols, the areal strain, e, was also obtained , e = λθθ* λzz – 1, where λθθ and λzz are 
the CIRC and RAD stretch values at the three equibiaxial membrane tension levels, respectively. In 
addition, the degree of anisotropy (DA) was calculated as the ratio of CIRC strain to RAD strain under 
equibiaxial stretching. With the value of DA approaching 1, the tissue response is considered isotropic, 
while others represent various degrees of anisotropy. The correlations between the mechanical property 
data and clinical variables were also examined.   
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9.2.4 Microstructural analysis 
The microscopic anatomy of representative AML and PML tissues used in mechanical testing 
were examined. Specimens were fixed in 10% formalin for 24 hours prior to histological process and 
analysis. After dehydrated and embedded in paraffin, the specimens were sectioned into 5 μm thick 
sections. Tissues were stained with Verhoeff Van-Gieson (VVG) for elastic fiber (as black), collagen 
fiber (as pink) and muscle cell (as dark brown/gray) visualization. Crimping of collagen fibers were also 
assessed using Picro-sirius red stain. The calcified deposits on the leaflets were identified with von-Kossa 
stain. Histological images were obtained from an Olympus U-TVO.5xC digital camera coupled to an 
Olympus BX40 light microscope.  
9.2.5 Constitutive Modeling 
The valve leaflet materials are assumed to be homogeneous and incompressible, and exhibited 
nonlinear, hyperelastic and anisotropic responses. The Fung-type model was utilized to model the biaxial 
mechanical responses of these valve samples. The in-plane 2nd Piola-Kirchhoff stresses, Sij, were derived 
from a strain energy function (SEF), W,  
 S୧୨ ൌ 	 ப୛ப୉౟ౠ       (9.1) 
where Eij is the Green-Lagrange strain tensor and W is expressed as:  
  W ൌ	 ୡଶ	ሺe୕ െ 1ሻ           (9.2) 
			Q ൌ 	AଵEଵଵଶ ൅	AଶEଶଶଶ ൅ 2AଷEଵଵEଶଶ ൅	AସEଵଶଶ ൅ 	2AହEଵଵEଵଶ ൅ 2A଺EଶଶEଵଶ			    (9.3) 
with c and A1-6 are material parameters. The constitutive model was fit to the seven stress controlled 
protocols for each individual specimen to obtain the material parameters. The goodness of the fit was 
determined by a correlation coefficient, R-square value, based on the nonlinear regression Levenberg-
Marquardt algorithm in SYSTAT 10 (Systat Software Inc., Chicago, IL). 
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9.2.6 Statistical analysis 
 Data were tested for normality prior to statistical tests. Statistical differences between the AML 
and PML variables were determined using the Student’s t-test. A paired-sample t-test was performed to 
compare the directional responses. Non-parametric tests, including the Wilcoxon signed-rank test (for 
paired data) and Mann-Whitney rank sum test, were used for non-normal distributed sample groups. 
Correlations between the parameters and clinical variables were determined using the Pearson’s (for 
normal) and Spearman (for non-parametric data) correlation coefficient (r), and p-values were calculated 
based on the aforementioned statistical tests. A p-value less than 0.05 was considered statistical 
significant, with high significance indicated by p < 0.001. Statistical analyses were performed using 
SigmaPlot (V11.0, Systat Software Inc., San Jose, CA) and SYSTAT 10 (Systat Software Inc., Chicago, 
IL). All measurements were presented as mean ± standard deviation (SD). 
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 Results 9.3
9.3.1 Valve leaflet thickness and degree of calcification 
The general observations of the leaflet samples were: thickening of leaflets, calcification and 
chordae tendineae fusion. As showed in Fig. 9-2, calcified regions on the leaflets were classified into four 
groups: 1) no calcification, defined as CALC 0, 2) focal or spotted dense mass of calcium deposition, 
defined as CALC 1, 2) dense and uniform calcium deposition over a large continuous region, defined as 
CALC 2, and 3) completely calcified and thickened leaflet, defined as CALC 3.  From the 20 AML 
samples, 35% (n = 7) had CALC 1, 60% (n = 12) had CALC 2, and 0.05% (n = 1) had a complete 
calcification or CALC 3. Therefore, all AML samples had some degree of calcification. The CALC 2 or a 
uniform and continuous distribution of calcification in the AML samples were observed mainly at the 
aortomitral curtain or the anterior annular region that is anatomically coupled to the aortic annulus [246], 
and focal calcified spots were observed at the regions of chordal insertions. There was no uniform 
calcification in 18 PML samples, 78% (n = 14) exhibited CAL 1, 0.06% (n = 1) with CAL 2 and 17% (n 
= 3) with no calcification. Similar to the AML samples, the focal calcification in PML samples were 
mostly found at the annular and chordal insertion regions.  
One valve had AML and PML thickness of 4.28 mm and 4.0 mm, respectively, due to severe 
calcification, which was identified as outliers and removed from the subsequent data analysis. The mean 
thickness of AML and PML samples were then 1.74 ± 0.37 (n = 19) and 1.83 ± 0.34 (n = 17) mm, p = 
0.51, respectively. Both the interquartile and overall ranges of both leaflet data sets are similar, see Fig. 9-
3. The mean belly and free-edge thickness values are also examined. It can be seen in Fig. 9-3 that the 
belly (denoted as AB) regions were significantly thinner than the free-edge (denoted as AE) regions of 
AML samples, 1.62 ± 0.34 mm versus 2.00 ± 0.54 mm, p < 0.05. Fusion of the chords and calcification 
most likely contributed to a higher value in thickness in the free-edge regions of all AML samples. No 
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difference between the free-edge (PE) and belly (PB) regions of the PML leaflets, 1.90 ± 0.44 mm versus 
1.70 ± 0.39 mm, p = 0.09. No correlation between age and thickness was observed in both leaflet groups. 
 
Figure 9-2: a) The anterior and b) posterior mitral valve leaflets showing calcification (CALC) degrees: 
(1) - focal or spotted dense mass of calcium deposit, (2) - dense and uniform calcium deposition over 
large continuous regions, and (3) completely calcified and thickened leaflet. 
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Figure 9-3:  Boxplots of the thickness of AML (n = 19) and PML (n = 17) samples (left side) and of 
thicknesses of belly and edge regions of AML and PML samples (right side). The black lines inside the 
boxes represent the median. The red dashes and the numbers represent the mean values. (*) indicates a 
statistical significant difference between two groups. AB – Anterior Belly, AE – Anterior Edge, PB – 
Posterior Belly, PE – Posterior Edge. 
 
9.3.2 Biomechanical responses 
 In general, the stress-strain response curve of leaflet tissues exhibits an anisotropic behavior, with 
the CIRC direction being the stiffer one. This MV leaflet characteristic has been observed and reported in 
studies of porcine [228] and human [43, 247] mitral leaflets. However, in our sample set, several AML (n 
= 6) samples had the RAD direction being stiffer than the CIRC direction, see Fig. 9-4b. This reverse 
directional response could be possibly due to the calcium deposits within the leaflet, which might 
dominate these leaflet responses. In our data analysis, we considered the samples with reverse directional 
response atypical for normal aged mitral leaflet tissues, and thus, they was excluded the subsequent data 
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analysis. The mean equibiaxial membrane tension-strain curves for the AML (n = 13) and PML (n = 14) 
samples in the CIRC and RAD directions after removal of reverse response data at 60 N/m are illustrated 
in Fig. 9-4a. 
The mean secant moduli of mitral leaflet samples were calculated (Fig. 9-5).  
The AML samples were significantly stiffer than the PML samples at the three membrane tension levels 
(10 and 60 N/m, p = 0.002, and 120 N/m, p = 0.006), see Fig. 9-6a. Similarity in the mean areal strains at 
60 and 120 N/m membrane tensions indicated that both AML and PML samples reached to a high 
stiffening region on a stress-strain curve at 60 N/m, where the collagen fibers may have already been 
straightened. Both leaflet groups were anisotropic with mean DA values of 0.46 ± 0.25 and 0.47 ± 0.26 at 
10 N/m, respectively, and the values did not change significantly at higher membrane tension levels, 0.48 
± 0.18 and 0.48 ± 0.27 at 60 N/m and 0.53 ± 0.13 and 0.46 ± 0.20 at 120 N/m, respectively, as shown in 
Fig. 9-6b. 
 
Figure 9-4: a) Mean equibiaxial protocols of the anterior (AML) and posterior (PML) mitral leaflet 
samples in circumferential (CIRC) and radial (RAD) directions prior to data removal, b) the AML (n = 6) 
and c) PML (n = 2, one sample had stiffness lower than 10 N/m) samples with reverse directions. 
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Figure 9-5: Comparing stiffness between the circumferential and radial directions (short bar) and 
between the AML and PML samples (long bar) (*) p < 0.05 and (**) p < 0.001. 
 
Figure 9-6: Comparison of a) the extensibility and b) the degree of anisotropy at 10, 60 and 120 N/m for 
the AML and PML samples, no significant variation in degree of anisotropy was found. (*) indicates 
statistical significant difference with p < 0.05. 
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9.3.3 Correlation with patients’ medical history  
No correlation was observed between the mechanical properties and patients’ characteristic data 
(Table 9-1) of age, smoking, and diabetes. The leaflet samples were further divided into subgroups of 
hypertension (HTN) versus normotensive (NTN), and calcification levels, and compared between the 
groups. Of note, for calcification levels, we compared CALC 1 versus CALC 2 for the AML samples, and 
CALC 0 versus CALC 1 for the PML samples. Table 9-3 listed the stiffness, the areal strain and the DA 
values of each subgroup at 60 N/m membrane tension. An increase in tissue stiffness was observed when 
CALC 1 was increased to CALC 2 and when NTN was increased to HTN. All samples remained 
anisotropic in all disease states. 
9.3.4 Constitutive modeling 
A representative seven-protocol stress-strain curves with the Fung-elastic model fits in each 
direction of a set of leaflet samples are illustrated in Fig. 9-7-a&b. The patient-specific material 
parameters obtained from fitting the multi-protocol experiment data to the seven-parameter Fung-elastic 
model of Eq. 9.2 for both leaflet groups are shown in Table 9-2. The model demonstrated an excellent fit 
with the mean R2 values of about 0.93 for AML and 0.92 for PML.  
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Table 9-2. Material parameters of mitral valve leaflets.  
 
Table 9-3. Differences in stiffness, areal strain and degree of anisotropy (DA) between tissue valve 
leaflets.  
 
NTN – normotensive, HTN – hypertensive, CALC – calcification, SM – Secant Modulus, CIRC – 
circumferential, RAD – radial, DA – Degree of Anisotrophy, AML – Anterior Mitral Leaflet, PML – 
Posterior Mitral Leaflet.   
 
Specs c A1 A2 A3 A4 A5 A6 R2 c A1 A2 A3 A4 A5 A6 R2
1 0.87 328.54 220.00 58.72 270.79 -26.74 15.92 0.98 0.71 145.59 65.70 42.81 104.35 -8.67 -10.32 0.96
3 0.85 354.72 294.61 115.29 13.94 0.59 4.96 0.98 - - - - - - - -
4 1.55 371.86 328.02 37.72 339.71 -33.78 65.17 0.95 5.30 389.56 66.31 92.15 13.65 -1.57 -4.02 0.82
5 0.37 672.03 94.99 80.02 42.72 -7.12 -4.07 0.93 0.33 99.93 85.12 0.03 13.85 4.33 1.81 0.97
6 - - - - - - - - 0.58 30.75 37.56 8.26 -28.74 5.34 -11.22 0.88
7 - - - - - - - - 0.76 227.88 57.53 7.95 13.80 -31.37 17.13 0.88
8 0.26 292.65 250.12 112.10 66.92 7.42 28.11 0.88 0.73 147.93 54.29 -20.76 10.39 -2.65 -3.97 0.98
9 0.61 188.25 74.98 1.68 1.21 0.01 0.71 0.96 0.65 26.67 23.90 8.94 5.47 1.26 1.71 0.89
10 - - - - - - - - 1.21 391.98 34.42 37.73 84.78 48.47 -5.05 0.79
11 - - - - - - - - 0.28 326.87 62.51 50.23 94.13 0.61 2.53 0.95
12 - - - - - - - - 0.46 83.72 19.45 11.85 1.39 -2.59 0.23 0.95
13 2.22 168.85 72.49 42.84 13.90 -8.62 1.89 0.98 0.71 327.54 163.94 35.08 34.74 5.47 7.39 0.95
14 0.98 974.11 221.35 -23.19 449.04 17.23 32.84 0.86 - - - - - - - -
15 1.10 351.79 1017.67 344.84 178.34 75.48 -9.12 0.85 - - - - - - - -
16 0.30 368.61 329.88 12.17 34.12 8.36 -3.04 0.93 - - - - - - - -
17 0.13 56.48 11.50 3.77 8.61 -8.30 -1.57 0.98 0.84 7.80 246.06 24.88 15.57 -1.89 -7.91 0.87
20 3.01 484.73 452.11 251.34 60.38 -41.49 32.19 0.86 0.34 228.46 201.21 0.65 11.11 3.87 -17.88 0.97
21 0.71 460.83 159.80 1.11 183.35 60.34 51.44 0.96 0.22 223.13 57.99 27.18 39.44 -5.10 1.58 0.96
Mean 1.00 390.26 271.35 79.88 127.92 3.34 16.57 0.93 0.94 189.84 84.00 23.36 29.57 1.11 -2.00 0.92
SD 0.83 233.15 256.84 107.55 145.67 33.40 23.49 0.05 1.28 133.21 69.15 27.74 38.59 16.48 8.68 0.06
n SM‐CIRC (MPa) p SM‐RAD (MPa) p Areal strain   p DA  p
AML NTN   6 2.03 ± 1.51 0.30 0.77 ± 0.57 0.10 0.19 ± 0.19 0.07 0.42 ± 0.20 0.24HTN   7 2.48 ± 1.28 1.28 ± 0.64 0.08 ± 0.03 0.54 ± 0.15
CALC 1 7 1.96 ± 1.27
0.45
0.88 ± 0.55
0.35
0.17 ± 0.18
0.45
0.46 ± 0.18
0.65CALC 2  6 2.64 ± 1.46 1.23 ± 0.73 0.09 ± 0.03 0.51 ± 0.19
PML   NTN  8 1.22 ± 0.99 0.57 0.42 ± 0.20 0.30 0.25 ± 0.09 0.29 0.52 ± 0.32 0.63HTN   6 1.39 ± 0.81 0.56 ± 0.29 0.19 ± 0.10 0.44 ± 0.21
CALC 0 2 0.94 ± 0.35
/
0.28 ± 0.09
/
0.29 ± 0.09
/
0.30 ± 0.01
/CALC 1 12 1.35 ± 0.95 0.51 ± 0.24 0.21 ± 0.09 0.52 ± 0.28
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Figure 9-7: Representative experimental data and Fung’s model fit of multiple biaxial in the 
circumferential (CIRC) and radial (RAD) of the AML (top) and PML (bottom) samples. 
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9.3.5 Microstructural analysis  
Figure 4-8 illustrates the Movat stain sections of the belly and free-edge regions of the 
representative AML and PML samples in both CIRC and RAD directions. Both AML and PML samples 
appeared to undergo the pathological changes: accumulation of fibrous components (arrows in Fig. 9-8), 
multiple replicated elastic lamellae in the atrialis layer and disorganized and fragmented elastin fibers 
(Fig. 9-8b). In the belly region, infiltration of the massive amount of proteoglycan (PG) and 
glycosaminoglycan (GAG) (Fig. 9-8a) together with disorientation of the collagen networks, appeared as 
marble-like structure as reported by Stephens et al. [248] in aged porcine mitral valve leaflets, were 
observed in both leaflet groups. In the free-edge region, collagen content was abundant in the fibrosa 
layer and also evident in spongiosa layer of the AML sample while the amount of PG/GAG was merely 
visible in the same region. Fibrin was also evident within the fibrosa layer and highly expressed in the 
belly regions in both AML and PML samples. In addition, the von Kossa stains showed the calcified 
deposits in the belly regions with a high distribution in the fibrosa layer of the AML sample, see Fig. 9-9. 
The calcification content decreased toward the free-edge region and disappeared near the belly and free-
edge junction. For the PML samples, only small calcified spots were observed, which scattered in the 
spongiosa layer along the radial direction of the valve leaflet. 
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Figure 9-8: Representative histological results of the AML and PML samples from one patient. The 
images on the top row show the cross sections through thickness in the circumferential (CIRC) direction, 
the one on the left is at the belly and the right is at the free-edge region. The bottom row displays images 
of sections cut in the radial direction. The pop-up image A on the bottom left shows the proteoglycan 
(PG) and glycosaminoglycan (GAG) infiltration in the belly region, and the pop-up image B on the right 
shows fragmented elastin fibers in the radial direction within the atrialis layer. The pop-up image C shows 
the reduction in undulation of collagen fibers stained with Picrosirius red stain 100x. Red arrows indicate 
the accumulation of fibrous layers in the atrialis layers. Asterisk (*) indicate the presence of fibrin 
(intense red color) in the fibrosa layers. Movat-pentachrome stains: collagen – yellow, elastin – black, 
PG/GAG – blue/greenish, red – muscle fibers, intense red – fibrinoid, fibrin.  All histology slides were 
captured with 10x magnification under the light microscope. Bar = 400 um.  
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Figure 9-9: Representative histological results for calcification (dark brown color indicated by the 
arrows) in the belly and belly/free-edge regions in the radial direction. Dense and thick calcified deposits 
were seen on the AML belly region covered the spongiosa and fibrosa layers and spots on belly/free-edge 
region in the fibrosa. Calcification were scattered throughout the thickness and along the radial direction 
of PML sample. Von Kossa stains. Bar is 400 µm. 
  
     164 
 Discussion 9.4
9.4.1 Tissue properties related to aging 
Heart valve disease mainly affects senior patients. Therefore, a study of normal and diseased 
valve tissue properties in advance aged patients is more relevant than a study of younger age groups, and 
it could enhance our understanding of the heart valve disease progression and the development of clinical 
treatment techniques. In this study, we presented, to our knowledge, the first comprehensive biaxial 
characterization of aged (82.62 ± 8.77 years old) human MV leaflets using a relatively large sample size 
(n = 21).   A comparative study of age-dependent valve property changes was conducted by Stephens et 
al. [248] using a porcine model. They compared the three age groups, i.e., 6 weeks, 6 months and 6 years 
old of porcine mitral and aortic valves and observed an elevated stiffness and a higher collagen fiber 
distribution with increasing age. Another animal study by Stephen et al. [249] showed that changes in 
valve PGs and GAGs with age are complex and distinct within valve type. In human mitral valve leaflets, 
the GAG content and many different PG subclasses were found to be significantly decreased with 
advancing age [250]. Other studies have also shown that age has a significant impact on the composition 
of soft tissues [251, 252], resulting in significant differences in both material and microstructural 
properties of human aortic tissues [253]. Interestingly, our results suggest that the mechanical properties 
of leaflet tissues remain unchanged for persons older than 65 years of age. A broad age range of 30 – 90 
years could possibly reveal significant differences as previously reported by others [253]. 
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9.4.2 Comparison with human MV tissue properties reported in the literature 
An early study of human mitral leaflet mechanics performed in 1970s by Clark [254] showed the 
unidirectional non-linear stress-strain behavior of generalized leaflets, though with unknown leaflet types, 
patient background and medical history. Recently, the uniaxial data of mitral valve tissues from a 88 year-
old patient in the study by Prot et al. [43] showed the CIRC and RAD maximum stretches were 
approximately 4% and 12% for the AML sample and 23% and 69% for the PML sample, respectively.  
Our mean maximum strains were similar to their data for the AML samples, 4% and 10% for CIRC and 
RAD directions, respectively, but our PML samples were much stiffer, with 6% and 17% for CIRC and 
RAD directions, respectively. Barber and coworkers [247] showed that normal posterior mitral valve 
leaflets could stretch up to 15.5 ± 6.2% and 24.1 ± 4.0% strain in the CIRC and RAD directions, 
respectively.  They cut the tissues into strips, stretched until failure (with higher load range 200-400g) and 
reported the maximum tangent modulus as stiffness, which were 6.1 ± 1.6 kN/m (CIRC) and 6.4 ± 0.3 
kN/m (RAD). Because of different testing methods (i.e., uniaxial versus biaxial tests), a direction 
comparison cannot be made across studies. However, in general, the mechanical behaviors of our samples 
seem to be stiffer than others. In our biaxial testing protocols, we performed rigorous pre-conditioning of 
at least 40 cycles and analyzed the experimental data using the post-preconditioning reference state. As 
shown in the studies by Martin and Sun [255] and Carew et al. [256], valve tissues exhibited significant 
residual strains upon unloading, even after 20 cycles of preconditioning. Therefore, in this study, the 
tissue response was evaluated after 40 cycles of preconditioning to obtain reproducible mechanical testing 
data. By applying rigorous preconditioning, the residual strain was removed when analyzed using the 
post-preconditioning state. Thus, the tissue responses obtained in this study were stiffer than ones 
analyzed using a less number of pre-conditioning cycles, as shown in the Figure 8 in Martin and Sun 
[255].  
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9.4.3 Valve microstructure 
 Even though the hearts collected from patients who were not diagnosed with valvular diseases, 
we observed that all AML samples and 88% of the PML samples exhibited a certain degree of 
calcification, some with severe calcification. Several retrospective studies of mitral valve calcification 
found that it is a degenerative process that commonly occurring in elderly [257, 258]. Woodring and West 
[259] found a prevalence of valvular calcification increased with increasing age, 36% of patients over 70 
years and 75% over 80. Hence, the mean age of our samples was 83 which could explain the present of 
calcification in all of our valves. Mechanically, the samples with more calcified deposits had higher 
stiffness and lower areal strain comparing to ones with less calcification. Furthermore, calcification was 
mostly found on the annulus and chordae insertion points. Recently, a computational study of mitral 
leaflet dynamics has shown that the annulus and chordae insertion locations are associated with high 
stress concentration [35]. Thus, the high stress could be one of the factors contributing to tissue 
calcification.  
Our histological data shows that the microstructure of our human MV leaflets was altered with 
evidences of massive calcified deposition, marbling of PG/GAGs, straightened collagen fibers, high 
collagen contents and fragmented elastin fibers. Similar observations were reported by Martin et al. [260] 
who compared porcine and human aortic valve leaflets and also found straighter collagen fibers that 
corresponding to higher stiffness in human tissues compared to porcine ones. The study by Pham and Sun 
[261] also found significantly stiffer mechanical properties of their human coronary sinus vessels, which 
exhibited a high collagen content in the intima layer, compared to those of porcine and ovine models.   
We also examined the difference in mechanical properties of MV tissues between individuals 
with and without hypertension. Hypertension has been shown to alter the structure and function of valve 
leaflets to accommodate an increase in blood pressure and consequently correlates with valvular disease 
such as degenerative and calcification [262-265]. We found that MV leaflets from hypertensive hearts 
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exhibited a higher stiffness and lower extensibility values compared to that of normotensive hearts. Yap et 
al. [266] studied the dynamic deformation of aortic valve during hypertensive loading conditions and 
showed that valves experienced an increased diastolic stretch with high pressure conditions. A long-term 
exposure to an increased tensile strain may lead to structural damages resulting in high stiffness and low 
extensibility. 
9.4.4 Modeling of MV leaflets 
 Although the overall thickness of the AML samples was similar to that of PML samples, AML 
free-edge regions were thicker compared to the belly regions, whereas PML tissues had a relatively 
uniform thickness. Mechanically, both of the AML and PML exhibited a nonlinear and anisotropic 
behavior. However, the AML leaflets were stiffer than the PML leaflets in both circumferential and radial 
directions. Differences between the anterior and posterior leaflets found in this study may indicate that 
AML and PML might need to be modeled with separate sets of material properties in computational 
studies. Finite element modeling (FEM) has been proven useful in predicting the biomechanics of mitral 
valve at pathological [43, 168-170] conditions as well as the mechanical behaviors in the edge-to-edge 
surgical repair [64 , 267, 268] and chordal replacement [53] techniques.  Up to now, the patient-specific 
material properties of heart valve have yet to be assessed in vivo. Thus, our ex vivo human biaxial material 
properties data and the constitutive models will be useful in computational studies of aged human mitral 
valve and provide more accurate prediction of valvular mechanical responses. 
9.4.5 Difference in the mechanical properties between animal and human MV leaflet 
tissues. 
 It is well known that some of bioprosthetic aortic valves are made from chemically-treated 
porcine aortic valve and the pre-clinical animal studies are required by the FDA. In addition, there are 
numerous studies in the literature that use either porcine or ovine valve tissue as a surrogate for human 
one to study MV tissue structure and mechanical properties. For example, planar biaxial mechanical data 
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of porcine mitral valve leaflets by May-Newman and Yin [228] and Kunzelman and Cochran [229] were 
widely used in constitutive material modeling [31, 164] and simulation of human mitral valve dynamics 
at physiological condition [46, 165-167, 236]. However, compared to our data, their tissue responses were 
much compliant. For instance, May-Newman and Yin [228] reported stretches of 17% and 20% for AML 
and 23% and 24% for PML at 20 N/m in the CIRC and RAD directions, respectively. This suggests that 
human MV leaflets were much stiffer than porcine ones and that porcine valve models might not reflect 
the functionality of aged human mitral valves. 
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9.4.6 Limitations  
 Studies in the literature have shown the differences between fresh and preserved tissues [269-
277]. Particularly, Clark [254] showed that freezing at -70 °C without any medium markedly altered the 
mechanical behavior of mitral valve tissues such that an increase in pre-transition modulus and a 
markedly increase in post-transition modulus in frozen samples compared with fresh ones.  Due to the 
limited access to fresh human tissues, the obtained data from frozen tissue samples could be different 
from those of fresh tissues. The additional freezing method using cryoprotectant at a very cold 
temperature at our laboratory, however, has been shown to provide a minimal effect in the mechanical 
properties [110]. The structures of both anterior and posterior valve leaflets were not homogeneous, 
particularly at the free-edge region where the tissue was thicker and exhibited disorganized fiber 
microstructures throughout the layers. An assumption of tissue homogeneity in the central region of the 
leaflet samples might not represent the material properties of the entire leaflet area. Thus, regional 
heterogeneity in mechanical properties of leaflet needs to be further studied. In addition, the degree of 
calcification was classified based on structural observation, thus no quantitative correlation with the 
mechanical data was assessed. A more detailed quantitative study of valvular pathogenesis including 
changes in the ECM components as well as immunohistochemical analysis is needed to further 
characterize and correlate with the mechanical data. Another limitation is our small range of ages. A 
larger sample size including younger human mitral valves would facilitate comparison and correlation 
data with age and further study the mechanics of pathologic valves. For instance, the myxomatous 
degenerative disease of the mitral valve leaflet is a common cause of mitral regurgitation [278, 279]. 
Myxomatous disease occurs more frequently in younger age group [280], and mitral valve repair is a 
common treatment technique [281]. Thus, material property data obtained for a younger patient 
population with myxomatous disease would be more valuable in FE simulations for evaluating diseased 
valvular structure and the efficacy of various surgical procedures. 
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 Summary  9.5
In this chapter, the mechanical properties of the human mitral valve leaflet tissues aged older than 
65 years of age were characterized using a multiple planar biaxial testing method. The overall nonlinear 
anisotropic valve leaflet tissue properties were quantified. We found that for mitral leaflets, the radial 
direction was significantly more compliant than the circumferential direction. The anterior leaflets were 
significantly stiffer and less compliant than the posterior leaflets in both directions. From the histological 
results, the changes in the elastic components including the fragmented and disorganized elastin network, 
high collagen content and the presence of fibrosis and PGs/GAGs infiltration were observed, suggesting 
possible valvular degenerative characteristics in the valve samples. Additionally, calcification was 
observed in most of the leaflet samples. Overall, stiffness increased and areal strain decreased with 
calcification severity. Leaflet tissues from hypertensive hearts also exhibited a higher stiffness and low 
areal strain than normotensive hearts. This study showed that the mechanical properties of aged human 
mitral tissues might not be equivalent to that of animal tissues. The anterior and posterior leaflet 
mechanical data herein could be implemented into finite element models to study the structure and 
function of aged human mitral valve tissues. 
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